https://lp-a.org/2026-08-18daily1.0 https://lp-a.org/library/2026-08-18daily0.9 https://lp-a.org/studies/2026-08-18daily0.6 https://lp-a.org/trials/2026-08-17weekly0.9 https://lp-a.org/agents/2026-08-17weekly0.8 https://lp-a.org/guidelines/2026-08-17weekly0.8 https://lp-a.org/video/2026-08-17weekly0.8 https://lp-a.org/podcasts/2026-08-17monthly0.5 https://lp-a.org/timeline/2026-08-17weekly0.8 https://lp-a.org/topics/2026-08-18weekly0.6 https://lp-a.org/2001/09/04/lp-a-predicts-heart-disease-risk-in-both-sexes-with-much-stronger-overall-risk-prediction-/2026-08-18monthly0.6 https://lp-a.org/2001/08/01/about-half-of-lp-a-apob-comes-from-pre-existing-ldl-not-fresh-liver-secretion-a-kinetic-st/2026-08-18monthly0.6 https://lp-a.org/2001/07/01/lp-a-predicts-intermittent-claudication-more-strongly-in-women-than-men-the-edinburgh-arte/2026-08-18monthly0.6 https://lp-a.org/2001/07/01/falling-triglycerides-shift-lp-a-density-in-step-with-ldl-independent-of-apo-a-size-a-stud/2026-08-18monthly0.6 https://lp-a.org/2001/05/16/lp-a-does-not-predict-peripheral-artery-disease-unlike-crp-and-the-cholesterol-ratio-a-stu/2026-08-18monthly0.6 https://lp-a.org/2001/03/01/lp-a-is-higher-in-heart-attacks-that-strike-in-the-early-morning-linking-it-to-a-circadian/2026-08-18monthly0.6 https://lp-a.org/2001/02/01/lp-a-triples-coronary-risk-in-men-with-low-hdl-cholesterol-the-procam-study-of-788-men-j-a/2026-08-18monthly0.6 https://lp-a.org/2001/01/01/lp-a-above-450-mg-l-predicts-earlier-restenosis-after-angioplasty-especially-combined-with/2026-08-18monthly0.6 https://lp-a.org/2000/12/01/elevated-lp-a-unexpectedly-raises-coronary-risk-in-older-women-just-as-strongly-as-in-youn/2026-08-18monthly0.6 https://lp-a.org/2000/11/01/lp-a-impairs-blood-vessel-dilation-in-healthy-postmenopausal-women-a-dutch-study-of-105-wo/2026-08-18monthly0.6 https://lp-a.org/2000/10/03/a-new-antibody-detects-oxidized-lp-a-specifically-revealing-higher-levels-in-hypertensive-/2026-08-18monthly0.6 https://lp-a.org/2000/10/01/lp-a-ability-to-bind-lysine-varies-because-ldl-and-fibronectin-mask-its-binding-site-not-b/2026-08-18monthly0.6 https://lp-a.org/2000/09/05/lp-a-in-the-top-third-raises-coronary-heart-disease-risk-by-60-a-meta-analysis-of-27-prosp/2026-08-18monthly0.6 https://lp-a.org/2000/08/01/vitamin-c-supplementation-does-not-lower-lp-a-a-randomised-trial-of-101-people-over-8-mont/2026-08-18monthly0.6 https://lp-a.org/2000/06/01/rabbits-lacking-a-functional-ldl-receptor-accumulate-over-4-times-more-lp-a-a-transgenic-a/2026-08-18monthly0.6 https://lp-a.org/2000/06/01/glycated-lp-a-worsens-blood-clot-dissolving-capacity-in-vascular-cells-more-than-native-lp/2026-08-18monthly0.6 https://lp-a.org/2000/06/01/lp-a-does-not-predict-ischemic-stroke-in-young-women-a-case-control-study-of-110-cases-and/2026-08-18monthly0.6 https://lp-a.org/2000/04/12/estrogen-plus-progestin-lowers-lp-a-and-benefits-women-with-high-baseline-lp-a-most-the-he/2026-08-18monthly0.6 https://lp-a.org/2000/04/01/lp-a-combined-with-chlamydia-antibodies-in-immune-complexes-nearly-quadruples-heart-attack/2026-08-18monthly0.6 https://lp-a.org/2000/04/01/lp-a-predicts-prior-heart-attack-in-patients-with-coronary-spasm-a-japanese-study-across-t/2026-08-18monthly0.6 https://lp-a.org/2000/03/01/oral-estrogen-lowers-lp-a-by-23-linked-to-a-doubling-of-igfbp-1-a-trial-of-73-postmenopaus/2026-08-18monthly0.6 https://lp-a.org/2000/02/01/lp-a-doubles-during-normal-pregnancy-but-is-not-further-raised-by-pre-eclampsia-a-scottish/2026-08-18monthly0.6 https://lp-a.org/2000/02/01/lp-a-and-homocysteine-together-raise-coronary-risk-nearly-5-fold-in-women-but-not-men-a-st/2026-08-18monthly0.6 https://lp-a.org/2000/02/01/homozygous-familial-hypercholesterolaemia-nearly-doubles-lp-a-compared-to-heterozygotes-sh/2026-08-18monthly0.6 https://lp-a.org/2000/02/01/nephrotic-syndrome-flares-triple-lp-a-binding-to-fibrin-revealing-a-competitive-tug-of-war/2026-08-18monthly0.6 https://lp-a.org/2000/02/01/lp-a-does-not-correlate-with-coronary-calcium-in-asymptomatic-postmenopausal-women-a-study/2026-08-18monthly0.6 https://lp-a.org/2000/02/01/garlic-supplements-have-no-effect-on-lp-a-a-randomised-trial-of-50-hypercholesterolaemic-p/2026-08-18monthly0.6 https://lp-a.org/2000/01/01/a-newer-lp-a-cholesterol-assay-adds-no-predictive-value-over-standard-lp-a-mass-testing-a-/2026-08-18monthly0.6 https://lp-a.org/1992/07/01/the-apo-a-gene-accounts-for-more-than-90-percent-of-the-variation-in-plasma-lp-a-boerwinkl/2026-08-17monthly0.6 https://lp-a.org/1989/11/17/the-mysteries-of-lipoprotein-a-utermann-science-1989/2026-08-17monthly0.6 https://lp-a.org/1987/11/01/apo-a-is-homologous-to-plasminogen-the-cdna-sequence-mclean-et-al-nature-1987/2026-08-17monthly0.6 https://lp-a.org/2026/08/13/five-late-stage-rna-and-small-molecule-lp-a-therapies-near-approval-from-pelacarsen-to-muv/2026-08-17monthly0.6 https://lp-a.org/2026/08/08/falling-lp-a-in-masld-reflects-liver-damage-not-falling-cardiovascular-risk-curr-cardiol-r/2026-08-17monthly0.6 https://lp-a.org/2026/08/06/alirocumab-slows-cardiac-graft-vasculopathy-only-when-ldl-c-and-lp-a-are-both-raised-cavia/2026-08-17monthly0.6 https://lp-a.org/2026/08/05/lp-a-adds-modest-but-real-predictive-value-for-mace-after-acute-coronary-syndrome-300-pati/2026-08-17monthly0.6 https://lp-a.org/2026/08/04/lp-a-drives-premature-cardiovascular-disease-even-at-goal-ldl-c-review-calls-for-universal/2026-08-17monthly0.6 https://lp-a.org/2026/08/01/masld-blunts-lp-a-yet-masld-with-elevated-lp-a-doubles-cardiovascular-risk-mesa-cohort-met/2026-08-17monthly0.6 https://lp-a.org/2026/08/01/distribution-of-lipoprotein-a-concentrations-in-children-and-young-people-with-familial-hy/2026-08-17monthly0.6 https://lp-a.org/2026/08/01/lipoprotein-apheresis-from-familial-hypercholesterolemia-and-elevated-lipoprotein-a-to-eme/2026-08-17monthly0.6 https://lp-a.org/2026/08/01/il-6-modifies-lp-a-associated-coronary-risk-but-not-aortic-stenosis-risk-uk-biobank-jama-c/2026-08-17monthly0.6 https://lp-a.org/2026/07/30/lp-a-and-homocysteine-each-independently-stiffen-arteries-in-treated-hypertension-366-pati/2026-08-17monthly0.6 https://lp-a.org/2026/07/28/lp-a-above-105-nmol-l-flags-cardiovascular-risk-in-chronic-kidney-disease-but-no-targeted-/2026-08-17monthly0.6 https://lp-a.org/2026/07/28/lp-a-drives-worse-outcomes-after-pci-and-progression-of-aortic-stenosis-before-tavi-review/2026-08-17monthly0.6 https://lp-a.org/2026/07/27/formula-based-lp-a-c-estimates-overstate-cholesterol-content-and-understate-true-ldl-c-dir/2026-08-17monthly0.6 https://lp-a.org/2026/07/25/combining-lp-a-and-severe-calcification-predicts-limb-events-after-endovascular-therapy-fo/2026-08-17monthly0.6 https://lp-a.org/2026/07/25/oxidised-phospholipids-and-autotaxin-link-lp-a-to-aortic-valve-calcification-mechanistic-r/2026-08-17monthly0.6 https://lp-a.org/2026/07/24/lp-a-lowering-therapy-would-be-cost-effective-at-up-to-5-500-a-year-in-secondary-preventio/2026-08-17monthly0.6 https://lp-a.org/2026/07/23/lp-a-predicts-post-stroke-cognitive-impairment-independent-of-inflammation-954-patient-chi/2026-08-17monthly0.6 https://lp-a.org/2026/07/22/lp-a-and-a-43-variant-genetic-risk-score-predict-sudden-cardiac-death-in-older-men-with-hi/2026-08-17monthly0.6 https://lp-a.org/2026/07/20/lp-a-is-not-linked-to-cardiac-allograft-vasculopathy-after-heart-transplant-271-patient-si/2026-08-17monthly0.6 https://lp-a.org/2026/07/20/lp-a-predicts-ascvd-coronary-disease-and-prior-mi-but-not-stroke-23-654-person-polish-real/2026-08-17monthly0.6 https://lp-a.org/2026/07/17/elevated-lp-a-and-insulin-resistance-jointly-double-cardiovascular-mortality-risk-in-masld/2026-08-17monthly0.6 https://lp-a.org/2026/07/16/2026-acc-aha-guideline-recommends-universal-one-time-lp-a-testing-review-for-endocrinologi/2026-08-17monthly0.6 https://lp-a.org/2026/07/16/elevated-lp-a-raises-cardiovascular-event-odds-or-5-3-in-people-living-with-hiv-186-patien/2026-08-17monthly0.6 https://lp-a.org/2026/07/15/lp-a-raises-coronary-event-risk-mainly-by-driving-plaque-burden-scapis-cohort-of-28-529-ja/2026-08-17monthly0.6 https://lp-a.org/2026/07/14/lp-a-is-roughly-twice-as-prevalent-in-coronary-heart-disease-patients-as-in-the-czech-gene/2026-08-17monthly0.6 https://lp-a.org/2026/07/14/lp-a-and-venous-thromboembolism-a-signal-in-premenopausal-women-and-in-postmenopausal-mht-/2026-08-17monthly0.6 https://lp-a.org/2026/07/12/masld-lowers-lp-a-in-men-and-postmenopausal-women-but-not-premenopausal-women-ship-and-uk-/2026-08-17monthly0.6 https://lp-a.org/2026/07/11/lp-a-and-insulin-resistance-jointly-predict-atherosclerotic-plaque-with-a-u-shaped-interac/2026-08-17monthly0.6 https://lp-a.org/2026/07/11/berberine-lowers-lp-a-and-apob-more-in-women-than-men-two-randomised-placebo-controlled-tr/2026-08-17monthly0.6 https://lp-a.org/2026/07/10/lp-a-is-not-clinically-linked-to-atrial-fibrillation-meta-analysis-of-16-observational-and/2026-08-17monthly0.6 https://lp-a.org/2026/07/10/lp-a-is-causally-linked-to-aortic-aneurysm-risk-by-mendelian-randomisation-uk-biobank-coho/2026-08-17monthly0.6 https://lp-a.org/2026/07/10/coronary-imaging-reveals-how-lp-a-drives-plaque-burden-and-high-risk-morphology-review-cur/2026-08-17monthly0.6 https://lp-a.org/2026/07/09/elevated-lp-a-raises-cardiovascular-death-risk-51-after-successful-cto-pci-1509-patient-co/2026-08-17monthly0.6 https://lp-a.org/2026/07/07/lp-a-lowering-therapies-a-promising-future-zhang-navar-tokgozoglu-ehj-2026/2026-08-17monthly0.6 https://lp-a.org/2026/07/07/first-degree-relatives-of-people-with-elevated-lp-a-have-more-mace-swedish-registry-cohort/2026-08-17monthly0.6 https://lp-a.org/2026/07/07/obicetrapib-lowers-lp-a-by-37-percent-15-nmol-l-in-high-risk-patients-pooled-analysis-nich/2026-08-17monthly0.6 https://lp-a.org/2026/07/06/lp-a-of-30-mg-dl-or-more-predicts-ckd-progression-and-cardiovascular-death-nationwide-chin/2026-08-17monthly0.6 https://lp-a.org/2026/07/05/lp-a-tracks-non-calcified-plaque-in-men-but-calcified-plaque-in-women-7201-person-asymptom/2026-08-17monthly0.6 https://lp-a.org/2026/07/04/lp-a-predicts-left-ventricular-dysfunction-in-chronic-total-occlusion-patients-309-patient/2026-08-17monthly0.6 https://lp-a.org/2026/07/04/twenty-clinical-trials-map-the-lp-a-lowering-therapeutic-landscape-across-three-drug-class/2026-08-17monthly0.6 https://lp-a.org/2026/07/03/lp-a-testing-is-available-but-underused-in-argentina-national-survey-of-518-laboratories-a/2026-08-17monthly0.6 https://lp-a.org/2026/07/03/only-apheresis-is-fda-approved-for-lp-a-today-review-of-the-rna-therapeutics-pipeline-movi/2026-08-17monthly0.6 https://lp-a.org/2026/07/02/lp-a-correlates-with-coronary-disease-severity-syntax-score-r-0-36-in-an-indian-angiograph/2026-08-17monthly0.6 https://lp-a.org/2026/07/02/first-trimester-lp-a-predicts-preeclampsia-119-woman-pilot-cohort-arch-gynecol-obstet-2026/2026-08-17monthly0.6 https://lp-a.org/2026/07/02/common-vitamin-and-supplement-use-does-not-shift-lp-a-over-time-uk-biobank-analysis-of-12-/2026-08-17monthly0.6 https://lp-a.org/2026/07/01/preoperative-lp-a-of-30-mg-dl-or-more-doubles-1-year-stroke-risk-after-intracranial-stenti/2026-08-17monthly0.6 https://lp-a.org/2026/07/01/elevated-lp-a-is-linked-to-3-5-times-higher-odds-of-treatment-intensification-530-patient-/2026-08-17monthly0.6 https://lp-a.org/2026/07/01/sglt2-inhibitors-slow-ckd-progression-and-raise-lp-a-normalisation-in-patients-with-elevat/2026-08-17monthly0.6 https://lp-a.org/2026/07/01/mg-dl-to-nmol-l-the-copenhagen-formula-beats-the-factor-2-5-in-the-lp-a-horizon-screening-/2026-08-17monthly0.6 https://lp-a.org/2026/07/01/lp-a-frontiers-apheresis-pelacarsen-replaces-lipoprotein-apheresis-in-25-of-26-patients-pa/2026-08-17monthly0.6 https://lp-a.org/2026/06/30/elevated-lp-a-is-associated-with-concentric-left-ventricular-hypertrophy-in-non-diabetic-h/2026-08-17monthly0.6 https://lp-a.org/2026/06/29/from-phenotype-to-genotype-and-beyond-insights-into-familial-hypercholesterolemia-and-fami/2026-08-17monthly0.6 https://lp-a.org/2026/06/28/lp-a-of-149-nmol-l-or-more-flags-greater-anatomic-coronary-disease-burden-angiography-regi/2026-08-17monthly0.6 https://lp-a.org/2026/06/26/improved-diagnosis-of-familial-hypercholesterolemia-by-correcting-ldl-c-for-lipoprotein-a-/2026-08-17monthly0.6 https://lp-a.org/2026/06/23/lp-a-predicts-coronary-events-but-not-stroke-and-evolocumab-benefits-at-any-lp-a-vesalius-/2026-08-17monthly0.6 https://lp-a.org/2026/06/21/polygenic-risk-scores-and-lp-a-extend-genetic-risk-stratification-beyond-monogenic-hyperch/2026-08-17monthly0.6 https://lp-a.org/2026/06/21/higher-vitamin-d-is-linked-to-lower-lp-a-in-elite-athletes-cross-sectional-study-of-773-nu/2026-08-17monthly0.6 https://lp-a.org/2026/06/21/adding-lp-a-nearly-doubles-lipid-lowering-treatment-eligibility-in-a-24-994-person-primary/2026-08-17monthly0.6 https://lp-a.org/2026/06/19/lp-a-fluctuates-substantially-in-youth-with-type-1-diabetes-challenging-the-single-lifetim/2026-08-17monthly0.6 https://lp-a.org/2026/06/18/markedly-elevated-lp-a-unmasks-vulnerable-plaque-missed-by-a-zero-calcium-score-case-repor/2026-08-17monthly0.6 https://lp-a.org/2026/06/15/obstructive-sleep-apnea-raises-cardiovascular-risk-only-in-acs-patients-with-above-median-/2026-08-17monthly0.6 https://lp-a.org/2026/06/15/combined-ldl-c-lp-a-and-hscrp-identify-highest-ascvd-risk-across-ethnicities-multiethnic-h/2026-08-17monthly0.6 https://lp-a.org/2026/06/13/high-lp-a-causes-concentration-dependent-overestimation-of-standard-ldl-c-assays-1-560-sam/2026-08-17monthly0.6 https://lp-a.org/2026/06/11/1-in-5-children-with-suspected-fh-have-lp-a-105-nmol-l-or-more-japanese-pediatric-screenin/2026-08-17monthly0.6 https://lp-a.org/2026/06/06/lp-a-raises-post-pci-cardiovascular-risk-mainly-when-pericoronary-inflammation-is-high-mac/2026-08-17monthly0.6 https://lp-a.org/2026/06/05/lp-a-shows-only-a-mild-link-to-coagulation-factor-v-angiographic-cohort-of-383-j-clin-lipi/2026-08-17monthly0.6 https://lp-a.org/2026/06/04/lp-a-above-46-8-nmol-l-below-current-guideline-thresholds-still-raises-mace-risk-20-in-sta/2026-08-17monthly0.6 https://lp-a.org/2026/06/04/lp-a-monocyte-associations-differ-by-race-in-single-cell-rna-seq-analysis-34-participant-p/2026-08-17monthly0.6 https://lp-a.org/2026/06/04/lp-a-does-not-predict-long-term-cardiometabolic-risk-in-healthy-women-despite-its-lipid-li/2026-08-17monthly0.6 https://lp-a.org/2026/06/04/olpasiran-tops-a-network-meta-analysis-of-51-trials-17-810-patients-ranking-lp-a-lowering-/2026-08-17monthly0.6 https://lp-a.org/2026/06/03/from-apheresis-to-crispr-review-maps-every-lp-a-lowering-therapy-in-development-curr-ather/2026-08-17monthly0.6 https://lp-a.org/2026/06/03/safety-of-low-lp-a-no-excess-of-bleeding-malignancy-neurocognitive-events-or-af-but-more-d/2026-08-17monthly0.6 https://lp-a.org/2026/06/02/elevated-lp-a-is-not-linked-to-dementia-risk-in-a-151-117-patient-propensity-matched-real-/2026-08-17monthly0.6 https://lp-a.org/2026/06/02/lipoprotein-a-and-premature-myocardial-infarction-mechanistic-insights-and-implications-fo/2026-08-17monthly0.6 https://lp-a.org/2026/06/01/lp-a-and-peripheral-artery-disease-independently-stiffen-arteries-in-hypertension-366-pati/2026-08-17monthly0.6 https://lp-a.org/2026/06/01/homocysteine-and-lp-a-are-elevated-together-in-young-onset-acute-coronary-syndrome-75-pati/2026-08-17monthly0.6 https://lp-a.org/2026/06/01/lp-a-tracks-coronary-complexity-mainly-in-patients-under-45-with-premature-mi-northeast-in/2026-08-17monthly0.6 https://lp-a.org/2026/06/01/impact-of-hypertension-on-associations-of-all-cause-mortality-with-admission-lipoprotein-a/2026-08-17monthly0.6 https://lp-a.org/2026/06/01/cascade-screening-for-lp-a-from-coronary-patients-three-relatives-to-screen-per-case-found/2026-08-17monthly0.6 https://lp-a.org/2026/05/29/lp-a-and-oxidised-phospholipids-track-myocardial-inflammation-after-heart-attack-in-a-pcsk/2026-08-17monthly0.6 https://lp-a.org/2026/05/29/molecular-mechanisms-and-therapeutic-targets-of-rna-based-and-traditional-lipid-lowering-a/2026-08-17monthly0.6 https://lp-a.org/2026/05/28/phenotypic-clustering-splits-high-lp-a-patients-into-distinct-cardiovascular-risk-groups-c/2026-08-17monthly0.6 https://lp-a.org/2026/05/26/lp-a-screening-moves-toward-routine-clinical-practice-review-for-advanced-practice-clinici/2026-08-17monthly0.6 https://lp-a.org/2026/05/26/glp-1-receptor-agonists-and-outcomes-in-obese-or-diabetic-patients-with-lp-a-above-50-mg-d/2026-08-17monthly0.6 https://lp-a.org/2026/05/26/coronary-artery-calcium-still-stratifies-risk-in-people-with-elevated-lp-a-a-four-cohort-s/2026-08-17monthly0.6 https://lp-a.org/2026/05/25/lp-a-of-75-nmol-l-or-more-predicts-worse-neurological-outcome-after-ischemic-stroke-spanis/2026-08-17monthly0.6 https://lp-a.org/2026/05/24/lipoprotein-a-and-residual-cardiovascular-risks-in-japanese-patients-with-coronary-artery-/2026-08-17monthly0.6 https://lp-a.org/2026/05/22/lpa-gene-variants-explain-28-of-lp-a-variability-but-not-coronary-anatomy-in-chronic-coron/2026-08-17monthly0.6 https://lp-a.org/2026/05/22/ckd-enriches-lp-a-with-triacylglycerols-diacylglycerols-and-oxidised-phospholipids-54-pati/2026-08-17monthly0.6 https://lp-a.org/2026/05/22/serum-and-plasma-lp-a-measurements-agree-closely-aric-study-of-100-participants-j-clin-lip/2026-08-17monthly0.6 https://lp-a.org/2026/05/22/elevated-lp-a-raises-pad-prevalence-or-1-81-and-triples-repeat-revascularisation-after-lim/2026-08-17monthly0.6 https://lp-a.org/2026/05/22/comparative-associations-of-ldl-c-lp-a-hscrp-and-il-6-with-cardiovascular-risk-insights-fr/2026-08-17monthly0.6 https://lp-a.org/2026/05/21/higher-lp-a-grade-tracks-with-cad-pad-retinopathy-and-ckd-but-not-stroke-in-japanese-type-/2026-08-17monthly0.6 https://lp-a.org/2026/05/21/lp-a-has-no-prognostic-significance-in-coronary-artery-spasm-without-stenosis-1-373-patien/2026-08-17monthly0.6 https://lp-a.org/2026/05/20/genetic-evidence-suggests-lp-a-lowering-is-unlikely-to-raise-pregnancy-complication-risk-m/2026-08-17monthly0.6 https://lp-a.org/2026/05/19/adding-laa-morphology-and-lp-a-to-a-thrombus-risk-model-beats-cha2ds2-va-in-atrial-fibrill/2026-08-17monthly0.6 https://lp-a.org/2026/05/18/lp-a-does-not-predict-bioprosthetic-aortic-valve-degeneration-unlike-native-valve-disease-/2026-08-17monthly0.6 https://lp-a.org/2026/05/18/lp-a-above-50-mg-dl-raises-first-mi-risk-mainly-in-women-with-type-2-diabetes-cohort-of-2-/2026-08-17monthly0.6 https://lp-a.org/2026/05/15/aspirin-shows-no-clear-cardiovascular-benefit-in-elevated-lp-a-or-high-risk-lpa-genotypes-/2026-08-17monthly0.6 https://lp-a.org/2026/05/14/high-lp-a-raises-coronary-heart-disease-risk-only-alongside-high-hscrp-in-a-4128-person-ch/2026-08-17monthly0.6 https://lp-a.org/2026/05/12/zerlasiran-cuts-lp-a-by-80-or-more-at-36-weeks-in-phase-2-review-of-mechanisms-and-evidenc/2026-08-17monthly0.6 https://lp-a.org/2026/05/11/lp-a-and-inflammation-car-jointly-predict-poor-90-day-outcome-after-stroke-in-elderly-pati/2026-08-17monthly0.6 https://lp-a.org/2026/05/08/zerlasiran-cuts-lp-a-by-up-to-97-8-in-a-japanese-phase-1-trial-of-18-participants-j-athero/2026-08-17monthly0.6 https://lp-a.org/2026/05/08/il-6-receptor-signalling-and-lp-a-independently-lower-cardiovascular-risk-mendelian-random/2026-08-17monthly0.6 https://lp-a.org/2026/05/08/adding-lp-a-to-apob-improves-aortic-stenosis-risk-prediction-especially-in-men-uk-biobank-/2026-08-17monthly0.6 https://lp-a.org/2026/05/07/clinical-risk-factors-cannot-distinguish-fh-from-elevated-lp-a-378-patient-lipid-clinic-st/2026-08-17monthly0.6 https://lp-a.org/2026/05/07/gulf-countries-expert-consensus-endorses-routine-lp-a-testing-in-cardiovascular-risk-asses/2026-08-17monthly0.6 https://lp-a.org/2026/05/05/lp-a-mortality-risk-varies-by-race-and-ethnicity-in-nhanes-iii-22-6-year-mean-follow-up-am/2026-08-17monthly0.6 https://lp-a.org/2026/05/02/first-nmol-l-standardised-lp-a-distribution-in-japanese-patients-proposes-25-and-125-nmol-/2026-08-17monthly0.6 https://lp-a.org/2026/05/01/lp-a-above-31-2-mg-dl-raises-poor-3-month-stroke-outcome-risk-79-cohort-of-175-brain-behav/2026-08-17monthly0.6 https://lp-a.org/2026/05/01/lp-a-above-58-mg-dl-overestimates-ldl-c-by-10-or-more-across-all-major-formulas-study-of-3/2026-08-17monthly0.6 https://lp-a.org/2026/05/01/monocyte-to-hdl-and-lymphocyte-to-monocyte-ratios-track-with-high-lp-a-in-healthy-adults-d/2026-08-17monthly0.6 https://lp-a.org/2026/04/30/lp-a-uniquely-predicts-low-density-noncalcified-plaque-beyond-cac-and-hscrp-ccta-cohort-of/2026-08-17monthly0.6 https://lp-a.org/2026/04/30/lp-a-remnant-cholesterol-and-hscrp-each-independently-add-to-mi-risk-prediction-uk-biobank/2026-08-17monthly0.6 https://lp-a.org/2026/04/30/elevated-lp-a-predicts-higher-6-month-mace-risk-after-myocardial-infarction-bosnian-cohort/2026-08-17monthly0.6 https://lp-a.org/2026/04/30/lp-a-tracks-with-coronary-disease-in-women-but-not-men-in-a-220-patient-hypercholesterolae/2026-08-17monthly0.6 https://lp-a.org/2026/04/29/elevated-lp-a-predicts-high-risk-plaque-features-but-not-calcified-volume-ccta-study-of-3-/2026-08-17monthly0.6 https://lp-a.org/2026/04/29/lp-a-shifts-across-pregnancy-and-menopause-and-demands-sex-specific-attention-review-of-wo/2026-08-17monthly0.6 https://lp-a.org/2026/04/28/elevated-lp-a-raises-restenosis-risk-3-fold-after-pci-meta-analysis-of-twenty-six-studies-/2026-08-17monthly0.6 https://lp-a.org/2026/04/28/2026-acc-aha-multisociety-guideline-on-the-management-of-dyslipidemia-blumenthal-morris-et/2026-08-17monthly0.6 https://lp-a.org/2026/04/27/it-s-time-to-test-all-adults-for-lp-a-commentary-on-the-2026-acc-aha-guideline-j-clin-lipi/2026-08-17monthly0.6 https://lp-a.org/2026/04/27/cholesterol-content-per-lp-a-particle-rises-with-larger-apo-a-isoform-size-direct-assay-st/2026-08-17monthly0.6 https://lp-a.org/2026/04/25/lp-a-concentration-and-fewer-kiv-2-repeats-each-independently-predict-mi-risk-in-china-int/2026-08-17monthly0.6 https://lp-a.org/2026/04/23/il-6-modifies-whether-lp-a-predicts-cardiovascular-events-uk-biobank-cohort-of-34-092-athe/2026-08-17monthly0.6 https://lp-a.org/2026/04/22/high-lp-a-tracks-with-advanced-coronary-calcium-and-carotid-atherosclerosis-in-asymptomati/2026-08-17monthly0.6 https://lp-a.org/2026/04/22/aspirin-shows-no-overall-mace-benefit-in-elevated-lp-a-but-a-signal-in-rs3798220-carriers-/2026-08-17monthly0.6 https://lp-a.org/2026/04/21/prevalence-of-lipoprotein-a-testing-in-patients-with-atherosclerotic-cardiovascular-diseas/2026-08-17monthly0.6 https://lp-a.org/2026/04/20/queensland-lp-a-testing-rose-from-652-to-4-364-tests-a-year-over-a-decade-still-underused-/2026-08-17monthly0.6 https://lp-a.org/2026/04/18/lp-a-at-the-crossroads-review-of-emerging-strategies-to-cut-residual-cardiovascular-risk-c/2026-08-17monthly0.6 https://lp-a.org/2026/04/18/lp-a-above-18-8-mg-dl-independently-predicts-coronary-plaque-vulnerability-on-ivus-292-pat/2026-08-17monthly0.6 https://lp-a.org/2026/04/16/elevated-lp-a-raises-cardiovascular-risk-mainly-when-homocysteine-is-also-high-coronary-di/2026-08-17monthly0.6 https://lp-a.org/2026/04/16/an-lp-a-linked-proteomic-signature-predicts-cardiovascular-disease-beyond-lp-a-alone-in-yo/2026-08-17monthly0.6 https://lp-a.org/2026/04/16/lipoprotein-a-high-sensitivity-c-reactive-protein-and-incident-ascvd-risk-in-individuals-w/2026-08-17monthly0.6 https://lp-a.org/2026/04/12/high-lp-a-drives-premature-progressive-coronary-disease-in-a-young-woman-despite-optimal-l/2026-08-17monthly0.6 https://lp-a.org/2026/04/09/lp-a-is-elevated-across-autoimmune-diseases-with-limited-evidence-that-anti-inflammatory-t/2026-08-17monthly0.6 https://lp-a.org/2026/04/09/sex-differences-in-lipids-and-lipoproteins-and-their-relationship-with-cardiovascular-dise/2026-08-17monthly0.6 https://lp-a.org/2026/04/07/investigational-agents-cut-lp-a-by-80-to-100-pharmacotherapy-review-am-j-health-syst-pharm/2026-08-17monthly0.6 https://lp-a.org/2026/04/03/patients-find-lp-a-testing-acceptable-and-motivating-despite-no-approved-therapy-interaspi/2026-08-17monthly0.6 https://lp-a.org/2026/04/03/hyperacute-phase-lp-a-predicts-intracoronary-thrombus-stable-phase-lp-a-predicts-layered-p/2026-08-17monthly0.6 https://lp-a.org/2026/04/03/olpasiran-leads-a-network-meta-analysis-of-25-trials-7-715-patients-ranking-every-lp-a-low/2026-08-17monthly0.6 https://lp-a.org/2026/04/03/lp-a-drives-coronary-microvascular-dysfunction-via-antifibrinolytic-and-oxidised-phospholi/2026-08-17monthly0.6 https://lp-a.org/2026/04/02/about-1-in-10-finnish-adults-has-elevated-lp-a-nationally-representative-survey-of-5-484-l/2026-08-17monthly0.6 https://lp-a.org/2026/04/02/cutting-saturated-fat-reshapes-the-lp-a-lipidome-in-african-americans-randomised-trial-of-/2026-08-17monthly0.6 https://lp-a.org/2026/04/01/pcsk9-inhibitors-lower-lp-a-by-20-30-with-tafolecimab-strongest-in-east-asians-review-j-ca/2026-08-17monthly0.6 https://lp-a.org/2026/04/01/elevated-lp-a-is-linked-to-mitral-annular-calcification-but-not-regurgitation-propensity-m/2026-08-17monthly0.6 https://lp-a.org/2026/04/01/lp-a-lowers-type-2-diabetes-risk-only-in-severe-prediabetes-uk-biobank-analysis-diabetes-m/2026-08-17monthly0.6 https://lp-a.org/2026/04/01/high-lp-a-raises-ami-risk-most-in-older-women-case-control-study-of-2-946-patients-j-int-m/2026-08-17monthly0.6 https://lp-a.org/2026/04/01/lp-a-tracks-coronary-stenosis-severity-and-gensini-score-chinese-angiography-cohort-of-778/2026-08-17monthly0.6 https://lp-a.org/2026/04/01/lp-a-raises-heart-failure-risk-in-a-nonlinear-plateauing-dose-response-pattern-meta-analys/2026-08-17monthly0.6 https://lp-a.org/2026/04/01/high-lp-a-predicts-worse-outcomes-but-poor-discrimination-after-drug-eluting-stent-pci-met/2026-08-17monthly0.6 https://lp-a.org/2026/04/01/lp-a-targeted-sirnas-and-asos-show-promise-in-phase-2-review-of-residual-cardiovascular-ri/2026-08-17monthly0.6 https://lp-a.org/2026/04/01/no-pcsk9-targeted-agent-beats-another-for-lowering-lp-a-meta-analysis-of-thirty-one-random/2026-08-17monthly0.6 https://lp-a.org/2026/03/31/lp-a-is-higher-in-japanese-coronary-disease-patients-than-controls-comparative-study-of-3-/2026-08-17monthly0.6 https://lp-a.org/2026/03/30/machine-learning-finds-26-253-more-elevated-lp-a-cases-per-test-than-universal-screening-m/2026-08-17monthly0.6 https://lp-a.org/2026/03/27/adding-lp-a-improves-pre-test-probability-calibration-for-obstructive-cad-derivation-cohor/2026-08-17monthly0.6 https://lp-a.org/2026/03/27/mass-spectrometry-method-changes-the-lp-a-proteome-but-a-34-protein-core-is-method-indepen/2026-08-17monthly0.6 https://lp-a.org/2026/03/27/joint-control-of-ldl-c-lp-a-and-crp-erases-the-excess-cardiovascular-risk-of-steatotic-liv/2026-08-17monthly0.6 https://lp-a.org/2026/03/26/women-have-higher-lp-a-than-men-in-acute-coronary-syndrome-portuguese-cohort-of-388-rev-po/2026-08-17monthly0.6 https://lp-a.org/2026/03/26/pcsk9-inhibition-leaves-monocyte-subsets-unchanged-but-lp-a-composition-tracks-inflammator/2026-08-17monthly0.6 https://lp-a.org/2026/03/25/preoperative-lp-a-of-30-mg-dl-or-more-independently-predicts-peri-procedural-stroke-after-/2026-08-17monthly0.6 https://lp-a.org/2026/03/25/menopause-transition-triggers-a-fourfold-larger-lp-a-rise-than-staying-pre-or-postmenopaus/2026-08-17monthly0.6 https://lp-a.org/2026/03/25/lp-a-causally-affects-coronary-disease-and-hba1c-but-not-diabetes-risk-uk-biobank-phenome-/2026-08-17monthly0.6 https://lp-a.org/2026/03/24/taiwan-society-of-lipid-and-atherosclerosis-issues-2026-lp-a-consensus-on-diagnosis-and-ri/2026-08-17monthly0.6 https://lp-a.org/2026/03/24/lp-a-reduction-explains-only-a-small-part-of-il-6-inhibition-s-cardiovascular-benefit-mend/2026-08-17monthly0.6 https://lp-a.org/2026/03/24/elevated-lp-a-adds-253-million-in-indirect-costs-over-5-years-in-a-us-markov-simulation-am/2026-08-17monthly0.6 https://lp-a.org/2026/03/24/cascade-screening-for-elevated-lp-a-in-relatives-of-children-who-visited-the-pediatric-lip/2026-08-17monthly0.6 https://lp-a.org/2026/03/23/olpasiran-achieves-more-than-95-lp-a-reduction-in-ocean-a-dose-review-of-its-pharmacology-/2026-08-17monthly0.6 https://lp-a.org/2026/03/23/lipid-lowering-therapy-reduces-oxidised-apob-immune-complexes-but-not-other-oxidative-mark/2026-08-17monthly0.6 https://lp-a.org/2026/03/18/lp-a-testing-is-linked-to-more-aggressive-lipid-treatment-and-better-ldl-c-goal-attainment/2026-08-17monthly0.6 https://lp-a.org/2026/03/18/lp-a-does-not-correlate-with-blood-pressure-in-essential-hypertension-despite-comorbidity-/2026-08-17monthly0.6 https://lp-a.org/2026/03/18/elevated-lp-a-does-not-predict-organ-damage-or-cardiovascular-events-in-a-low-risk-primary/2026-08-17monthly0.6 https://lp-a.org/2026/03/17/managing-progressive-ascvd-in-patients-with-elevated-lp-a-despite-optimal-ldl-c-control-re/2026-08-17monthly0.6 https://lp-a.org/2026/03/17/high-lp-a-may-worsen-long-term-survival-after-tavi-despite-similar-12-month-macce-prospect/2026-08-17monthly0.6 https://lp-a.org/2026/03/17/elevated-lp-a-raises-repeat-revascularisation-risk-after-pci-meta-analysis-of-eighteen-stu/2026-08-17monthly0.6 https://lp-a.org/2026/03/14/triple-lipid-lowering-therapy-after-acs-cuts-ldl-c-59-but-raises-lp-a-91-indian-cohort-of-/2026-08-17monthly0.6 https://lp-a.org/2026/03/13/lp-a-falls-21-within-weeks-of-kidney-transplant-unrelated-to-autotaxin-activity-polish-coh/2026-08-17monthly0.6 https://lp-a.org/2026/03/13/high-risk-lp-a-accelerates-coronary-plaque-progression-across-ccta-ivus-and-oct-meta-analy/2026-08-17monthly0.6 https://lp-a.org/2026/03/12/lp-a-tracks-with-coronary-plaque-burden-but-not-long-term-mortality-in-established-ascvd-c/2026-08-17monthly0.6 https://lp-a.org/2026/03/12/from-niacin-to-oral-small-molecules-review-maps-every-strategy-for-lowering-lp-a-j-clin-me/2026-08-17monthly0.6 https://lp-a.org/2026/03/11/lp-a-affects-20-of-the-population-review-of-biology-guidelines-and-the-emerging-therapy-pi/2026-08-17monthly0.6 https://lp-a.org/2026/03/09/lp-a-of-50-mg-dl-or-more-raises-recurrent-mace-risk-82-6-in-very-young-acute-coronary-synd/2026-08-17monthly0.6 https://lp-a.org/2026/03/07/high-lp-a-predicts-worse-long-term-outcomes-after-stemi-in-japanese-patients-868-patient-c/2026-08-17monthly0.6 https://lp-a.org/2026/03/06/lp-a-does-not-track-with-carotid-thickness-or-stenosis-despite-its-stroke-risk-link-biosig/2026-08-17monthly0.6 https://lp-a.org/2026/03/06/lp-a-contributes-15-of-circulating-apob-in-asian-healthcare-workers-with-very-high-lp-a-co/2026-08-17monthly0.6 https://lp-a.org/2026/03/04/lepodisiran-advances-to-phase-3-acclaim-lp-a-outcomes-trial-updated-review-cardiol-rev-202/2026-08-17monthly0.6 https://lp-a.org/2026/03/04/lp-a-variability-after-acs-mainly-reclassifies-intermediate-risk-patients-cohort-of-235-j-/2026-08-17monthly0.6 https://lp-a.org/2026/03/01/lp-a-predicts-recurrent-acs-despite-negative-fractional-flow-reserve-testing-chinese-cohor/2026-08-17monthly0.6 https://lp-a.org/2026/03/01/doubling-evolocumab-frequency-cuts-lp-a-34-7-but-leaves-it-markedly-elevated-fh-case-repor/2026-08-17monthly0.6 https://lp-a.org/2026/03/01/children-with-parental-heart-disease-have-lp-a-7-10-mg-dl-higher-meta-analysis-of-fifty-on/2026-08-17monthly0.6 https://lp-a.org/2026/03/01/elevated-lp-a-raises-mace-risk-up-to-4-3-fold-after-pci-systematic-review-of-23-421-patien/2026-08-17monthly0.6 https://lp-a.org/2026/02/27/association-of-elevated-lipoprotein-a-and-diabetes-mellitus-with-survival-outcomes-in-pati/2026-08-17monthly0.6 https://lp-a.org/2026/02/27/lipid-modifying-efficacy-and-safety-of-obicetrapib-in-high-risk-cardiovascular-patients-a-/2026-08-17monthly0.6 https://lp-a.org/2026/02/27/linear-and-nonlinear-associations-between-lipoprotein-a-and-the-risks-of-atherosclerotic-c/2026-08-17monthly0.6 https://lp-a.org/2026/02/26/lp-a-is-unrelated-to-body-composition-unlike-hdl-c-and-triglycerides-high-risk-cohort-of-2/2026-08-17monthly0.6 https://lp-a.org/2026/02/26/association-of-coronary-microvascular-dysfunction-with-lipoprotein-a-levels-in-patients-wi/2026-08-17monthly0.6 https://lp-a.org/2026/02/24/lp-a-drives-residual-cardiovascular-risk-after-acs-with-rna-therapies-pending-outcome-tria/2026-08-17monthly0.6 https://lp-a.org/2026/02/24/the-impact-of-lipid-apheresis-on-changes-of-lipoprotein-a-a-systematic-review-and-meta-ana/2026-08-17monthly0.6 https://lp-a.org/2026/02/24/lipoprotein-a-levels-in-children-with-hypercholesterolemia/2026-08-17monthly0.6 https://lp-a.org/2026/02/23/high-lp-a-and-high-bmi-jointly-maximize-ascvd-risk-danish-and-uk-biobank-cohorts-of-512-68/2026-08-17monthly0.6 https://lp-a.org/2026/02/23/beyond-cacs-can-lp-a-and-ai-ccta-unmask-invisible-residual-cardiovascular-risk/2026-08-17monthly0.6 https://lp-a.org/2026/02/23/analytical-validation-of-direct-lipoprotein-a-cholesterol-assay/2026-08-17monthly0.6 https://lp-a.org/2026/02/22/il-6-inhibition-lowers-lp-a-meta-analysis-of-10-studies-and-1-201-patients-am-j-prev-cardi/2026-08-17monthly0.6 https://lp-a.org/2026/02/22/genetic-prediction-of-circulating-lipoprotein-a-levels-in-diverse-populations/2026-08-17monthly0.6 https://lp-a.org/2026/02/21/regular-aspirin-use-and-lower-incidence-of-aortic-valve-calcium-and-severe-stenosis-in-peo/2026-08-17monthly0.6 https://lp-a.org/2026/02/20/lowering-lp-a-and-il-6-signalling-together-additively-cuts-coronary-disease-risk-mendelian/2026-08-17monthly0.6 https://lp-a.org/2026/02/20/lp-a-drives-adverse-cardiac-remodeling-only-in-hispanic-adults-mesa-cohort-of-2-366-circ-p/2026-08-17monthly0.6 https://lp-a.org/2026/02/20/lp-a-and-triglyceride-rich-particles-are-several-fold-more-atherogenic-than-ldl-per-partic/2026-08-17monthly0.6 https://lp-a.org/2026/02/20/elevated-lp-a-marks-a-high-risk-phenotype-in-advanced-coronary-calcification-ivus-study-of/2026-08-17monthly0.6 https://lp-a.org/2026/02/16/global-lp-a-standardization-nears-reality-with-a-mass-spectrometry-reference-method-review/2026-08-17monthly0.6 https://lp-a.org/2026/02/13/distribution-of-lipoprotein-a-levels-and-clinical-associations-in-a-lebanese-adult-populat/2026-08-17monthly0.6 https://lp-a.org/2026/02/12/elevated-lp-a-tracks-with-peripheral-artery-disease-in-masld-cross-sectional-study-of-468-/2026-08-17monthly0.6 https://lp-a.org/2026/02/11/lp-a-and-insulin-resistance-jointly-raise-cardiovascular-risk-32-uk-biobank-cohort-of-328-/2026-08-17monthly0.6 https://lp-a.org/2026/02/10/new-assay-reveals-lp-a-particles-are-4-fold-richer-in-triglycerides-in-hypertriglyceridemi/2026-08-17monthly0.6 https://lp-a.org/2026/02/10/lp-a-frontiers-expansion-enrols-422-black-and-hispanic-patients-for-a-pelacarsen-trial-ahe/2026-08-17monthly0.6 https://lp-a.org/2026/02/10/lipoprotein-a-in-familial-hypercholesterolemia/2026-08-17monthly0.6 https://lp-a.org/2026/02/09/elevated-lp-a-independently-predicts-stenotic-bioprosthetic-valve-degeneration-cohort-of-1/2026-08-17monthly0.6 https://lp-a.org/2026/02/09/rna-interference-could-become-the-standard-of-care-for-lipid-disorders-review-of-sirna-the/2026-08-17monthly0.6 https://lp-a.org/2026/02/07/lipoprotein-a-and-cardiovascular-disease-from-genetic-risk-factor-to-therapeutic-target/2026-08-17monthly0.6 https://lp-a.org/2026/02/06/sequencing-advances-resolve-lpa-genetic-architecture-across-ancestries-but-the-lp-a-recept/2026-08-17monthly0.6 https://lp-a.org/2026/02/04/lp-a-and-an-ldl-subfraction-synergistically-predict-mace-after-acs-cohort-of-2-061-angiolo/2026-08-17monthly0.6 https://lp-a.org/2026/02/04/time-weighted-lp-a-outpredicts-single-measurement-lp-a-for-calcific-aortic-valve-disease-c/2026-08-17monthly0.6 https://lp-a.org/2026/02/02/diagnostic-and-severity-assessment-of-coronary-artery-disease-using-apob-apoa-i-ratio-insi/2026-08-17monthly0.6 https://lp-a.org/2026/02/01/adding-lp-a-to-the-eas-risk-score-improves-chd-reclassification-in-type-2-diabetes-pilot-s/2026-08-17monthly0.6 https://lp-a.org/2026/02/01/the-lp-a-implementation-gap-screening-stays-below-1-despite-affecting-20-of-the-world-revi/2026-08-17monthly0.6 https://lp-a.org/2026/02/01/thirty-year-cardiovascular-risk-in-healthy-women-by-lp-a-threshold-the-women-s-health-stud/2026-08-17monthly0.6 https://lp-a.org/2026/01/29/genetic-lp-a-raises-large-artery-stroke-risk-23-but-not-small-vessel-stroke-mendelian-rand/2026-08-17monthly0.6 https://lp-a.org/2026/01/28/machine-learning-cuts-number-needed-to-test-by-more-than-50-for-finding-elevated-lp-a-revi/2026-08-17monthly0.6 https://lp-a.org/2026/01/27/lp-a-50-mg-dl-or-more-raises-intracranial-stenosis-odds-4-5-fold-in-ischemic-stroke-cohort/2026-08-17monthly0.6 https://lp-a.org/2026/01/27/quality-improvement-initiative-roughly-doubles-lp-a-ordering-in-an-outpatient-cardiology-c/2026-08-17monthly0.6 https://lp-a.org/2026/01/27/lp-a-varies-little-within-individuals-repeat-testing-rarely-needed-cohort-of-250-j-clin-li/2026-08-17monthly0.6 https://lp-a.org/2026/01/27/lipoprotein-a-concentration-and-achieving-target-values-of-low-density-lipoprotein-cholest/2026-08-17monthly0.6 https://lp-a.org/2026/01/26/lp-a-doubles-peripheral-arterial-disease-risk-in-type-2-diabetes-cohort-of-590-br-j-hosp-m/2026-08-17monthly0.6 https://lp-a.org/2026/01/24/ldl-c-targets-are-met-in-only-a-fifth-of-very-high-lp-a-patients-despite-statins-spanish-l/2026-08-17monthly0.6 https://lp-a.org/2026/01/23/elevated-lp-a-links-to-multivessel-disease-and-high-coronary-calcium-across-two-spanish-pr/2026-08-17monthly0.6 https://lp-a.org/2026/01/23/cumulative-ldl-c-and-lp-a-predict-coronary-disease-in-statin-naive-elderly-turkish-cohort-/2026-08-17monthly0.6 https://lp-a.org/2026/01/22/lp-a-independently-predicts-premature-coronary-disease-5-fold-regardless-of-pcsk9-malaysia/2026-08-17monthly0.6 https://lp-a.org/2026/01/21/muvalaplin-cuts-lp-a-by-up-to-86-in-phase-2-without-injection-site-reactions-review-cardio/2026-08-17monthly0.6 https://lp-a.org/2026/01/21/lp-a-predicts-ascvd-across-glucose-metabolism-status-independent-of-crp-uk-biobank-cohort-/2026-08-17monthly0.6 https://lp-a.org/2026/01/19/very-high-lp-a-predicts-earlier-heart-attack-and-16-fold-higher-recurrent-mi-risk-matched-/2026-08-17monthly0.6 https://lp-a.org/2026/01/19/pcsk9-inhibitors-cut-lp-a-by-up-to-47-umbrella-review-of-twenty-one-meta-analyses-and-231-/2026-08-17monthly0.6 https://lp-a.org/2026/01/14/elevated-lp-a-predicts-mortality-only-in-high-traditional-cardiovascular-risk-nhanes-iii-c/2026-08-17monthly0.6 https://lp-a.org/2026/01/14/canadian-cardiovascular-society-practical-framework-for-lp-a-screening-risk-assessment-and/2026-08-17monthly0.6 https://lp-a.org/2026/01/14/individualised-phenotype-guided-dyslipidaemia-management-for-stroke-prevention-review-cove/2026-08-17monthly0.6 https://lp-a.org/2026/01/13/efficacy-and-safety-of-oral-pcsk9-inhibitor-enlicitide-in-adults-with-heterozygous-familia/2026-08-17monthly0.6 https://lp-a.org/2026/01/06/elevated-lp-a-raises-vldl-particle-number-not-composition-in-normotriglyceridemic-adults-s/2026-08-17monthly0.6 https://lp-a.org/2026/01/06/lp-a-causally-raises-abdominal-aortic-aneurysm-risk-uk-biobank-analysis-of-1-026-cases-jac/2026-08-17monthly0.6 https://lp-a.org/2026/01/06/new-point-of-care-device-shows-strong-correlation-with-lab-lp-a-assays-validation-study-of/2026-08-17monthly0.6 https://lp-a.org/2026/01/01/early-health-technology-assessment-finds-both-olpasiran-and-pelacarsen-highly-cost-effecti/2026-08-17monthly0.6 https://lp-a.org/2026/01/01/uric-acid-and-lp-a-track-with-neurological-damage-severity-in-diabetic-patients-with-penet/2026-08-17monthly0.6 https://lp-a.org/2026/01/01/high-risk-lp-a-above-50-mg-dl-is-nearly-twice-as-common-in-inflammatory-bowel-disease-pati/2026-08-17monthly0.6 https://lp-a.org/2026/01/01/a-53-year-old-woman-with-lp-a-of-492-nmol-l-family-history-and-coronary-disease-needing-st/2026-08-17monthly0.6 https://lp-a.org/2026/01/01/routine-lp-a-testing-changed-management-in-most-uk-lipid-clinic-patients-above-50-mg-dl-ev/2026-08-17monthly0.6 https://lp-a.org/2026/01/01/elevated-lp-a-predicts-higher-baseline-coronary-plaque-burden-and-faster-low-attenuation-p/2026-08-17monthly0.6 https://lp-a.org/2026/01/01/higher-lp-a-predicts-contrast-induced-nephropathy-risk-in-928-diabetic-patients-undergoing/2026-08-17monthly0.6 https://lp-a.org/2026/01/01/lp-a-tracks-with-coronary-inflammation-in-men-with-hiv-and-undetectable-viral-load-and-sta/2026-08-17monthly0.6 https://lp-a.org/2026/01/01/lower-lp-a-tracks-the-onset-and-progression-of-fatty-liver-disease-across-three-cohorts-to/2026-08-17monthly0.6 https://lp-a.org/2026/01/01/adding-enhanced-external-counterpulsation-to-cardiac-exercise-rehabilitation-lowers-lp-a-i/2026-08-17monthly0.6 https://lp-a.org/2026/01/01/low-early-pregnancy-lp-a-independently-predicts-gestational-diabetes-in-a-14-527-woman-coh/2026-08-17monthly0.6 https://lp-a.org/2026/01/01/optimal-lp-a-cutoff-for-cardiovascular-disease-drops-to-70-mg-l-in-diabetic-patients-compa/2026-08-17monthly0.6 https://lp-a.org/2026/01/01/a-kazakhstani-angiographic-cohort-finds-obstructive-coronary-disease-risk-rising-at-lp-a-o/2026-08-17monthly0.6 https://lp-a.org/2026/01/01/serum-lp-a-predicts-progression-free-survival-and-severe-adverse-events-in-227-lung-adenoc/2026-08-17monthly0.6 https://lp-a.org/2026/01/01/a-case-of-lp-a-at-925-nmol-l-with-recurrent-cardiovascular-events-and-a-confirmed-hypercoa/2026-08-17monthly0.6 https://lp-a.org/2026/01/01/tea-s-benefit-after-coronary-heart-disease-is-greatest-when-lp-a-is-low-and-crp-is-high-uk/2026-08-17monthly0.6 https://lp-a.org/2026/01/01/dual-high-lp-a-and-inflammatory-lipid-index-carries-an-8-fold-mace-risk-in-1-910-acs-patie/2026-08-17monthly0.6 https://lp-a.org/2026/01/01/high-lp-a-plus-high-homocysteine-triples-mace-risk-after-premature-myocardial-infarction-i/2026-08-17monthly0.6 https://lp-a.org/2026/01/01/only-two-of-eighteen-gps-routinely-tested-for-lp-a-before-lilac-for-lp-a-training-reshaped/2026-08-17monthly0.6 https://lp-a.org/2026/01/01/hepatic-and-renal-function-markers-modulate-lp-a-variability-in-153-dyslipidaemic-cardiova/2026-08-17monthly0.6 https://lp-a.org/2026/01/01/lp-a-drives-cardiomyocyte-ferroptosis-through-a-ros-p38-p53-slc7a11-pathway-in-vitro-and-m/2026-08-17monthly0.6 https://lp-a.org/2026/01/01/in-347-japanese-acs-patients-discharged-alive-after-primary-pci-lp-a-of-30-mg-dl-or-higher/2026-08-17monthly0.6 https://lp-a.org/2026/01/01/lp-a-is-significantly-higher-in-crohn-s-disease-and-ulcerative-colitis-than-in-healthy-con/2026-08-17monthly0.6 https://lp-a.org/2026/01/01/lp-a-drives-atherosclerosis-through-endothelial-injury-inflammation-and-impaired-fibrinoly/2026-08-17monthly0.6 https://lp-a.org/2026/01/01/olpasiran-ranks-as-the-most-effective-lp-a-lowering-therapy-network-meta-analysis-of-1-432/2026-08-17monthly0.6 https://lp-a.org/2026/01/01/statins-raise-lp-a-while-pcsk9-and-cetp-inhibitors-lower-it-review-of-current-and-emerging/2026-08-17monthly0.6 https://lp-a.org/2026/01/01/lp-a-shows-no-significant-link-to-masld-meta-analysis-of-21-studies-and-418-755-front-nutr/2026-08-17monthly0.6 https://lp-a.org/2026/01/01/fixed-30-lp-a-cholesterol-correction-can-misclassify-risk-review-calls-for-harmonised-mola/2026-08-17monthly0.6 https://lp-a.org/2026/01/01/lp-a-rises-as-kidney-function-declines-adding-unaddressed-cardiovascular-risk-in-ckd-revie/2026-08-17monthly0.6 https://lp-a.org/2026/01/01/clinical-value-of-lipoprotein-a-combined-with-catlet-coronary-score-in-predicting-adverse-/2026-08-17monthly0.6 https://lp-a.org/2026/01/01/association-of-lipoprotein-a-oxidized-phospholipids-and-apolipoprotein-b100-in-acute-ische/2026-08-17monthly0.6 https://lp-a.org/2025/12/30/high-lp-a-more-than-doubles-the-risk-of-death-and-progression-in-364-pancreatic-cancer-pat/2026-08-17monthly0.6 https://lp-a.org/2025/12/30/lp-a-lowering-agents-could-become-the-first-pharmacological-therapy-for-aortic-valve-steno/2026-08-17monthly0.6 https://lp-a.org/2025/12/29/chronic-lipoprotein-apheresis-progresses-aortic-valve-stenosis-at-a-similar-rate-whether-o/2026-08-17monthly0.6 https://lp-a.org/2025/12/29/two-isotope-dilution-mass-spectrometry-reference-materials-for-lp-a-certified-at-212-50-an/2026-08-17monthly0.6 https://lp-a.org/2025/12/29/lp-a-testing-rose-from-3-052-to-8-425-orders-a-year-across-a-us-health-system-cohort-of-45/2026-08-17monthly0.6 https://lp-a.org/2025/12/27/a-minireview-makes-the-case-for-standardised-lp-a-measurement-as-ldl-c-normal-cardiovascul/2026-08-17monthly0.6 https://lp-a.org/2025/12/27/lp-a-did-not-predict-lipid-lowering-therapy-escalation-in-431-patients-despite-growing-cli/2026-08-17monthly0.6 https://lp-a.org/2025/12/24/structural-model-separates-functional-lpa-gene-variants-from-bystanders-shaping-lp-a-and-c/2026-08-17monthly0.6 https://lp-a.org/2025/12/23/elevated-lp-a-improves-20-year-ascvd-risk-reclassification-beyond-hellenicscoreii-two-gree/2026-08-17monthly0.6 https://lp-a.org/2025/12/22/a-practical-roadmap-for-managing-elevated-lp-a-today-from-apheresis-s-60-75-cut-to-rna-age/2026-08-17monthly0.6 https://lp-a.org/2025/12/22/only-36-7-of-surveyed-latin-american-physicians-request-lp-a-testing-citing-unavailability/2026-08-17monthly0.6 https://lp-a.org/2025/12/21/lp-a-predicts-post-pci-cardiac-events-in-coronary-disease-and-diabetes-but-evidence-is-inc/2026-08-17monthly0.6 https://lp-a.org/2025/12/20/81-of-us-clinicians-see-lp-a-as-a-major-risk-driver-but-only-41-back-universal-testing-nat/2026-08-17monthly0.6 https://lp-a.org/2025/12/17/proteomic-screen-of-48-859-uk-biobank-participants-finds-itih3-and-cbln4-as-a-non-heritabl/2026-08-17monthly0.6 https://lp-a.org/2025/12/16/lp-a-above-50-mg-dl-predicts-mace-and-improves-score2-pce-performance-ambulatory-cohort-of/2026-08-17monthly0.6 https://lp-a.org/2025/12/16/oxidised-phospholipids-on-apob-predict-mace-after-acs-and-alirocumab-abolishes-the-relatio/2026-08-17monthly0.6 https://lp-a.org/2025/12/15/star-lp-a-study-finds-meaningful-lp-a-drift-within-1-3-years-in-1-263-patients-challenging/2026-08-17monthly0.6 https://lp-a.org/2025/12/15/lp-a-rises-after-50-in-women-and-60-in-men-polish-reference-study-of-1-046-adults-and-276-/2026-08-17monthly0.6 https://lp-a.org/2025/12/12/cumulative-lp-a-burden-not-just-a-single-measurement-tracks-with-worse-outcomes-in-2-634-h/2026-08-17monthly0.6 https://lp-a.org/2025/12/11/korean-lp-a-task-force-proposes-a-3-tier-classification-30-50-mg-dl-tailored-to-korean-coh/2026-08-17monthly0.6 https://lp-a.org/2025/12/11/combining-lp-a-with-the-suita-score-improves-high-risk-plaque-prediction-in-japanese-patie/2026-08-17monthly0.6 https://lp-a.org/2025/12/09/elevated-lp-a-more-than-doubles-myocardial-infarction-risk-in-16-117-us-hispanic-and-latin/2026-08-17monthly0.6 https://lp-a.org/2025/12/05/lpa-risk-alleles-rs3798220-and-rs10455872-raise-coronary-disease-odds-up-to-75-meta-analys/2026-08-17monthly0.6 https://lp-a.org/2025/12/04/lp-a-may-be-the-mechanistic-bridge-between-inflammation-and-excess-cardiovascular-risk-in-/2026-08-17monthly0.6 https://lp-a.org/2025/12/04/cost-distress-and-clinician-reluctance-are-the-main-barriers-to-lp-a-testing-qualitative-s/2026-08-17monthly0.6 https://lp-a.org/2025/12/04/lp-a-and-pcsk9-are-markedly-elevated-in-first-acs-but-don-t-track-coronary-severity-indian/2026-08-17monthly0.6 https://lp-a.org/2025/12/03/lp-a-may-drive-diabetic-kidney-disease-via-tgf-beta-fibrosis-and-podocyte-injury-review-of/2026-08-17monthly0.6 https://lp-a.org/2025/12/02/rising-lp-a-independently-predicts-coronary-plaque-progression-on-serial-ivus-despite-aggr/2026-08-17monthly0.6 https://lp-a.org/2025/12/02/lp-a-rises-with-chronic-kidney-disease-and-independently-predicts-cardiovascular-risk-in-c/2026-08-17monthly0.6 https://lp-a.org/2025/12/01/pelacarsen-olpasiran-lepodisiran-and-zerlasiran-cut-lp-a-by-80-to-almost-100-with-phase-3-/2026-08-17monthly0.6 https://lp-a.org/2025/12/01/a-pharmacology-review-surveys-the-antisense-sirna-and-small-molecule-agents-advancing-lp-a/2026-08-17monthly0.6 https://lp-a.org/2025/12/01/only-1-in-20-young-ischemic-stroke-patients-had-ever-been-tested-for-lp-a-by-2024-despite-/2026-08-17monthly0.6 https://lp-a.org/2025/12/01/olpasiran-and-apolipoprotein-b-particles-what-sirna-mediated-lp-a-removal-does-to-the-apob/2026-08-17monthly0.6 https://lp-a.org/2025/11/30/ldl-c-in-the-normal-range-cannot-rule-out-very-high-lp-a-danish-cohort-of-1-346-lipids-202/2026-08-17monthly0.6 https://lp-a.org/2025/11/28/over-a-quarter-of-17-594-us-patients-with-premature-ascvd-have-lp-a-of-125-nmol-l-or-above/2026-08-17monthly0.6 https://lp-a.org/2025/11/28/abo-blood-group-a-or-b-sharpens-lp-a-s-link-to-mace-in-chronic-coronary-syndrome-replicate/2026-08-17monthly0.6 https://lp-a.org/2025/11/26/both-very-low-and-very-high-lp-a-raise-stroke-recurrence-risk-in-3-311-diabetic-stroke-pat/2026-08-17monthly0.6 https://lp-a.org/2025/11/26/genetic-evidence-suggests-fatty-liver-damage-lowers-lp-a-not-the-reverse-while-combined-hi/2026-08-17monthly0.6 https://lp-a.org/2025/11/26/updated-meta-analysis-confirms-psoriasis-patients-have-significantly-higher-lp-a-with-the-/2026-08-17monthly0.6 https://lp-a.org/2025/11/26/lp-a-explains-part-of-the-residual-vascular-risk-in-diabetes-driving-both-macro-and-microv/2026-08-17monthly0.6 https://lp-a.org/2025/11/25/lp-a-and-interleukin-6-are-independent-additive-predictors-of-coronary-events-mesa-and-uk-/2026-08-17monthly0.6 https://lp-a.org/2025/11/24/over-30-of-screened-portuguese-children-have-intermediate-or-high-lp-a-real-world-pediatri/2026-08-17monthly0.6 https://lp-a.org/2025/11/22/elevated-lp-a-is-linked-to-fewer-vascular-repair-progenitor-cells-and-more-inflammatory-mo/2026-08-17monthly0.6 https://lp-a.org/2025/11/21/lp-a-and-dementia-in-539-478-people-no-association-with-alzheimer-s-or-vascular-dementia-o/2026-08-17monthly0.6 https://lp-a.org/2025/11/21/lp-a-and-recurrent-ascvd-in-273-770-us-patients-risk-rises-continuously-to-a-hazard-ratio-/2026-08-17monthly0.6 https://lp-a.org/2025/11/20/lp-a-biology-and-the-full-emerging-therapy-pipeline-review-spanning-asos-to-crispr-and-obi/2026-08-17monthly0.6 https://lp-a.org/2025/11/18/pcsk9-inhibitors-lower-lp-a-by-about-17-in-real-world-practice-with-a-bigger-effect-at-hig/2026-08-17monthly0.6 https://lp-a.org/2025/11/17/lp-a-concentrations-vary-more-than-100-fold-by-ancestry-yet-the-relative-ascvd-risk-per-un/2026-08-17monthly0.6 https://lp-a.org/2025/11/17/nearly-one-in-three-argentines-has-elevated-lp-a-and-it-predicts-mace-most-strongly-in-sta/2026-08-17monthly0.6 https://lp-a.org/2025/11/14/elevated-lp-a-predicts-mechanical-prosthetic-heart-valve-thrombosis-with-a-threshold-above/2026-08-17monthly0.6 https://lp-a.org/2025/11/14/elevated-lp-a-brought-more-cardiovascular-events-over-5-years-and-real-psychosocial-distre/2026-08-17monthly0.6 https://lp-a.org/2025/11/13/very-high-lp-a-predicts-worse-coronary-plaque-burden-and-higher-risk-of-heart-attack-revas/2026-08-17monthly0.6 https://lp-a.org/2025/11/13/lp-a-as-a-shared-driver-of-atherosclerosis-aortic-stenosis-and-abdominal-aortic-aneurysm-w/2026-08-17monthly0.6 https://lp-a.org/2025/11/07/2025-focused-update-of-the-2019-esc-eas-dyslipidaemia-guidelines-mach-koskinas-roeters-van/2026-08-17monthly0.6 https://lp-a.org/2025/11/06/coronary-calcium-score-adds-prognostic-value-over-lp-a-in-men-but-not-women-mesa-analysis-/2026-08-17monthly0.6 https://lp-a.org/2025/11/05/a-meta-analysis-of-20-678-atrial-fibrillation-patients-finds-modestly-higher-lp-a-in-those/2026-08-17monthly0.6 https://lp-a.org/2025/11/05/high-lp-a-erases-the-mortality-benefit-of-high-hdl-c-especially-in-men-cohort-of-97-396-co/2026-08-17monthly0.6 https://lp-a.org/2025/11/04/serum-lp-a-predicts-endothelial-dysfunction-in-123-hemodialysis-patients-with-auc-up-to-0-/2026-08-17monthly0.6 https://lp-a.org/2025/11/03/a-cleveland-clinic-journal-of-medicine-primer-distills-what-clinicians-need-to-know-about-/2026-08-17monthly0.6 https://lp-a.org/2025/11/01/elevated-hs-crp-ldl-c-and-lp-a-each-independently-predict-30-year-stroke-risk-in-healthy-w/2026-08-17monthly0.6 https://lp-a.org/2025/11/01/12-of-vietnamese-cardiologists-screened-at-a-national-congress-had-elevated-lp-a-even-amon/2026-08-17monthly0.6 https://lp-a.org/2025/11/01/muvalaplin-cut-lp-a-by-up-to-85-5-on-a-novel-intact-assay-in-the-phase-2-kraken-trial-revi/2026-08-17monthly0.6 https://lp-a.org/2025/11/01/a-10-study-meta-analysis-links-higher-lp-a-to-atrial-fibrillation-itself-but-with-very-low/2026-08-17monthly0.6 https://lp-a.org/2025/11/01/zerlasiran-s-long-half-life-and-infrequent-dosing-make-it-a-promising-sirna-candidate-for-/2026-08-17monthly0.6 https://lp-a.org/2025/11/01/elevated-lp-a-amplifies-peripheral-arterial-disease-risk-and-worsens-outcomes-but-apheresi/2026-08-17monthly0.6 https://lp-a.org/2025/11/01/twelve-years-of-lipoprotein-apheresis-for-lp-a-associated-progressive-ascvd-pro-a-life-kli/2026-08-17monthly0.6 https://lp-a.org/2025/10/31/lp-a-is-procoagulant-not-antifibrinolytic-in-whole-particle-form-mechanistic-clot-study-j-/2026-08-17monthly0.6 https://lp-a.org/2025/10/30/in-patients-75-and-older-with-established-ascvd-inflammation-predicts-mace-more-strongly-t/2026-08-17monthly0.6 https://lp-a.org/2025/10/30/lp-a-of-30-mg-dl-or-above-more-than-quadruples-multivessel-disease-risk-in-young-nstemi-bu/2026-08-17monthly0.6 https://lp-a.org/2025/10/30/genetically-elevated-lp-a-dysregulates-vascular-redox-signalling-via-enos-uncoupling-and-p/2026-08-17monthly0.6 https://lp-a.org/2025/10/29/adding-lp-a-to-score2-reclassified-most-moderate-risk-patients-to-high-risk-and-made-61-el/2026-08-17monthly0.6 https://lp-a.org/2025/10/28/epa-uniquely-blocks-lp-a-s-faster-oxidation-compared-with-other-apob-particles-mechanistic/2026-08-17monthly0.6 https://lp-a.org/2025/10/28/nearly-a-quarter-of-a-dubai-multiethnic-cohort-has-high-risk-lp-a-independent-of-ldl-c-stu/2026-08-17monthly0.6 https://lp-a.org/2025/10/28/smoking-is-inversely-linked-to-lp-a-in-a-korean-cohort-of-146-129-j-lipid-atheroscler-2026/2026-08-17monthly0.6 https://lp-a.org/2025/10/24/a-machine-learning-model-adding-lp-a-predicts-1-year-ascvd-risk-better-than-smoking-or-dia/2026-08-17monthly0.6 https://lp-a.org/2025/10/22/lp-a-of-30-mg-dl-or-above-predicts-mace-in-both-primary-and-secondary-prevention-51-934-su/2026-08-17monthly0.6 https://lp-a.org/2025/10/22/fifteen-years-of-lp-a-guidelines-have-moved-toward-universal-screening-but-important-evide/2026-08-17monthly0.6 https://lp-a.org/2025/10/20/lp-a-targeted-rna-therapies-cut-levels-by-80-100-but-outcome-data-are-still-pending-korean/2026-08-17monthly0.6 https://lp-a.org/2025/10/18/lp-a-tracks-with-subclinical-coronary-disease-in-low-risk-ageing-endurance-athletes-but-do/2026-08-17monthly0.6 https://lp-a.org/2025/10/18/no-correlation-between-apo-a-isoform-size-and-lp-a-concentration-in-43-acute-coronary-synd/2026-08-17monthly0.6 https://lp-a.org/2025/10/16/one-in-five-hospitalised-polish-patients-has-high-lp-a-and-male-sex-predicts-lower-odds-of/2026-08-17monthly0.6 https://lp-a.org/2025/10/15/ldl-c-and-lp-a-push-monocytes-and-macrophages-into-a-self-perpetuating-foam-cell-forming-p/2026-08-17monthly0.6 https://lp-a.org/2025/10/14/pelacarsen-tqj230-achieved-up-to-97-lp-a-reduction-in-phase-1-2-trials-with-phase-3-outcom/2026-08-17monthly0.6 https://lp-a.org/2025/10/14/lp-a-as-a-multisystem-risk-factor-beyond-the-heart-and-what-rna-based-therapies-could-mean/2026-08-17monthly0.6 https://lp-a.org/2025/10/14/ldl-c-lp-a-and-hs-crp-are-independent-and-synergistic-predictors-of-mace-on-and-off-statin/2026-08-17monthly0.6 https://lp-a.org/2025/10/14/one-time-ldl-c-hs-crp-and-lp-a-screening-predicts-20-year-events-in-european-men-and-women/2026-08-17monthly0.6 https://lp-a.org/2025/10/12/high-lp-a-combined-with-elevated-monocyte-to-hdl-c-ratio-predicts-peripheral-artery-diseas/2026-08-17monthly0.6 https://lp-a.org/2025/10/12/the-lp-a-paradox-high-levels-drive-atherosclerosis-but-very-low-levels-may-raise-type-2-di/2026-08-17monthly0.6 https://lp-a.org/2025/10/10/lp-a-above-26-65-nmol-l-predicts-new-onset-aortic-valve-calcification-in-coronary-artery-d/2026-08-17monthly0.6 https://lp-a.org/2025/10/09/when-lp-a-dominates-a-patient-s-atherogenic-particle-burden-multivessel-coronary-disease-b/2026-08-17monthly0.6 https://lp-a.org/2025/10/09/high-lp-a-drives-greater-fibrotic-coronary-plaque-volume-in-men-but-not-women-on-ct-angiog/2026-08-17monthly0.6 https://lp-a.org/2025/10/08/in-severe-aortic-stenosis-lp-a-does-not-track-with-valve-calcium-and-shows-only-a-modest-m/2026-08-17monthly0.6 https://lp-a.org/2025/10/07/a-systematic-review-of-lp-a-in-japanese-cardiovascular-disease-patients-confirms-the-eleva/2026-08-17monthly0.6 https://lp-a.org/2025/10/07/impact-of-obicetrapib-on-major-adverse-cardiovascular-events-in-high-risk-patients-a-poole/2026-08-17monthly0.6 https://lp-a.org/2025/10/05/lp-a-s-link-to-coronary-stenosis-holds-only-under-low-systemic-inflammation-1-513-patient-/2026-08-17monthly0.6 https://lp-a.org/2025/10/03/srebp1-gut-derived-tmao-and-lp-a-all-feed-residual-risk-left-after-ldl-c-control-precision/2026-08-17monthly0.6 https://lp-a.org/2025/10/03/each-50-mg-dl-rise-in-lp-a-raises-premature-ascvd-risk-by-30-in-a-pooled-27-756-person-mul/2026-08-17monthly0.6 https://lp-a.org/2025/10/03/from-kringle-iv-type-2-copy-number-to-arterial-wall-the-mechanistic-biology-of-lp-a-review/2026-08-17monthly0.6 https://lp-a.org/2025/10/03/a-clinical-practice-review-of-lp-a-risk-stratification-and-the-emerging-lowering-agents-eu/2026-08-17monthly0.6 https://lp-a.org/2025/10/02/higher-lp-a-and-lower-apoa1-mark-stroke-patients-whose-ischaemic-penumbra-is-preserved-bey/2026-08-17monthly0.6 https://lp-a.org/2025/10/01/mild-hepatic-impairment-modestly-raises-pelacarsen-exposure-but-does-not-compromise-its-sa/2026-08-17monthly0.6 https://lp-a.org/2025/10/01/higher-lp-a-is-linked-to-worse-five-year-recurrence-free-prognosis-in-296-endometrial-canc/2026-08-17monthly0.6 https://lp-a.org/2025/10/01/higher-lp-a-percentile-predicts-rising-risk-of-atrial-fibrillation-recurrence-after-pulsed/2026-08-17monthly0.6 https://lp-a.org/2025/10/01/mendelian-randomization-confirms-lp-a-causally-raises-risk-of-five-cardiovascular-diseases/2026-08-17monthly0.6 https://lp-a.org/2025/10/01/imaging-confirms-lp-a-drives-high-risk-coronary-plaque-features-from-lipid-rich-cores-to-t/2026-08-17monthly0.6 https://lp-a.org/2025/10/01/lp-a-stays-stable-at-the-extremes-but-a-third-of-mid-range-patients-reclassify-to-higher-r/2026-08-17monthly0.6 https://lp-a.org/2025/09/30/cutting-dietary-saturated-fat-raises-lp-a-levels-and-reshapes-its-lipid-composition-not-ju/2026-08-17monthly0.6 https://lp-a.org/2025/09/26/the-diabetes-drug-pioglitazone-significantly-lowers-lp-a-meta-analysis-of-254-patients-acr/2026-08-17monthly0.6 https://lp-a.org/2025/09/26/does-lp-a-protect-against-or-promote-cancer-experimental-and-clinical-evidence-remain-cont/2026-08-17monthly0.6 https://lp-a.org/2025/09/24/lp-a-and-ldl-c-synergistically-raise-mi-risk-amplified-by-polygenic-risk-score-uk-biobank-/2026-08-17monthly0.6 https://lp-a.org/2025/09/23/lp-a-only-weakly-tracks-with-coronary-calcium-and-mainly-in-men-over-65-star-lp-a-study-of/2026-08-17monthly0.6 https://lp-a.org/2025/09/19/lower-bmi-combined-with-lower-lp-a-tracks-with-the-least-atrial-fibrillation-and-mendelian/2026-08-17monthly0.6 https://lp-a.org/2025/09/18/top-quartile-lp-a-raises-mace-risk-30-and-limb-event-risk-19-in-peripheral-artery-disease-/2026-08-17monthly0.6 https://lp-a.org/2025/09/18/living-with-hiv-is-not-independently-linked-to-elevated-lp-a-copenhagen-study-of-789-peopl/2026-08-17monthly0.6 https://lp-a.org/2025/09/17/lepodisiran-achieved-up-to-97-lp-a-reduction-in-phase-1-with-a-durable-phase-2-effect-and-/2026-08-17monthly0.6 https://lp-a.org/2025/09/17/a-structural-and-clinical-review-of-lp-a-s-bidirectional-risk-and-the-emerging-therapies-t/2026-08-17monthly0.6 https://lp-a.org/2025/09/16/lp-a-drives-coronary-artery-spasm-through-a-cd36-rhoa-il-6-inflammatory-pathway-that-a-nat/2026-08-17monthly0.6 https://lp-a.org/2025/09/15/about-1-in-5-children-with-new-onset-diabetes-has-abnormal-lp-a-and-levels-can-fluctuate-w/2026-08-17monthly0.6 https://lp-a.org/2025/09/10/higher-lp-a-predicts-secondary-events-after-first-time-acs-with-levels-highest-in-indian-a/2026-08-17monthly0.6 https://lp-a.org/2025/09/09/elevated-lp-a-links-to-both-coronary-calcification-and-low-bone-density-in-310-statin-naiv/2026-08-17monthly0.6 https://lp-a.org/2025/09/08/nearly-20-of-tested-kazakhstani-patients-have-elevated-lp-a-but-the-marker-discriminates-a/2026-08-17monthly0.6 https://lp-a.org/2025/09/08/combining-lp-a-with-ct-quantified-pericoronary-fat-inflammation-sharpens-mace-prediction-i/2026-08-17monthly0.6 https://lp-a.org/2025/09/04/what-the-suboptimal-rollout-of-ldl-c-therapy-should-teach-the-field-before-lp-a-lowering-d/2026-08-17monthly0.6 https://lp-a.org/2025/09/03/a-61-year-old-with-lp-a-of-233-nmol-l-survives-a-ruptured-7-3-cm-root-and-ascending-aortic/2026-08-17monthly0.6 https://lp-a.org/2025/09/01/statins-and-ezetimibe-raise-oxidized-phospholipids-on-lp-a-even-as-pcsk9-inhibitors-leave-/2026-08-17monthly0.6 https://lp-a.org/2025/09/01/a-systematic-review-of-20-896-acs-pci-patients-across-five-countries-confirms-lp-a-as-a-co/2026-08-17monthly0.6 https://lp-a.org/2025/09/01/elevated-lp-a-s-apparent-link-to-worse-1-year-outcomes-in-peripheral-artery-disease-disapp/2026-08-17monthly0.6 https://lp-a.org/2025/09/01/what-existing-lipid-lowering-drugs-do-to-lp-a-meta-analysis-of-147-rcts-xie-et-al-atherosc/2026-08-17monthly0.6 https://lp-a.org/2025/09/01/design-and-rationale-of-lp-a-horizon-the-first-lp-a-outcomes-trial-pelacarsen-in-8-323-pat/2026-08-17monthly0.6 https://lp-a.org/2025/08/29/only-half-of-physicians-with-access-to-lp-a-testing-use-it-routinely-and-a-third-can-t-def/2026-08-17monthly0.6 https://lp-a.org/2025/08/28/a-large-multi-cohort-study-fails-to-replicate-the-earlier-signal-that-aspirin-cuts-cardiov/2026-08-17monthly0.6 https://lp-a.org/2025/08/26/lepodisiran-sustained-over-90-lp-a-reduction-and-durable-effects-through-a-year-of-biannua/2026-08-17monthly0.6 https://lp-a.org/2025/08/26/a-lifespan-review-traces-lp-a-s-clinical-relevance-from-early-vascular-dysfunction-markers/2026-08-17monthly0.6 https://lp-a.org/2025/08/25/certain-ssris-boost-lp-a-uptake-into-cells-via-serotonin-and-a-plasminogen-receptor-raisin/2026-08-17monthly0.6 https://lp-a.org/2025/08/22/lp-a-above-50-mg-dl-nearly-doubles-calcific-aortic-valve-disease-risk-and-lab-work-shows-i/2026-08-17monthly0.6 https://lp-a.org/2025/08/22/only-1-4-of-ascvd-free-and-4-9-of-ascvd-patients-were-ever-tested-for-lp-a-over-18-years-b/2026-08-17monthly0.6 https://lp-a.org/2025/08/22/lp-a-has-reached-a-tipping-point-where-universal-one-time-screening-is-justified-today-bha/2026-08-17monthly0.6 https://lp-a.org/2025/08/22/lp-a-s-link-to-venous-thromboembolism-stays-unsettled-even-as-new-agents-cut-lp-a-by-up-to/2026-08-17monthly0.6 https://lp-a.org/2025/08/21/a-single-olpasiran-dose-cut-lp-a-by-up-to-99-2-in-chinese-participants-phase-1-trial-finds/2026-08-17monthly0.6 https://lp-a.org/2025/08/19/low-dose-aspirin-cuts-heart-attack-risk-38-and-kidney-failure-risk-28-in-ckd-patients-with/2026-08-17monthly0.6 https://lp-a.org/2025/08/19/lp-a-testing-for-primary-prevention-is-cost-saving-across-every-high-income-country-modell/2026-08-17monthly0.6 https://lp-a.org/2025/08/18/higher-lp-a-independently-predicts-cognitive-impairment-after-ischaemic-stroke-790-patient/2026-08-17monthly0.6 https://lp-a.org/2025/08/09/recurrent-in-stent-restenosis-with-markedly-elevated-lp-a-and-no-other-risk-factors-leads-/2026-08-17monthly0.6 https://lp-a.org/2025/08/09/nearly-30-of-irish-lipid-clinic-patients-have-lp-a-above-125-nmol-l-largest-irish-distribu/2026-08-17monthly0.6 https://lp-a.org/2025/08/07/olpasiran-s-infrequent-dosing-could-make-it-a-cost-effective-route-to-profound-lp-a-reduct/2026-08-17monthly0.6 https://lp-a.org/2025/08/07/lp-a-is-as-potent-a-driver-of-peripheral-artery-disease-as-of-coronary-disease-but-its-mec/2026-08-17monthly0.6 https://lp-a.org/2025/08/06/elevated-lp-a-independently-predicts-incident-atrial-fibrillation-regardless-of-inflammato/2026-08-17monthly0.6 https://lp-a.org/2025/08/05/systemic-sclerosis-patients-have-higher-lp-a-and-triglycerides-but-lower-hdl-c-than-health/2026-08-17monthly0.6 https://lp-a.org/2025/08/05/higher-lp-a-predicts-carotid-plaque-ulceration-on-angiography-in-patients-considered-for-c/2026-08-17monthly0.6 https://lp-a.org/2025/08/01/lp-a-falls-as-liver-fibrosis-worsens-in-fatty-liver-disease-but-cardiovascular-risk-stays-/2026-08-17monthly0.6 https://lp-a.org/2025/08/01/lp-a-above-50-mg-dl-independently-flags-complex-coronary-disease-with-75-specificity-in-a-/2026-08-17monthly0.6 https://lp-a.org/2025/08/01/beyond-oxidised-phospholipids-diacylglycerols-a-novel-endothelial-receptor-and-accelerated/2026-08-17monthly0.6 https://lp-a.org/2025/08/01/prevent-equations-perform-well-but-lp-a-adds-independent-risk-most-in-borderline-and-low-r/2026-08-17monthly0.6 https://lp-a.org/2025/07/30/a-new-genomic-method-predicting-lp-a-from-exome-data-flags-high-risk-individuals-better-th/2026-08-17monthly0.6 https://lp-a.org/2025/07/28/combined-hormone-therapy-lowers-lp-a-by-5-1-mg-dl-in-postmenopausal-women-meta-analysis-of/2026-08-17monthly0.6 https://lp-a.org/2025/07/28/lp-a-predicts-not-just-new-peripheral-artery-disease-and-carotid-stenosis-but-their-progre/2026-08-17monthly0.6 https://lp-a.org/2025/07/24/pirillo-and-catapano-review-how-lp-a-targeted-rna-therapies-and-the-oral-inhibitor-muvalap/2026-08-17monthly0.6 https://lp-a.org/2025/07/23/pcsk9-gain-of-function-gene-variants-show-no-measurable-effect-on-lipids-or-arterial-wall-/2026-08-17monthly0.6 https://lp-a.org/2025/07/23/pcsk9-inhibitors-curb-endothelial-inflammation-triggered-by-lp-a-itself-not-just-ldl-in-co/2026-08-17monthly0.6 https://lp-a.org/2025/07/23/1-in-5-patients-show-high-lp-a-variability-between-tests-with-the-biggest-risk-category-ch/2026-08-17monthly0.6 https://lp-a.org/2025/07/23/german-men-have-more-than-double-the-lp-a-of-german-women-and-1-in-5-adults-from-a-pre-sta/2026-08-17monthly0.6 https://lp-a.org/2025/07/21/patients-with-prior-ascvd-and-lp-a-above-90-mg-dl-rack-up-2-5-times-higher-healthcare-cost/2026-08-17monthly0.6 https://lp-a.org/2025/07/21/lp-a-testing-is-already-actionable-in-primary-prevention-parcha-and-bittner-argue-proposin/2026-08-17monthly0.6 https://lp-a.org/2025/07/21/peripheral-artery-disease-patients-carry-high-residual-risk-from-lp-a-and-rna-targeted-the/2026-08-17monthly0.6 https://lp-a.org/2025/07/19/kronenberg-group-finds-lp-a-is-truly-stable-once-technical-variability-is-removed-suggesti/2026-08-17monthly0.6 https://lp-a.org/2025/07/18/the-lpa-rs10455872-genotype-does-not-predict-childhood-obesity-itself-but-tracks-with-insu/2026-08-17monthly0.6 https://lp-a.org/2025/07/18/the-lpa-121-g-a-variant-protects-against-venous-thromboembolism-but-lp-a-protein-level-its/2026-08-17monthly0.6 https://lp-a.org/2025/07/17/elevated-lp-a-impairs-coronary-flow-reserve-a-marker-of-subclinical-vasomotor-dysfunction-/2026-08-17monthly0.6 https://lp-a.org/2025/07/14/lp-a-stays-stable-at-the-extremes-but-women-statin-users-and-those-with-ascvd-or-high-ldl-/2026-08-17monthly0.6 https://lp-a.org/2025/07/14/an-optimal-life-s-simple-7-score-cuts-ascvd-risk-regardless-of-lp-a-level-mesa-cohort-of-6/2026-08-17monthly0.6 https://lp-a.org/2025/07/14/elevated-lp-a-independently-raises-new-onset-atrial-fibrillation-risk-by-11-75-376-patient/2026-08-17monthly0.6 https://lp-a.org/2025/07/14/lp-a-s-link-to-mace-is-significantly-stronger-in-atherosclerotic-patients-with-type-2-diab/2026-08-17monthly0.6 https://lp-a.org/2025/07/14/elevated-lp-a-does-not-predict-new-or-progressing-coronary-calcium-large-41-929-person-kor/2026-08-17monthly0.6 https://lp-a.org/2025/07/14/colchicine-s-cardiovascular-benefit-in-the-lodoco2-trial-was-greatest-in-patients-with-ele/2026-08-17monthly0.6 https://lp-a.org/2025/07/14/one-in-four-south-asians-has-lp-a-above-50-mg-dl-helping-explain-heart-attacks-nearly-a-de/2026-08-17monthly0.6 https://lp-a.org/2025/07/12/despite-esc-guidance-lp-a-was-measured-in-only-a-third-of-stemi-and-15-of-nstemi-patients-/2026-08-17monthly0.6 https://lp-a.org/2025/07/10/adding-lp-a-boosts-prediction-of-mace-and-limb-loss-after-lower-limb-revascularisation-in-/2026-08-17monthly0.6 https://lp-a.org/2025/07/08/elevated-lp-a-causes-more-diffuse-coronary-flow-limitation-pioneer-iv-substudy-of-150-matc/2026-08-17monthly0.6 https://lp-a.org/2025/07/07/elevated-lp-a-independently-predicts-ventricular-arrhythmias-even-after-adjusting-for-ascv/2026-08-17monthly0.6 https://lp-a.org/2025/07/01/higher-lp-a-predicts-obstructive-coronary-disease-only-in-asymptomatic-people-with-diabete/2026-08-17monthly0.6 https://lp-a.org/2025/07/01/combining-the-diagonal-earlobe-crease-with-lp-a-gives-a-0-729-auc-for-diagnosing-coronary-/2026-08-17monthly0.6 https://lp-a.org/2025/07/01/lp-a-is-not-linked-to-diastolic-dysfunction-with-preserved-ejection-fraction-but-statin-th/2026-08-17monthly0.6 https://lp-a.org/2025/07/01/serum-lp-a-rises-with-disease-severity-and-correlates-with-bile-acid-levels-in-intrahepati/2026-08-17monthly0.6 https://lp-a.org/2025/07/01/a-critical-review-examines-how-middle-eastern-genetic-diversity-and-high-consanguinity-rat/2026-08-17monthly0.6 https://lp-a.org/2025/07/01/the-brussels-international-declaration-on-lp-a-testing-and-management-kronenberg-et-al-ath/2026-08-17monthly0.6 https://lp-a.org/2025/06/29/lp-a-above-125-nmol-l-predicts-ischaemic-stroke-in-men-but-not-women-and-equally-across-ag/2026-08-17monthly0.6 https://lp-a.org/2025/06/26/elevated-lp-a-combined-with-a-high-monocyte-count-carries-the-greatest-risk-of-carotid-pla/2026-08-17monthly0.6 https://lp-a.org/2025/06/25/one-in-five-people-worldwide-has-elevated-lp-a-yet-testing-rates-remain-poor-review-of-eme/2026-08-17monthly0.6 https://lp-a.org/2025/06/24/elevated-lp-a-is-significantly-higher-in-diabetic-retinopathy-and-higher-still-in-its-prol/2026-08-17monthly0.6 https://lp-a.org/2025/06/24/high-lp-a-raises-death-mi-and-stroke-risk-by-33-50-after-pci-meta-analysis-of-40-241-patie/2026-08-17monthly0.6 https://lp-a.org/2025/06/23/phenotypic-clustering-splits-high-lp-a-patients-into-four-ascvd-risk-subgroups-red-carpet-/2026-08-17monthly0.6 https://lp-a.org/2025/06/21/global-lp-a-testing-rose-from-0-009-to-just-0-032-of-adults-between-2015-and-2023-trinetx-/2026-08-17monthly0.6 https://lp-a.org/2025/06/16/elevated-lp-a-tracks-with-vulnerable-intracranial-plaque-features-on-high-resolution-mri-a/2026-08-17monthly0.6 https://lp-a.org/2025/06/13/lp-a-meets-most-established-criteria-for-a-population-screening-test-on-health-societal-an/2026-08-17monthly0.6 https://lp-a.org/2025/06/13/lipoprotein-apheresis-remains-the-only-approved-lp-a-specific-option-for-peripheral-artery/2026-08-17monthly0.6 https://lp-a.org/2025/06/12/high-lp-a-raises-coronary-heart-disease-risk-just-as-much-in-people-with-zero-or-one-tradi/2026-08-17monthly0.6 https://lp-a.org/2025/06/11/first-trimester-lp-a-elevation-raises-preeclampsia-risk-more-than-fourfold-150-woman-prosp/2026-08-17monthly0.6 https://lp-a.org/2025/06/03/adding-lp-a-to-standard-risk-models-improves-coronary-disease-reclassification-by-up-to-42/2026-08-17monthly0.6 https://lp-a.org/2025/06/03/lp-a-tracks-focal-vulnerable-plaques-ldl-c-tracks-pancoronary-plaque-burden-prospect-ii-er/2026-08-17monthly0.6 https://lp-a.org/2025/06/03/elevated-lp-a-in-2-9-million-chinese-adults-and-its-association-with-multisite-subclinical/2026-08-17monthly0.6 https://lp-a.org/2025/06/03/only-13-percent-of-coronary-patients-worldwide-would-meet-a-150-nmol-l-trial-threshold-int/2026-08-17monthly0.6 https://lp-a.org/2025/06/01/elevated-lp-a-does-not-predict-earlier-alzheimer-s-onset-in-adults-with-down-syndrome-hint/2026-08-17monthly0.6 https://lp-a.org/2025/06/01/a-44-year-old-woman-with-low-calculated-ascvd-risk-but-severe-calcified-coronary-disease-i/2026-08-17monthly0.6 https://lp-a.org/2025/06/01/high-lp-a-predicts-carotid-atherosclerosis-but-not-all-cause-mortality-over-nearly-three-d/2026-08-17monthly0.6 https://lp-a.org/2025/05/30/just-0-8-of-a-diverse-266-612-person-us-cohort-had-ever-been-tested-for-lp-a-with-black-pa/2026-08-17monthly0.6 https://lp-a.org/2025/05/28/why-how-and-in-whom-to-measure-lp-a-a-review-makes-the-case-for-prioritising-african-and-s/2026-08-17monthly0.6 https://lp-a.org/2025/05/27/lp-a-of-50-mg-dl-or-above-predicts-mace-but-not-cardiovascular-death-after-rotational-athe/2026-08-17monthly0.6 https://lp-a.org/2025/05/26/only-0-5-of-150-083-mexican-tertiary-care-patients-were-tested-for-lp-a-and-just-26-of-tho/2026-08-17monthly0.6 https://lp-a.org/2025/05/26/elevated-lp-a-predicts-heart-failure-in-white-but-not-black-participants-pooled-16-771-per/2026-08-17monthly0.6 https://lp-a.org/2025/05/24/a-panvascular-disease-framework-unifies-lp-a-s-role-across-coronary-cerebral-peripheral-an/2026-08-17monthly0.6 https://lp-a.org/2025/05/23/sirna-agents-for-lp-a-mark-a-path-toward-precision-cardiovascular-medicine-review-by-kanba/2026-08-17monthly0.6 https://lp-a.org/2025/05/22/lp-a-s-coronary-risk-is-amplified-in-patients-with-high-cholesterol-or-triglycerides-but-n/2026-08-17monthly0.6 https://lp-a.org/2025/05/22/lp-a-does-not-predict-limb-events-after-clti-revascularisation-but-predicts-all-cause-deat/2026-08-17monthly0.6 https://lp-a.org/2025/05/21/lp-a-tracks-with-pad-incidence-and-limb-threatening-ischaemia-severity-but-whether-lowerin/2026-08-17monthly0.6 https://lp-a.org/2025/05/19/from-galnac-conjugated-injectables-to-the-oral-inhibitor-muvalaplin-review-surveys-the-lp-/2026-08-17monthly0.6 https://lp-a.org/2025/05/19/cutting-saturated-fat-raises-lp-a-even-as-it-lowers-ldl-c-a-diet-effect-long-assumed-not-t/2026-08-17monthly0.6 https://lp-a.org/2025/05/19/lp-a-of-30-mg-dl-or-above-predicts-faster-growth-of-untreated-non-culprit-plaques-after-ac/2026-08-17monthly0.6 https://lp-a.org/2025/05/16/lp-a-raises-cardiovascular-risk-in-diabetes-yet-paradoxically-low-lp-a-predicts-developing/2026-08-17monthly0.6 https://lp-a.org/2025/05/13/autoimmune-disease-and-elevated-lp-a-combine-additively-to-nearly-double-mace-risk-353-035/2026-08-17monthly0.6 https://lp-a.org/2025/05/11/a-patient-his-endocrinologist-and-a-patient-association-describe-living-with-diagnosing-an/2026-08-17monthly0.6 https://lp-a.org/2025/05/08/a-systematic-review-of-20-rcts-confirms-sirna-therapies-significantly-lower-lp-a-with-most/2026-08-17monthly0.6 https://lp-a.org/2025/05/08/children-with-prader-willi-syndrome-have-markedly-higher-lp-a-and-hs-crp-than-controls-wit/2026-08-17monthly0.6 https://lp-a.org/2025/05/07/a-practical-review-positions-lp-a-as-predictive-of-aortic-stenosis-onset-progression-and-e/2026-08-17monthly0.6 https://lp-a.org/2025/05/06/elevated-lp-a-nearly-triples-the-odds-of-significant-white-matter-damage-in-young-stroke-p/2026-08-17monthly0.6 https://lp-a.org/2025/05/05/lp-a-activates-monocytes-via-tlr2-and-nf-kb-to-drive-tissue-factor-expression-the-first-me/2026-08-17monthly0.6 https://lp-a.org/2025/05/02/lp-a-above-15-mg-dl-raises-1-year-mace-risk-68-after-stroke-or-tia-specifically-in-atherot/2026-08-17monthly0.6 https://lp-a.org/2025/05/01/over-a-quarter-of-suspected-fh-patients-at-a-lipid-clinic-have-high-risk-lp-a-which-tracks/2026-08-17monthly0.6 https://lp-a.org/2025/05/01/a-30-minute-lp-a-teaching-session-nearly-tripled-residents-lp-a-test-ordering-and-raised-c/2026-08-17monthly0.6 https://lp-a.org/2025/05/01/higher-lp-a-predicts-worse-long-term-outcomes-after-heart-attack-especially-in-women-and-p/2026-08-17monthly0.6 https://lp-a.org/2025/05/01/east-asians-have-lower-lp-a-on-average-but-even-modest-elevations-still-raise-ascvd-risk-c/2026-08-17monthly0.6 https://lp-a.org/2025/05/01/elevated-lp-a-raises-stroke-recurrence-odds-by-69-and-poor-functional-outcome-odds-by-over/2026-08-17monthly0.6 https://lp-a.org/2025/05/01/olpasiran-lowers-oxidised-phospholipids-on-apob-by-about-90-percent-without-moving-hs-crp-/2026-08-17monthly0.6 https://lp-a.org/2025/05/01/alpaca-lepodisiran-400-mg-lowers-lp-a-by-94-percent-from-day-60-to-180-and-by-95-percent-o/2026-08-17monthly0.6 https://lp-a.org/2025/04/30/one-in-four-russians-has-lp-a-above-30-mg-dl-and-levels-run-higher-in-women-73-763-patient/2026-08-17monthly0.6 https://lp-a.org/2025/04/29/lp-a-s-causal-effect-on-mi-and-large-artery-stroke-matches-across-east-asian-and-european-/2026-08-17monthly0.6 https://lp-a.org/2025/04/26/one-in-four-clinicians-never-checks-lp-a-narrative-review-finds-blaming-cost-isoform-varia/2026-08-17monthly0.6 https://lp-a.org/2025/04/26/il-6-not-hscrp-unmasks-lp-a-and-oxidised-phospholipid-associated-cardiovascular-risk-in-th/2026-08-17monthly0.6 https://lp-a.org/2025/04/25/lp-a-is-firmly-linked-to-large-artery-atherosclerotic-stroke-but-its-role-in-other-stroke-/2026-08-17monthly0.6 https://lp-a.org/2025/04/25/pcsk9-inhibitors-cut-post-pci-coronary-slow-flow-and-cardiovascular-events-in-stemi-patien/2026-08-17monthly0.6 https://lp-a.org/2025/04/19/a-clinical-review-by-thanassoulis-s-group-consolidates-lp-a-biology-phenotypes-and-the-lat/2026-08-17monthly0.6 https://lp-a.org/2025/04/17/highly-bioavailable-curcumin-formulations-significantly-reduce-lp-a-meta-analysis-of-rando/2026-08-17monthly0.6 https://lp-a.org/2025/04/16/top-percentile-lp-a-more-than-doubles-cardiovascular-event-risk-in-both-sexes-without-prio/2026-08-17monthly0.6 https://lp-a.org/2025/04/11/elevated-lp-a-plus-high-hs-crp-together-confer-the-highest-ascvd-risk-pooled-15-933-person/2026-08-17monthly0.6 https://lp-a.org/2025/04/08/evolocumab-stabilises-coronary-plaque-more-effectively-in-acs-patients-with-high-lp-a-than/2026-08-17monthly0.6 https://lp-a.org/2025/04/08/aspirin-cuts-coronary-and-ascvd-mortality-risk-by-about-50-in-people-with-lp-a-above-50-mg/2026-08-17monthly0.6 https://lp-a.org/2025/04/07/elevated-lp-a-more-than-doubles-arterial-stroke-risk-in-children-and-youth-meta-analysis-o/2026-08-17monthly0.6 https://lp-a.org/2025/04/04/lp-a-30-mg-dl-or-more-predicts-cardiovascular-death-or-hf-hospitalization-cohort-of-1-088-/2026-08-17monthly0.6 https://lp-a.org/2025/04/02/aggressive-lipid-lowering-achieved-similar-ldl-c-targets-regardless-of-lp-a-level-in-263-p/2026-08-17monthly0.6 https://lp-a.org/2025/04/01/an-isoform-insensitive-lp-a-assay-correlates-well-with-traditional-polyclonal-methods-in-a/2026-08-18monthly0.6 https://lp-a.org/2025/04/01/combined-lipoprotein-apheresis-and-hemodialysis-cut-cardiovascular-events-by-57-in-9-patie/2026-08-18monthly0.6 https://lp-a.org/2025/04/01/a-45-year-old-with-lp-a-of-180-mg-dl-and-near-total-coronary-occlusion-improved-on-intensi/2026-08-18monthly0.6 https://lp-a.org/2025/04/01/alirocumab-lowers-both-lp-a-and-ldl-c-but-they-pull-new-onset-diabetes-risk-in-opposite-di/2026-08-18monthly0.6 https://lp-a.org/2025/04/01/high-lp-a-raises-diabetic-nephropathy-risk-64-in-type-2-diabetes-meta-analysis-of-15-studi/2026-08-18monthly0.6 https://lp-a.org/2025/04/01/from-niacin-s-20-cut-to-apo-a-targeted-drugs-80-reduction-a-mini-review-maps-the-full-spec/2026-08-18monthly0.6 https://lp-a.org/2025/04/01/low-lp-a-aids-clot-dissolution-but-oxidised-lp-a-blocks-it-a-biphasic-effect-mechanistic-s/2026-08-17monthly0.6 https://lp-a.org/2025/04/01/lp-a-in-the-top-quintile-nearly-doubles-stroke-tia-odds-and-doubles-cerebral-injury-odds-i/2026-08-17monthly0.6 https://lp-a.org/2025/03/30/lp-a-of-30-mg-dl-or-above-raises-coronary-heart-disease-risk-but-not-stroke-risk-in-japan-/2026-08-17monthly0.6 https://lp-a.org/2025/03/27/diabetes-and-elevated-lp-a-interact-multiplicatively-giving-patients-with-both-a-2-57-fold/2026-08-17monthly0.6 https://lp-a.org/2025/03/27/higher-lp-a-tracks-with-more-severe-coronary-disease-by-syntax-score-in-a-51-patient-south/2026-08-17monthly0.6 https://lp-a.org/2025/03/26/elevated-lp-a-predicts-periprocedural-stroke-and-later-acs-after-carotid-endarterectomy-bu/2026-08-18monthly0.6 https://lp-a.org/2025/03/24/high-lp-a-patients-with-intracranial-stenosis-get-the-most-benefit-from-remote-ischemic-co/2026-08-17monthly0.6 https://lp-a.org/2025/03/24/highest-tertile-lp-a-independently-predicts-both-cardiovascular-and-all-cause-mortality-in/2026-08-17monthly0.6 https://lp-a.org/2025/03/22/a-genome-scale-crispr-screen-identifies-the-ldl-receptor-not-a-disputed-alternative-as-the/2026-08-18monthly0.6 https://lp-a.org/2025/03/21/only-1-in-4-aortic-stenosis-patients-has-high-lp-a-limiting-how-many-could-benefit-from-fu/2026-08-18monthly0.6 https://lp-a.org/2025/03/21/olpasiran-cuts-lp-a-by-92-in-a-network-meta-analysis-of-14-trials-outperforming-non-target/2026-08-17monthly0.6 https://lp-a.org/2025/03/19/pelacarsen-olpasiran-and-lepodisiran-have-shown-lp-a-reductions-from-35-to-101-across-phas/2026-08-17monthly0.6 https://lp-a.org/2025/03/19/real-world-data-on-how-elevated-lp-a-patients-are-actually-managed-remains-scarce-review-a/2026-08-17monthly0.6 https://lp-a.org/2025/03/13/lp-a-of-125-nmol-l-or-above-raises-valve-replacement-risk-58-in-calcific-aortic-valve-sten/2026-08-18monthly0.6 https://lp-a.org/2025/03/12/higher-lp-a-linearly-tracks-with-lower-fatty-liver-disease-risk-nhanes-iii-analysis-of-2-3/2026-08-18monthly0.6 https://lp-a.org/2025/03/06/a-new-fully-automated-latex-immunoturbidimetric-lp-a-assay-matches-an-existing-commercial-/2026-08-18monthly0.6 https://lp-a.org/2025/03/06/a-clinician-focused-review-consolidates-lp-a-s-path-from-biomarker-discovery-to-emerging-t/2026-08-17monthly0.6 https://lp-a.org/2025/03/04/high-lp-a-is-linked-to-diabetic-peripheral-neuropathy-in-asian-but-not-european-studies-me/2026-08-18monthly0.6 https://lp-a.org/2025/03/04/higher-lp-a-drives-earlier-onset-and-faster-pressure-gradient-progression-in-calcific-aort/2026-08-17monthly0.6 https://lp-a.org/2025/03/03/lp-a-rose-significantly-3-months-after-acute-coronary-syndrome-in-all-40-patients-studied-/2026-08-17monthly0.6 https://lp-a.org/2025/03/01/10-30-of-the-world-s-population-has-lp-a-above-50-mg-dl-spanish-clinical-laboratory-review/2026-08-18monthly0.6 https://lp-a.org/2025/03/01/adding-lp-a-to-standard-risk-factors-raises-coronary-calcium-prediction-accuracy-from-0-74/2026-08-18monthly0.6 https://lp-a.org/2025/02/27/twenty-year-follow-up-of-dutch-familial-hypercholesterolaemia-cohort-finds-no-link-between/2026-08-18monthly0.6 https://lp-a.org/2025/02/25/meta-analysis-of-20-271-patients-finds-lp-a-above-30-mg-dl-more-than-quadruples-ascvd-risk/2026-08-18monthly0.6 https://lp-a.org/2025/02/25/elevated-lp-a-compounds-subclinical-atherosclerosis-risk-specifically-in-diabetic-chest-pa/2026-08-18monthly0.6 https://lp-a.org/2025/02/25/a-uk-reference-change-value-study-finds-lp-a-must-shift-by-more-than-24-32-between-tests-t/2026-08-17monthly0.6 https://lp-a.org/2025/02/24/lp-a-and-fibrinogen-act-synergistically-on-carotid-plaque-in-3-913-chinese-coronary-artery/2026-08-18monthly0.6 https://lp-a.org/2025/02/18/mass-based-and-molar-based-lp-a-immunoassays-are-interchangeable-near-identically-predicti/2026-08-17monthly0.6 https://lp-a.org/2025/02/18/seven-investigational-agents-from-sirnas-to-a-gene-editing-candidate-and-a-repurposed-cetp/2026-08-17monthly0.6 https://lp-a.org/2025/02/16/factorial-mendelian-randomisation-in-385-917-uk-biobank-participants-finds-lp-a-lowering-b/2026-08-18monthly0.6 https://lp-a.org/2025/02/14/measured-lp-a-molar-concentration-outperforms-lpa-genetic-variants-for-predicting-coronary/2026-08-18monthly0.6 https://lp-a.org/2025/02/14/lp-a-affects-up-to-a-quarter-of-the-world-s-population-and-carries-fh-comparable-risk-revi/2026-08-18monthly0.6 https://lp-a.org/2025/02/13/elevated-lp-a-predicts-higher-baseline-plaque-burden-and-faster-low-attenuation-plaque-gro/2026-08-18monthly0.6 https://lp-a.org/2025/02/13/serum-lp-a-is-higher-in-rheumatic-heart-valve-disease-and-tracks-with-mitral-stenosis-seve/2026-08-17monthly0.6 https://lp-a.org/2025/02/12/early-health-economic-modelling-of-olpasiran-and-pelacarsen-offers-a-preview-of-lp-a-lower/2026-08-18monthly0.6 https://lp-a.org/2025/02/11/review-argues-coronary-artery-calcium-and-lp-a-testing-should-be-used-together-not-as-alte/2026-08-18monthly0.6 https://lp-a.org/2025/02/11/lp-a-as-a-pharmacological-target-premises-promises-and-prospects-greco-et-al-circulation-2/2026-08-17monthly0.6 https://lp-a.org/2025/02/07/the-rs3798220-c-lpa-variant-tracks-with-higher-lp-a-and-more-early-myocardial-infarction-i/2026-08-18monthly0.6 https://lp-a.org/2025/02/06/high-il-6-not-hscrp-amplifies-the-cardiovascular-mortality-risk-of-markedly-elevated-lp-a-/2026-08-17monthly0.6 https://lp-a.org/2025/02/03/neither-lp-a-concentration-nor-apo-a-isoform-size-predicts-new-onset-diabetes-in-prediabet/2026-08-18monthly0.6 https://lp-a.org/2025/02/03/persistently-high-lp-a-from-admission-to-one-year-raises-macce-risk-87-after-heart-attack-/2026-08-17monthly0.6 https://lp-a.org/2025/02/01/elevated-lp-a-tracks-with-cardiac-mri-signs-of-myocardial-fibrosis-in-group-ii-pulmonary-h/2026-08-18monthly0.6 https://lp-a.org/2025/01/31/lp-a-s-heart-attack-risk-is-not-explained-by-prothrombotic-mechanisms-410-177-person-uk-bi/2026-08-17monthly0.6 https://lp-a.org/2025/01/30/mendelian-randomisation-finds-no-causal-link-between-lp-a-and-nine-immune-mediated-inflamm/2026-08-18monthly0.6 https://lp-a.org/2025/01/30/elevated-lp-a-predicts-worse-graft-occlusion-and-mace-after-cabg-review-argues-for-routine/2026-08-17monthly0.6 https://lp-a.org/2025/01/28/lp-a-risk-persists-at-the-lowest-achieved-ldl-c-participant-level-meta-analysis-of-six-sta/2026-08-17monthly0.6 https://lp-a.org/2025/01/27/genetically-predicted-lp-a-tracks-coronary-plaque-severity-independent-of-ldl-c-in-nearly-/2026-08-18monthly0.6 https://lp-a.org/2025/01/25/review-surveys-ten-rna-based-agents-targeting-lp-a-pcsk9-apoc-iii-and-angptl3-in-dyslipida/2026-08-18monthly0.6 https://lp-a.org/2025/01/24/cutting-dietary-saturated-fat-raises-lp-a-by-24-in-african-americans-more-so-with-smaller-/2026-08-18monthly0.6 https://lp-a.org/2025/01/24/adding-lp-a-to-an-ehr-based-ascvd-risk-score-reclassifies-21-3-of-borderline-risk-patients/2026-08-18monthly0.6 https://lp-a.org/2025/01/23/a-random-survival-forest-model-beats-traditional-risk-scores-at-predicting-cardiovascular-/2026-08-18monthly0.6 https://lp-a.org/2025/01/23/a-machine-learning-tool-arise-could-raise-lp-a-testing-yield-in-health-systems-where-only-/2026-08-18monthly0.6 https://lp-a.org/2025/01/23/elevated-lp-a-doubles-cardiovascular-risk-in-familial-hypercholesterolaemia-but-not-in-fam/2026-08-17monthly0.6 https://lp-a.org/2025/01/22/review-weighs-conflicting-evidence-on-whether-lowering-ldl-c-blunts-the-cardiovascular-ris/2026-08-18monthly0.6 https://lp-a.org/2025/01/21/kraken-oral-muvalaplin-lowers-lp-a-by-82-to-86-percent-on-an-intact-particle-assay-nicholl/2026-08-17monthly0.6 https://lp-a.org/2025/01/18/first-real-world-portuguese-cohort-finds-28-7-have-elevated-lp-a-rising-to-55-7-among-thos/2026-08-18monthly0.6 https://lp-a.org/2025/01/12/mendelian-randomization-finds-lp-a-causally-raises-depression-risk-while-depression-and-bi/2026-08-18monthly0.6 https://lp-a.org/2025/01/11/lp-a-shows-a-u-shaped-not-linear-relationship-with-mace-in-1-504-three-vessel-disease-acs-/2026-08-18monthly0.6 https://lp-a.org/2025/01/10/meta-analysis-of-randomised-trials-confirms-pcsk9-inhibitor-antibodies-cut-lp-a-by-an-aver/2026-08-18monthly0.6 https://lp-a.org/2025/01/10/systematic-review-of-26-studies-finds-mendelian-randomisation-but-not-observational-data-s/2026-08-18monthly0.6 https://lp-a.org/2025/01/07/very-high-lp-a-carries-67-higher-odds-of-coronary-stenosis-in-patients-newly-presenting-wi/2026-08-18monthly0.6 https://lp-a.org/2025/01/07/tamoxifen-lowers-lp-a-by-3-35-mg-dl-with-the-effect-nearly-40-stronger-at-doses-of-20-mg-d/2026-08-18monthly0.6 https://lp-a.org/2025/01/06/adding-lp-a-and-an-inflammation-index-to-the-timi-score-sharpens-mace-prediction-after-ste/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/systematic-review-of-20-trials-and-6-651-patients-finds-lepodisiran-and-olpasiran-cut-apol/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/first-report-links-elevated-lp-a-to-aortic-root-dilatation-specifically-in-hypertensive-pa/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/low-preoperative-lp-a-independently-predicts-fatty-liver-after-pancreatectomy-anticancer-r/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/nirs-imaging-in-the-reassure-registry-shows-combined-ldl-c-and-lp-a-control-cuts-high-risk/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/combining-lp-a-with-hs-crp-raises-coronary-heart-disease-diagnostic-auc-to-0-924-beating-e/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/elevated-lp-a-cuts-24-month-event-free-survival-after-pci-from-91-76-to-74-13-in-360-patie/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/perspective-piece-asks-whether-digital-health-tools-can-push-lp-a-testing-toward-the-ubiqu/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/patients-call-elevated-lp-a-an-invisible-disorder-with-clinicians-often-reluctant-to-test-/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/44-of-singapore-cardiology-and-endocrinology-specialists-never-test-for-lp-a-mainly-citing/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/in-44-354-korean-adults-having-both-high-lp-a-and-coronary-calcium-raises-ascvd-odds-2-4-f/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/in-mesa-elevated-lp-a-only-raises-ascvd-risk-when-waist-to-hip-ratio-is-also-high-prog-car/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/carrying-the-cyp2c19-aa-genotype-alongside-elevated-lp-a-raises-the-odds-of-poor-stroke-re/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/cdc-standardization-program-finds-lp-a-interassay-variability-up-to-69-1-across-eight-clin/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/lp-a-of-97-5-mg-l-predicts-coronary-heart-disease-in-type-2-diabetes-and-six-months-of-ros/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/elevated-lp-a-predicts-both-higher-mortality-and-faster-bioprosthetic-valve-degeneration-a/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/case-report-a-2-year-old-with-cerebral-venous-sinus-thrombosis-had-both-iron-deficiency-an/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/the-batary-survey-of-49-spanish-laboratories-finds-most-lack-lp-a-testing-protocols-despit/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/unbiased-clustering-of-661-portuguese-adults-reveals-a-distinct-high-lp-a-profile-older-ma/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/in-67-statin-naive-adults-lp-a-is-independent-of-the-standard-lipid-profile-but-rises-with/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/case-series-two-young-patients-presented-with-spontaneous-coronary-dissection-and-thrombos/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/even-mildly-elevated-lp-a-doubles-coronary-heart-disease-risk-in-591-patients-with-early-o/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/annual-review-names-2024-the-year-of-lipoprotein-a-as-three-rna-based-lp-a-lowering-agents/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/review-by-nicholls-and-nelson-asks-which-patients-stand-to-benefit-most-as-lp-a-lowering-a/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/lp-a-above-the-90th-percentile-predicts-recurrent-ischaemic-stroke-in-2-029-patients-with-/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/lp-a-at-or-above-50-mg-dl-tracks-with-younger-heart-attacks-and-more-diseased-coronary-ves/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/in-a-uk-nhs-lipid-clinic-46-of-192-tested-patients-had-abnormal-lp-a-with-16-at-high-or-ve/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/fewer-than-one-in-four-patients-with-elevated-lp-a-had-their-lipid-lowering-therapy-intens/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/every-45-mg-l-rise-in-lp-a-tracks-a-linear-5-increase-in-cardiovascular-mortality-among-57/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/higher-lp-a-tertile-independently-predicts-mace-in-399-patients-with-heart-attack-complica/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/first-large-scale-brazilian-data-median-lp-a-is-13-90-mg-dl-in-women-versus-11-58-mg-dl-in/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/ivus-study-links-elevated-lp-a-to-more-neoatherosclerosis-and-a-3-4-fold-higher-odds-of-st/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/reduced-thyroid-hormone-sensitivity-tracks-with-higher-lp-a-in-1-097-euthyroid-patients-wi/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/moli-sani-cohort-study-finds-lp-a-above-90-mg-dl-raises-secondary-cardiovascular-event-ris/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/in-2-247-chinese-t2dm-patients-the-combination-of-low-adipose-insulin-resistance-and-high-/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/lp-a-at-or-above-70-nmol-l-on-admission-nearly-doubles-two-year-mortality-in-520-hospitali/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/case-report-the-igf-1-receptor-blocker-teprotumumab-drove-lp-a-above-the-atherogenic-thres/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/review-details-how-pelacarsen-s-galnac-conjugated-antisense-design-achieved-an-80-or-great/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/case-report-lp-a-of-113-mg-dl-behind-recurrent-deep-vein-thrombosis-and-cerebral-venous-si/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/lp-a-at-or-above-180-mg-dl-nearly-triples-mace-risk-even-after-ldl-c-targets-are-met-in-di/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/review-maps-twelve-active-lp-a-lowering-drug-trials-including-three-phase-3-outcome-studie/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/at-a-bronx-safety-net-hospital-elevated-lp-a-tracked-with-hfpef-and-higher-ldl-but-not-wit/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/survey-of-1-001-people-with-elevated-lp-a-finds-most-share-results-with-family-but-decisio/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/referchol-study-of-2-979-heterozygous-fh-patients-finds-extreme-lp-a-confers-cardiovascula/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/amsterdam-umc-study-finds-high-lp-a-raises-monocyte-inflammation-genes-but-not-chromatin-a/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/lp-a-above-40-nmol-l-predicts-ascvd-and-coronary-disease-in-2-341-thai-patients-vasc-healt/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/a-nine-mirna-signature-links-high-lp-a-to-coronary-calcification-through-inflammation-and-/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/qualitative-interviews-with-41-cardiology-staff-in-singapore-reveal-why-lp-a-testing-still/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/randomised-trial-finds-niacin-lowers-lp-a-by-11-4-and-stabilises-phosphorus-and-potassium-/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/the-largest-arabian-gulf-survey-of-its-kind-finds-only-23-6-of-1-069-physicians-have-ever-/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/a-one-off-gamified-lecture-doubles-resident-lp-a-knowledge-scores-and-modestly-lifts-scree/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/corneal-arcus-and-thick-achilles-tendons-flag-elevated-lp-a-and-higher-mace-risk-in-484-pa/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/lp-a-at-or-above-30-mg-dl-predicts-severe-coronary-stenosis-with-72-5-prevalence-versus-8-/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/star-lp-a-study-of-2-594-patients-finds-lp-a-driven-atherosclerosis-risk-is-largely-mitiga/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/opinion-review-argues-lp-a-must-move-from-a-neglected-biomarker-to-a-routinely-measured-on/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/combining-monocyte-to-hdl-ratio-with-lp-a-lifts-in-stent-restenosis-prediction-to-an-auc-o/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/case-report-a-veteran-athlete-with-a-qrisk3-score-of-4-1-turns-out-to-have-75-coronary-ste/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/clinically-oriented-review-outlines-how-to-bring-lp-a-testing-into-routine-polish-practice/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/review-maps-how-lp-a-s-proatherogenic-and-prothrombotic-biology-may-drive-atrial-fibrillat/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/meta-analysis-of-43-randomised-trials-confirms-statins-do-not-meaningfully-change-lp-a-lev/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/review-consolidates-the-case-for-lp-a-as-a-causal-driver-of-ascvd-and-aortic-valve-stenosi/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/meta-analysis-of-forty-one-studies-finds-lp-a-nearly-12-mg-dl-higher-in-pre-eclampsia-but-/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/systematic-review-of-153-192-participants-confirms-a-dose-dependent-lp-a-aortic-valve-dise/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/narrative-review-ties-lp-a-s-pro-inflammatory-and-prothrombotic-biology-to-higher-peripher/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/review-finds-lp-a-is-a-weaker-predictor-of-cerebral-atherosclerosis-and-stroke-than-of-cor/2026-08-18monthly0.6 https://lp-a.org/2025/01/01/review-argues-an-absolute-lp-a-drop-of-at-least-50-mg-dl-is-needed-for-cardiovascular-bene/2026-08-18monthly0.6 https://lp-a.org/2024/12/28/apheresis-cuts-lp-a-by-75-and-the-cetp-inhibitor-obicetrapib-by-40-but-a-100-mg-dl-reducti/2026-08-18monthly0.6 https://lp-a.org/2024/12/27/elevated-lp-a-independently-predicts-lipid-rich-vulnerable-coronary-plaque-on-oct-in-202-a/2026-08-17monthly0.6 https://lp-a.org/2024/12/26/lp-a-predicts-coronary-artery-disease-regardless-of-family-history-in-4-512-japanese-patie/2026-08-18monthly0.6 https://lp-a.org/2024/12/24/each-lp-a-tertile-increase-brings-a-premature-heart-attack-0-83-years-earlier-and-adds-8-p/2026-08-17monthly0.6 https://lp-a.org/2024/12/21/lp-a-does-not-predict-cardiac-allograft-vasculopathy-in-385-heart-transplant-recipients-un/2026-08-18monthly0.6 https://lp-a.org/2024/12/19/lipoprotein-apheresis-reduces-oxidative-susceptibility-of-both-lp-a-and-ldl-particles-a-po/2026-08-18monthly0.6 https://lp-a.org/2024/12/17/alpacar-zerlasiran-lowers-time-averaged-lp-a-by-more-than-80-percent-over-36-weeks-in-ascv/2026-08-17monthly0.6 https://lp-a.org/2024/12/11/lp-a-shows-no-association-with-valve-calcium-burden-or-mortality-in-454-tavr-patients-clin/2026-08-18monthly0.6 https://lp-a.org/2024/12/11/combined-elevation-of-lp-a-hs-crp-and-homocysteine-triples-stroke-risk-in-the-multi-ethnic/2026-08-18monthly0.6 https://lp-a.org/2024/12/11/low-lp-a-tracking-with-worse-liver-disease-in-cross-sectional-studies-is-reverse-causality/2026-08-17monthly0.6 https://lp-a.org/2024/12/07/lp-a-above-90-mg-dl-predicts-recurrent-heart-attack-almost-fourfold-in-women-over-65-but-s/2026-08-18monthly0.6 https://lp-a.org/2024/12/06/a-new-isoform-insensitive-lp-a-particle-assay-reveals-commercial-assays-underestimated-muv/2026-08-18monthly0.6 https://lp-a.org/2024/12/06/higher-lp-a-is-an-independent-risk-factor-for-type-i-cardiorenal-syndrome-in-269-coronary-/2026-08-18monthly0.6 https://lp-a.org/2024/12/05/elevated-apob-is-needed-for-high-lp-a-to-raise-ascvd-risk-in-the-aric-study-am-heart-j-202/2026-08-18monthly0.6 https://lp-a.org/2024/12/05/inflammation-cholesterol-lp-a-and-30-year-cardiovascular-outcomes-in-women-ridker-et-al-ne/2026-08-17monthly0.6 https://lp-a.org/2024/12/04/apo-a-isoform-size-not-baseline-lp-a-explains-why-pcsk9-inhibitor-combination-therapy-lowe/2026-08-18monthly0.6 https://lp-a.org/2024/12/04/lp-a-heritage-us-subanalysis-finds-only-14-of-7-679-ascvd-patients-had-ever-been-tested-de/2026-08-18monthly0.6 https://lp-a.org/2024/12/02/pcsk9-inhibitors-cut-mace-risk-by-13-while-lowering-lp-a-alongside-ldl-c-meta-analysis-of-/2026-08-17monthly0.6 https://lp-a.org/2024/12/01/ppargamma-suppresses-il-6-driven-lp-a-production-in-liver-cells-and-the-diabetes-drug-piog/2026-08-18monthly0.6 https://lp-a.org/2024/12/01/combining-lp-pla2-with-lp-a-outperforms-either-marker-alone-for-predicting-stroke-recurren/2026-08-18monthly0.6 https://lp-a.org/2024/12/01/case-report-an-11-year-old-girl-s-sudden-retinal-artery-occlusion-was-linked-to-elevated-l/2026-08-18monthly0.6 https://lp-a.org/2024/11/24/lp-a-above-166-16-nmol-l-flags-severe-coronary-anatomy-syntax-score-23-with-97-sensitivity/2026-08-18monthly0.6 https://lp-a.org/2024/11/23/meta-analysis-of-11-studies-links-high-lp-a-to-a-doubled-risk-of-diabetic-retinopathy-in-t/2026-08-18monthly0.6 https://lp-a.org/2024/11/23/pre-appointment-ehr-messages-to-providers-more-than-triple-lp-a-test-orders-in-a-us-commun/2026-08-18monthly0.6 https://lp-a.org/2024/11/22/thanassoulis-and-anchouche-map-the-lp-a-lowering-drug-pipeline-as-pelacarsen-and-olpasiran/2026-08-18monthly0.6 https://lp-a.org/2024/11/22/lp-a-is-elevated-in-people-with-hiv-and-inversely-tracks-with-coronary-endothelial-functio/2026-08-18monthly0.6 https://lp-a.org/2024/11/19/meta-analysis-of-562-301-participants-confirms-lp-a-raises-mace-risk-independent-of-hs-crp/2026-08-18monthly0.6 https://lp-a.org/2024/11/19/a-single-dose-of-lipid-nanoparticle-delivered-talen-mrna-cuts-lp-a-by-over-80-for-at-least/2026-08-18monthly0.6 https://lp-a.org/2024/11/16/lp-a-at-or-above-30-mg-dl-triples-myocardial-infarction-risk-in-a-106-patient-case-control/2026-08-18monthly0.6 https://lp-a.org/2024/11/15/once-ldl-c-is-controlled-below-70-mg-dl-after-pci-elevated-lp-a-no-longer-predicts-mace-or/2026-08-17monthly0.6 https://lp-a.org/2024/11/13/meta-analysis-of-11-trials-finds-medroxyprogesterone-acetate-raises-lp-a-while-lowering-ap/2026-08-18monthly0.6 https://lp-a.org/2024/11/11/elevated-lp-a-independently-predicts-long-term-in-stent-restenosis-in-1-209-mayo-clinic-pc/2026-08-18monthly0.6 https://lp-a.org/2024/11/08/german-chronic-kidney-disease-study-finds-each-10-mg-dl-rise-in-lp-a-independently-raises-/2026-08-18monthly0.6 https://lp-a.org/2024/11/06/recalibrating-five-lp-a-immunoassays-against-an-ifcc-mass-spectrometry-reference-sharply-c/2026-08-17monthly0.6 https://lp-a.org/2024/11/04/across-5-us-health-systems-just-0-4-of-595-684-ascvd-patients-were-tested-for-lp-a-with-ol/2026-08-18monthly0.6 https://lp-a.org/2024/11/01/pacman-ami-substudy-shows-high-baseline-lp-a-blunts-plaque-lipid-core-regression-despite-a/2026-08-18monthly0.6 https://lp-a.org/2024/11/01/review-explains-why-statins-raise-lp-a-by-10-20-while-pcsk9-inhibitors-and-inclisiran-lowe/2026-08-18monthly0.6 https://lp-a.org/2024/11/01/lp-a-and-hs-crp-rise-with-age-specifically-in-chinese-t2dm-patients-who-also-have-coronary/2026-08-18monthly0.6 https://lp-a.org/2024/10/31/review-of-33-trials-finds-unsaturated-fat-diets-modestly-lower-lp-a-while-saturated-fat-di/2026-08-18monthly0.6 https://lp-a.org/2024/10/31/lp-a-predicts-cardiovascular-events-specifically-in-very-high-risk-ascvd-patients-not-lowe/2026-08-18monthly0.6 https://lp-a.org/2024/10/30/review-argues-lp-a-is-an-under-recognised-modifiable-driver-of-aortic-stenosis-progression/2026-08-18monthly0.6 https://lp-a.org/2024/10/29/lp-a-does-not-correlate-with-thrombus-burden-on-ct-pulmonary-angiography-in-90-patients-wi/2026-08-18monthly0.6 https://lp-a.org/2024/10/29/review-traces-how-lp-a-shifts-from-newborn-to-menopause-and-argues-women-carry-equal-or-gr/2026-08-18monthly0.6 https://lp-a.org/2024/10/25/only-1-0-of-a-1-48-million-person-northern-california-cohort-ever-received-lp-a-testing-wi/2026-08-18monthly0.6 https://lp-a.org/2024/10/24/a-new-short-read-caller-for-the-kiv-2-repeat-region-correlates-with-lp-a-protein-levels-an/2026-08-18monthly0.6 https://lp-a.org/2024/10/22/review-surveys-lp-a-s-biochemistry-disease-associations-and-the-emerging-case-for-pharmaco/2026-08-18monthly0.6 https://lp-a.org/2024/10/22/only-3-of-150-000-chinese-health-checkup-attendees-were-tested-for-lp-a-yet-it-still-predi/2026-08-18monthly0.6 https://lp-a.org/2024/10/19/high-lp-a-roughly-halves-the-wound-healing-rate-after-endovascular-therapy-for-critical-li/2026-08-17monthly0.6 https://lp-a.org/2024/10/18/high-lp-a-plus-high-hs-crp-together-confer-a-4-74-fold-risk-of-subclinical-valve-leaflet-t/2026-08-18monthly0.6 https://lp-a.org/2024/10/18/at-mayo-clinic-only-0-15-of-257-225-patients-with-a-lipid-panel-had-lp-a-tested-within-a-y/2026-08-18monthly0.6 https://lp-a.org/2024/10/17/meta-analysis-of-74-691-individuals-finds-lp-a-similar-between-nafld-patients-and-controls/2026-08-18monthly0.6 https://lp-a.org/2024/10/14/narrative-review-separates-settled-from-unresolved-lp-a-firmly-drives-mi-and-aortic-stenos/2026-08-18monthly0.6 https://lp-a.org/2024/10/11/meta-analysis-of-rcts-finds-tamoxifen-modestly-lowers-lp-a-alongside-apob-in-women-treated/2026-08-18monthly0.6 https://lp-a.org/2024/10/08/a-new-nanopore-sequencing-method-resolves-the-notoriously-complex-lpa-kiv-2-repeat-region-/2026-08-18monthly0.6 https://lp-a.org/2024/10/05/just-0-42-of-700-580-japanese-ascvd-prevention-patients-were-tested-for-lp-a-despite-7-of-/2026-08-18monthly0.6 https://lp-a.org/2024/10/04/blocking-microrna-221-3p-restores-angiogenesis-in-lp-a-injured-endothelial-progenitor-cell/2026-08-18monthly0.6 https://lp-a.org/2024/10/02/boffa-and-koschinsky-review-the-biochemistry-behind-lp-a-s-disease-causing-potential-as-ph/2026-08-18monthly0.6 https://lp-a.org/2024/10/02/a-machine-learning-decision-tree-using-ldl-c-chd-status-family-history-and-age-identifies-/2026-08-18monthly0.6 https://lp-a.org/2024/10/02/review-traces-why-statins-raise-lp-a-while-pcsk9-inhibitors-lower-it-and-what-that-means-f/2026-08-18monthly0.6 https://lp-a.org/2024/10/01/hegele-group-finds-lp-a-is-paradoxically-halved-in-patients-with-severe-hypertriglyceridae/2026-08-18monthly0.6 https://lp-a.org/2024/10/01/in-10-000-pci-patients-elevated-lp-a-only-predicts-death-when-ldl-c-and-hs-crp-are-both-hi/2026-08-18monthly0.6 https://lp-a.org/2024/10/01/meta-analysis-of-fourteen-studies-confirms-elevated-lp-a-raises-mace-mortality-mi-and-reva/2026-08-18monthly0.6 https://lp-a.org/2024/10/01/star-lp-a-study-finds-21-5-of-2-475-outpatient-cardiology-patients-had-elevated-lp-a-more-/2026-08-18monthly0.6 https://lp-a.org/2024/10/01/meta-analysis-of-11-958-stroke-patients-finds-high-lp-a-more-than-doubles-the-odds-of-poor/2026-08-18monthly0.6 https://lp-a.org/2024/09/27/new-risk-weighted-apob-metric-corrects-for-apob-underestimating-risk-when-lp-a-is-high-usi/2026-08-18monthly0.6 https://lp-a.org/2024/09/26/review-argues-lp-a-testing-and-risk-based-management-should-not-wait-for-outcome-trial-res/2026-08-18monthly0.6 https://lp-a.org/2024/09/25/nicholls-and-colleagues-review-muvalaplin-the-first-oral-lp-a-lowering-agent-as-it-enters-/2026-08-18monthly0.6 https://lp-a.org/2024/09/23/lp-a-at-or-above-30-mg-dl-predicts-multivessel-coronary-disease-in-256-young-acute-myocard/2026-08-18monthly0.6 https://lp-a.org/2024/09/23/lp-a-testing-among-us-veterans-rose-ninefold-from-2014-to-2023-but-remains-extremely-rare-/2026-08-18monthly0.6 https://lp-a.org/2024/09/19/systematic-review-of-2-058-patients-finds-elevated-lp-a-consistently-linked-to-vulnerable-/2026-08-18monthly0.6 https://lp-a.org/2024/09/18/amsterdam-umc-review-finds-cascade-screening-for-elevated-lp-a-needs-as-few-as-1-3-relativ/2026-08-18monthly0.6 https://lp-a.org/2024/09/14/uk-biobank-observational-and-mendelian-randomisation-analyses-find-lp-a-raises-abdominal-a/2026-08-18monthly0.6 https://lp-a.org/2024/09/14/lp-a-above-50-mg-dl-raises-incident-hypertension-risk-in-normotensive-adults-over-50-but-n/2026-08-18monthly0.6 https://lp-a.org/2024/09/12/a-lancet-review-by-nordestgaard-and-langsted-finds-one-in-five-people-carry-high-risk-lp-a/2026-08-18monthly0.6 https://lp-a.org/2024/09/11/kamstrup-and-colleagues-quantify-lp-a-as-a-causal-risk-factor-for-peripheral-artery-diseas/2026-08-18monthly0.6 https://lp-a.org/2024/09/10/lp-a-above-100-mg-dl-nearly-doubles-risk-of-severe-degenerative-aortic-stenosis-but-not-bi/2026-08-18monthly0.6 https://lp-a.org/2024/09/06/promise-trial-analysis-of-1-815-patients-finds-elevated-lp-a-predicts-obstructive-coronary/2026-08-18monthly0.6 https://lp-a.org/2024/09/05/comparing-503-tavi-patients-against-25-343-controls-finds-only-a-mild-lp-a-elevation-in-se/2026-08-18monthly0.6 https://lp-a.org/2024/09/04/in-195-children-already-followed-for-cardiovascular-risk-factors-17-had-elevated-lp-a-desp/2026-08-18monthly0.6 https://lp-a.org/2024/09/04/elevated-lp-a-predicts-both-coronary-disease-severity-and-7-year-mace-risk-in-4-332-patien/2026-08-18monthly0.6 https://lp-a.org/2024/09/01/amsterdam-umc-s-decade-long-serial-ct-scans-show-high-lp-a-drives-more-plaque-more-low-den/2026-08-18monthly0.6 https://lp-a.org/2024/09/01/in-1-193-turkish-ascvd-patients-women-were-eight-times-more-likely-than-men-to-have-lp-a-a/2026-08-18monthly0.6 https://lp-a.org/2024/09/01/lp-a-at-or-above-30-mg-dl-predicts-coronary-disease-in-women-but-not-men-while-50-mg-dl-wo/2026-08-18monthly0.6 https://lp-a.org/2024/09/01/jama-cardiology-meta-analysis-of-710-patients-finds-top-tertile-lp-a-drives-41-57-faster-e/2026-08-18monthly0.6 https://lp-a.org/2024/09/01/systematic-review-of-29-studies-finds-statins-fibrates-and-ezetimibe-do-little-for-lp-a-wh/2026-08-18monthly0.6 https://lp-a.org/2024/08/31/a-repeat-lp-a-test-reclassifies-over-half-of-patients-out-of-the-eas-grey-zone-in-a-study-/2026-08-18monthly0.6 https://lp-a.org/2024/08/31/meta-analysis-of-1-345-patients-finds-young-stroke-patients-are-61-more-likely-to-have-ele/2026-08-18monthly0.6 https://lp-a.org/2024/08/29/mendelian-randomisation-finds-genetically-higher-insulin-causally-lowers-lp-a-helping-expl/2026-08-18monthly0.6 https://lp-a.org/2024/08/28/familial-hypercholesterolaemia-not-familial-hypobetalipoproteinaemia-is-linked-to-higher-l/2026-08-18monthly0.6 https://lp-a.org/2024/08/27/after-stopping-olpasiran-lp-a-stays-40-to-50-percent-below-baseline-for-nearly-a-year-ocea/2026-08-17monthly0.6 https://lp-a.org/2024/08/25/switching-lp-a-assays-at-a-norwegian-national-lab-changed-who-counted-as-high-risk-the-roc/2026-08-18monthly0.6 https://lp-a.org/2024/08/25/systematic-review-of-49-871-individuals-suggests-aspirin-lowers-cardiovascular-risk-in-pri/2026-08-18monthly0.6 https://lp-a.org/2024/08/23/meta-analysis-of-12-trials-finds-raloxifene-lowers-lp-a-and-apob-while-raising-apoa-i-in-p/2026-08-18monthly0.6 https://lp-a.org/2024/08/22/review-notes-lp-a-s-link-to-peripheral-artery-disease-and-carotid-atherosclerosis-is-real-/2026-08-18monthly0.6 https://lp-a.org/2024/08/17/highest-lp-a-quartile-carries-19-higher-mace-risk-and-57-higher-mortality-in-8-382-chinese/2026-08-18monthly0.6 https://lp-a.org/2024/08/16/apob-and-lp-a-testing-make-up-less-than-1-of-all-us-lipid-panel-testing-across-four-nation/2026-08-18monthly0.6 https://lp-a.org/2024/08/14/review-argues-an-elevated-lp-a-is-actionable-today-through-ldl-c-control-pcsk9-inhibitors-/2026-08-18monthly0.6 https://lp-a.org/2024/08/13/narrative-review-traces-lp-a-s-pediatric-research-history-from-stroke-risk-marker-to-a-pro/2026-08-18monthly0.6 https://lp-a.org/2024/08/13/review-by-boren-and-colleagues-explains-why-lp-a-is-roughly-six-times-more-atherogenic-tha/2026-08-18monthly0.6 https://lp-a.org/2024/08/09/an-lpa-genetic-risk-score-explaining-45-of-lp-a-variation-predicts-calcific-aortic-valve-d/2026-08-18monthly0.6 https://lp-a.org/2024/08/08/in-200-primary-care-patients-without-cardiovascular-disease-elevated-lp-a-tracked-with-nei/2026-08-18monthly0.6 https://lp-a.org/2024/08/06/smoking-high-lp-a-and-heavy-cumulative-ldl-c-exposure-together-push-coronary-disease-risk-/2026-08-18monthly0.6 https://lp-a.org/2024/08/01/lp-a-at-or-above-30-mg-l-independently-predicts-ascvd-in-265-beijing-haemodialysis-patient/2026-08-18monthly0.6 https://lp-a.org/2024/08/01/hegele-case-series-16-elderly-patients-with-lp-a-above-230-nmol-l-recorded-zero-incident-c/2026-08-18monthly0.6 https://lp-a.org/2024/08/01/quantifying-lpa-kiv-2-repeat-number-by-qpcr-better-predicts-5-year-mace-than-measured-lp-a/2026-08-18monthly0.6 https://lp-a.org/2024/08/01/only-212-lp-a-tests-were-run-per-year-across-a-nationwide-pakistani-lab-network-yet-37-2-o/2026-08-18monthly0.6 https://lp-a.org/2024/08/01/systematic-review-finds-hypothyroidism-correlates-with-higher-lp-a-but-thyroid-hormone-rep/2026-08-18monthly0.6 https://lp-a.org/2024/08/01/amsterdam-umc-case-based-review-argues-interventional-cardiologists-should-measure-lp-a-ro/2026-08-18monthly0.6 https://lp-a.org/2024/07/31/a-polynesian-specific-slc22a3-gene-variant-lowers-lp-a-independent-of-apo-a-isoform-size-i/2026-08-18monthly0.6 https://lp-a.org/2024/07/31/amsterdam-umc-case-control-study-finds-lp-a-above-50-mg-dl-is-nearly-seven-times-more-comm/2026-08-18monthly0.6 https://lp-a.org/2024/07/31/bidirectional-mendelian-randomisation-confirms-lp-a-causally-raises-chronic-kidney-disease/2026-08-18monthly0.6 https://lp-a.org/2024/07/26/adding-lp-a-and-three-other-markers-to-the-grace-score-lifts-in-hospital-mace-prediction-a/2026-08-18monthly0.6 https://lp-a.org/2024/07/20/elevated-lp-a-nearly-doubles-ischaemic-event-recurrence-after-cerebral-vascular-stenting-i/2026-08-18monthly0.6 https://lp-a.org/2024/07/20/one-in-three-stable-lipid-clinic-patients-showed-lp-a-swings-over-25-challenging-the-once-/2026-08-18monthly0.6 https://lp-a.org/2024/07/18/nhanes-iii-analysis-finds-high-lp-a-plus-high-fibrinogen-together-carry-a-2-4-fold-higher-/2026-08-18monthly0.6 https://lp-a.org/2024/07/18/mass-general-brigham-lp-a-registry-finds-diabetes-plus-elevated-lp-a-drives-a-nearly-eight/2026-08-18monthly0.6 https://lp-a.org/2024/07/12/cardiac-ct-in-207-diabetic-patients-links-elevated-lp-a-to-high-risk-plaque-but-not-to-per/2026-08-18monthly0.6 https://lp-a.org/2024/07/11/very-low-lp-a-raises-new-onset-diabetes-and-fatty-liver-risk-in-uk-biobank-but-mendelian-r/2026-08-18monthly0.6 https://lp-a.org/2024/07/09/in-68-748-subjects-correcting-ldl-c-for-its-lp-a-cholesterol-content-adds-nothing-at-the-p/2026-08-18monthly0.6 https://lp-a.org/2024/07/06/higher-lp-a-tracks-with-better-lung-function-in-679-older-adults-but-mendelian-randomisati/2026-08-18monthly0.6 https://lp-a.org/2024/07/04/in-a-10-week-rct-sugar-sweetened-beverages-lowered-lp-a-by-13-in-overweight-adults-indepen/2026-08-18monthly0.6 https://lp-a.org/2024/07/02/meta-analysis-of-27-rcts-finds-lower-saturated-fat-diets-modestly-raise-lp-a-especially-wh/2026-08-18monthly0.6 https://lp-a.org/2024/07/01/miami-heart-study-finds-elevated-lp-a-predicts-coronary-plaque-even-in-1-200-asymptomatic-/2026-08-18monthly0.6 https://lp-a.org/2024/07/01/review-notes-lp-a-s-stroke-association-is-well-replicated-in-epidemiology-but-only-margina/2026-08-18monthly0.6 https://lp-a.org/2024/06/26/a-larger-early-drop-in-lp-a-after-emergency-pci-paradoxically-predicts-worse-outcomes-in-a/2026-08-18monthly0.6 https://lp-a.org/2024/06/26/lp-a-alone-without-added-oxidized-phospholipid-measures-doubles-the-odds-of-a-major-limb-e/2026-08-18monthly0.6 https://lp-a.org/2024/06/26/tsimikas-marks-lp-a-s-61st-birthday-with-an-atvb-centennial-essay-on-six-decades-of-discov/2026-08-18monthly0.6 https://lp-a.org/2024/06/23/in-227-hypertensive-patients-elevated-lp-a-tracks-specifically-with-worse-nocturnal-blood-/2026-08-18monthly0.6 https://lp-a.org/2024/06/20/girls-with-genetic-fh-have-45-higher-baseline-lp-a-than-boys-a-sex-gap-that-persists-over-/2026-08-18monthly0.6 https://lp-a.org/2024/06/19/johns-hopkins-testing-rate-for-lp-a-rose-tenfold-over-five-years-but-only-20-of-those-foun/2026-08-18monthly0.6 https://lp-a.org/2024/06/15/review-by-koschinsky-rosenson-and-colleagues-explains-why-lp-a-runs-up-to-threefold-higher/2026-08-18monthly0.6 https://lp-a.org/2024/06/15/review-explores-lp-a-s-dual-role-in-both-driving-and-in-some-contexts-dampening-the-inflam/2026-08-18monthly0.6 https://lp-a.org/2024/06/12/in-aric-and-mesa-healthier-lifestyle-and-social-determinants-barely-dent-lp-a-s-link-to-he/2026-08-18monthly0.6 https://lp-a.org/2024/06/11/casablanca-study-finds-lp-a-above-150-nmol-l-nearly-doubles-the-risk-of-stage-a-b-heart-fa/2026-08-18monthly0.6 https://lp-a.org/2024/06/10/new-lc-ms-ms-method-quantifies-lp-a-alongside-13-other-apolipoproteins-from-just-5-microli/2026-08-18monthly0.6 https://lp-a.org/2024/06/06/a-cardiac-surgeon-s-perspective-argues-lp-a-testing-should-refine-risk-assessment-after-ao/2026-08-18monthly0.6 https://lp-a.org/2024/06/05/serum-lp-a-predicts-aortic-stiffness-with-an-auc-of-0-77-in-148-long-term-peritoneal-dialy/2026-08-18monthly0.6 https://lp-a.org/2024/06/05/review-asks-whether-lp-a-measurement-is-accurate-enough-yet-to-support-large-scale-outcome/2026-08-18monthly0.6 https://lp-a.org/2024/06/01/elevated-preoperative-lp-a-triples-the-risk-of-shorter-survival-after-biliary-tract-cancer/2026-08-18monthly0.6 https://lp-a.org/2024/06/01/mesa-study-of-6-792-participants-over-16-7-years-finds-a-zero-aortic-valve-calcium-score-b/2026-08-18monthly0.6 https://lp-a.org/2024/06/01/in-130-colombian-outpatients-higher-lp-a-weakly-but-significantly-correlated-with-less-sev/2026-08-18monthly0.6 https://lp-a.org/2024/06/01/nicholls-reviews-mipomersen-pelacarsen-rnai-agents-and-muvalaplin-as-guidelines-already-pu/2026-08-18monthly0.6 https://lp-a.org/2024/06/01/review-argues-lp-a-s-well-established-link-to-coronary-and-cerebrovascular-disease-remains/2026-08-18monthly0.6 https://lp-a.org/2024/06/01/review-explains-how-lp-a-drives-both-atherosclerosis-and-aortic-valve-calcification-throug/2026-08-18monthly0.6 https://lp-a.org/2024/05/31/in-a-korean-longitudinal-study-higher-lp-a-tertiles-were-associated-with-lower-not-higher-/2026-08-18monthly0.6 https://lp-a.org/2024/05/28/review-examines-lp-a-s-paradox-in-diabetes-high-levels-compound-cardiovascular-risk-but-lo/2026-08-18monthly0.6 https://lp-a.org/2024/05/22/review-surveys-the-lp-a-lowering-pipeline-from-antisense-oligonucleotides-to-crispr-cas9-g/2026-08-18monthly0.6 https://lp-a.org/2024/05/22/nearly-19-of-a-korean-general-population-cohort-showed-coronary-calcium-progression-and-hi/2026-08-17monthly0.6 https://lp-a.org/2024/05/21/meta-analysis-of-227-178-subjects-finds-the-highest-lp-a-concentrations-carry-37-lower-ris/2026-08-18monthly0.6 https://lp-a.org/2024/05/19/high-neutrophil-to-lymphocyte-ratio-unmasks-lp-a-s-prognostic-harm-after-pci-especially-in/2026-08-17monthly0.6 https://lp-a.org/2024/05/18/mass-general-brigham-registry-finds-high-lp-a-carries-the-same-heart-attack-risk-as-having/2026-08-18monthly0.6 https://lp-a.org/2024/05/16/review-argues-electronegative-ldl-l5-deserves-the-same-attention-as-lp-a-as-a-distinct-ath/2026-08-18monthly0.6 https://lp-a.org/2024/05/14/black-and-hispanic-ascvd-patients-had-lp-a-tested-at-roughly-a-tenth-the-rate-of-white-pat/2026-08-18monthly0.6 https://lp-a.org/2024/05/14/zerlasiran-single-and-multiple-doses-in-ascvd-patients-lp-a-down-90-percent-at-201-days-af/2026-08-17monthly0.6 https://lp-a.org/2024/05/13/a-new-lp-a-inclusive-risk-calculator-recategorised-two-thirds-of-671-patients-upward-but-a/2026-08-18monthly0.6 https://lp-a.org/2024/05/12/genome-scale-crispr-screen-resolves-a-long-standing-controversy-the-ldl-receptor-not-a-ded/2026-08-18monthly0.6 https://lp-a.org/2024/05/11/lipidcardio-study-of-975-angiography-patients-finds-lp-a-above-150-nmol-l-doubles-chronic-/2026-08-18monthly0.6 https://lp-a.org/2024/05/11/kamstrup-nordestgaard-and-colleagues-propose-minimum-data-standards-to-harmonise-future-lp/2026-08-18monthly0.6 https://lp-a.org/2024/05/07/low-attenuation-coronary-plaque-mediates-73-3-of-lp-a-s-effect-on-future-heart-attack-risk/2026-08-18monthly0.6 https://lp-a.org/2024/05/02/among-13-689-tested-californians-black-patients-had-2-5-fold-higher-odds-of-lp-a-above-50-/2026-08-18monthly0.6 https://lp-a.org/2024/05/01/nature-paper-unveils-muvalaplin-an-oral-small-molecule-that-blocks-the-very-first-step-of-/2026-08-18monthly0.6 https://lp-a.org/2024/05/01/arise-machine-learning-tool-validated-across-four-cohorts-totalling-nearly-480-000-people-/2026-08-18monthly0.6 https://lp-a.org/2024/05/01/meta-analysis-of-45-059-pci-patients-confirms-elevated-lp-a-raises-mace-risk-by-38-and-car/2026-08-18monthly0.6 https://lp-a.org/2024/04/27/twenty-six-year-nhanes-iii-follow-up-finds-regular-aspirin-cuts-ascvd-mortality-by-52-spec/2026-08-18monthly0.6 https://lp-a.org/2024/04/26/meta-analysis-of-100-540-participants-finds-elevated-lp-a-more-than-doubles-premature-ascv/2026-08-18monthly0.6 https://lp-a.org/2024/04/24/in-patients-referred-for-coronary-angiography-elevated-lp-a-tracks-with-premature-and-mult/2026-08-18monthly0.6 https://lp-a.org/2024/04/23/pooling-mesa-cardia-jhs-fhs-and-aric-over-21-years-top-decile-lp-a-raises-ascvd-risk-46-ov/2026-08-18monthly0.6 https://lp-a.org/2024/04/23/genotype-based-rct-finds-both-plant-based-omega-3-and-omega-6-oils-lower-lp-a-by-7-10-rega/2026-08-18monthly0.6 https://lp-a.org/2024/04/23/lipoprotein-a-blood-levels-and-cardiovascular-risk-reduction-with-icosapent-ethyl/2026-08-17monthly0.6 https://lp-a.org/2024/04/21/review-traces-lp-a-research-from-kare-berg-s-1963-discovery-to-five-emerging-lp-a-lowering/2026-08-18monthly0.6 https://lp-a.org/2024/04/19/lp-a-at-or-above-30-mg-dl-plus-carotid-plaque-together-carry-a-4-18-fold-ascvd-risk-over-1/2026-08-18monthly0.6 https://lp-a.org/2024/04/18/meta-analysis-of-23-105-asymptomatic-patients-finds-elevated-lp-a-raises-the-odds-of-any-c/2026-08-18monthly0.6 https://lp-a.org/2024/04/15/periodontal-inflammation-area-correlates-with-both-il-6-and-lp-a-in-diabetic-patients-more/2026-08-18monthly0.6 https://lp-a.org/2024/04/15/lp-a-is-rarely-tested-before-cardiac-rehab-despite-high-prevalence-german-registry-of-3-39/2026-08-17monthly0.6 https://lp-a.org/2024/04/13/elevated-lp-a-plus-a-family-history-of-coronary-disease-nearly-doubles-mace-risk-in-6-056-/2026-08-18monthly0.6 https://lp-a.org/2024/04/12/her-a-study-finds-59-4-of-first-degree-relatives-of-high-lp-a-acs-patients-also-have-eleva/2026-08-18monthly0.6 https://lp-a.org/2024/04/03/reyes-soffer-yeang-michos-and-ballantyne-argue-lp-a-population-screening-should-start-now-/2026-08-18monthly0.6 https://lp-a.org/2024/04/02/swiss-corisk-cohort-externally-validates-lp-a-as-a-marker-of-large-artery-atherosclerosis-/2026-08-18monthly0.6 https://lp-a.org/2024/04/01/practical-guidance-review-outlines-managing-elevated-lp-a-today-while-four-rna-based-agent/2026-08-18monthly0.6 https://lp-a.org/2024/04/01/lp-a-raises-cardiovascular-risk-regardless-of-hs-crp-in-primary-and-secondary-prevention-s/2026-08-17monthly0.6 https://lp-a.org/2024/03/29/review-surveys-lp-a-as-a-risk-enhancing-factor-and-aortic-stenosis-driver-as-aso-and-sirna/2026-08-18monthly0.6 https://lp-a.org/2024/03/27/biomarcare-project-of-71-678-people-finds-lp-a-predicts-recurrent-coronary-events-only-in-/2026-08-18monthly0.6 https://lp-a.org/2024/03/26/review-updates-on-four-rnai-drugs-that-cut-lp-a-by-more-than-80-now-entering-phase-3-outco/2026-08-18monthly0.6 https://lp-a.org/2024/03/21/review-takes-stock-of-lp-a-s-role-in-atherosclerosis-and-thrombosis-while-highlighting-muv/2026-08-18monthly0.6 https://lp-a.org/2024/03/14/fragment-based-drug-design-screens-61-600-molecular-fragments-to-find-a-novel-small-molecu/2026-08-18monthly0.6 https://lp-a.org/2024/03/13/patients-with-high-lp-a-but-low-ldl-c-carry-over-9-times-the-ascvd-risk-of-those-with-the-/2026-08-17monthly0.6 https://lp-a.org/2024/03/12/review-surveys-the-full-lp-a-lowering-toolkit-from-statins-and-pcsk9-inhibitors-to-apheres/2026-08-18monthly0.6 https://lp-a.org/2024/03/05/in-16-419-boston-patients-followed-nearly-12-years-the-lp-a-threshold-for-elevated-mace-ri/2026-08-18monthly0.6 https://lp-a.org/2024/03/04/review-finds-bempedoic-acid-lowers-ldl-c-and-hs-crp-well-but-has-minimal-effect-on-lp-a-cu/2026-08-18monthly0.6 https://lp-a.org/2024/03/01/digital-droplet-pcr-outperforms-quantitative-pcr-for-measuring-the-lpa-kiv2-repeat-that-dr/2026-08-18monthly0.6 https://lp-a.org/2024/02/28/german-life-child-cohort-finds-lp-a-is-unrelated-to-bmi-age-or-sex-in-512-children-and-sta/2026-08-18monthly0.6 https://lp-a.org/2024/02/28/antisense-and-sirna-therapies-have-reopened-the-decades-long-question-of-lp-a-s-causal-rol/2026-08-17monthly0.6 https://lp-a.org/2024/02/21/review-asks-whether-rna-therapeutics-can-finally-deliver-effective-lp-a-lowering-where-pri/2026-08-18monthly0.6 https://lp-a.org/2024/02/20/nordestgaard-led-study-of-15-danish-lipid-clinics-finds-elevated-lp-a-explains-27-of-clini/2026-08-18monthly0.6 https://lp-a.org/2024/02/16/first-demonstration-that-combining-lp-a-with-fibrinogen-nearly-quintuples-stroke-risk-in-8/2026-08-18monthly0.6 https://lp-a.org/2024/02/09/in-10-435-pci-patients-lp-a-s-cardiovascular-risk-sharpens-as-kidney-function-worsens-and-/2026-08-18monthly0.6 https://lp-a.org/2024/02/06/aspirin-use-and-lower-chd-events-in-people-with-lp-a-above-50-mg-dl-mesa-bhatia-et-al-jaha/2026-08-17monthly0.6 https://lp-a.org/2024/02/05/nordestgaard-and-langsted-review-lp-a-drugs-achieving-up-to-a-106-relative-reduction-as-ph/2026-08-18monthly0.6 https://lp-a.org/2024/02/02/lipoprotein-apheresis-removes-cell-derived-extracellular-vesicles-alongside-lp-a-a-possibl/2026-08-18monthly0.6 https://lp-a.org/2024/01/31/lipoprotein-a-interacts-with-albuminuria-not-egfr-to-raise-chronic-kidney-disease-risk-in-/2026-08-18monthly0.6 https://lp-a.org/2024/01/31/lipoprotein-a-correlates-with-dna-damage-in-heterozygous-familial-hypercholesterolaemia-wi/2026-08-18monthly0.6 https://lp-a.org/2024/01/30/meta-analysis-of-seven-mendelian-randomisation-studies-confirms-lp-a-causally-raises-heart/2026-08-18monthly0.6 https://lp-a.org/2024/01/29/high-lipoprotein-a-predicts-bioprosthetic-aortic-valve-degeneration-in-210-patients-heart-/2026-08-18monthly0.6 https://lp-a.org/2024/01/28/weight-loss-red-wine-exercise-and-trans-fats-each-shift-lp-a-levels-a-review-of-lifestyle-/2026-08-18monthly0.6 https://lp-a.org/2024/01/25/amsterdam-umc-team-finds-lp-a-carried-diacylglycerols-drive-monocyte-inflammation-via-nlrp/2026-08-18monthly0.6 https://lp-a.org/2024/01/24/a-faster-lc-ms-comparison-method-matches-the-lp-a-reference-measurement-procedure-easing-t/2026-08-18monthly0.6 https://lp-a.org/2024/01/23/lp-a-is-about-six-times-more-atherogenic-than-ldl-per-particle-apob-based-mendelian-random/2026-08-17monthly0.6 https://lp-a.org/2024/01/22/lipoprotein-a-is-positively-associated-with-moyamoya-disease-in-a-1012-patient-case-contro/2026-08-18monthly0.6 https://lp-a.org/2024/01/22/elevated-lp-a-predicts-left-atrial-thrombus-or-spontaneous-echo-contrast-in-481-atrial-fib/2026-08-18monthly0.6 https://lp-a.org/2024/01/22/kronenberg-traces-how-genetic-studies-absent-good-animal-models-first-proved-lp-a-causal-i/2026-08-18monthly0.6 https://lp-a.org/2024/01/19/over-1-in-5-of-18-544-bypass-surgery-patients-had-high-lp-a-which-raised-death-risk-31-and/2026-08-18monthly0.6 https://lp-a.org/2024/01/18/mendelian-randomisation-using-290-497-uk-biobank-participants-finds-no-causal-link-between/2026-08-18monthly0.6 https://lp-a.org/2024/01/06/an-lp-a-gene-haplotype-rs10455872-rs3798220-is-linked-to-higher-inflammation-and-antifibri/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/rdw-homocysteine-and-lp-a-are-independent-risk-factors-for-new-onset-atrial-fibrillation-i/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/higher-lp-a-and-tg-hdl-c-ratio-flag-unstable-carotid-plaque-in-142-acute-ischaemic-stroke-/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/elevated-lp-a-50-mg-dl-predicts-failure-to-reach-ldl-c-targets-in-870-patients-with-stable/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/lp-a-is-linked-to-greater-peri-coronary-inflammation-in-people-with-hiv-compared-to-those-/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/the-polish-cardiac-society-and-polish-lipid-association-publish-the-country-first-expert-r/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/only-81-of-surveyed-uk-lipid-clinics-can-measure-lp-a-and-reporting-units-still-vary-widel/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/rosuvastatin-with-or-without-fenofibrate-raises-lp-a-despite-lowering-ldl-cholesterol-in-a/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/elevated-lp-a-more-than-doubles-ascvd-risk-in-an-underserved-non-metropolitan-german-regio/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/dietary-fat-intake-does-not-modify-the-link-between-lp-a-and-cardiovascular-death-in-22-80/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/advanced-age-and-higher-hba1c-are-linked-to-elevated-lp-a-in-600-cardiovascular-disease-pa/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/high-lp-a-30-mg-dl-raises-ischaemic-stroke-risk-in-atrial-fibrillation-patients-across-fou/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/higher-lp-a-is-independently-associated-with-diabetic-nephropathy-in-767-han-chinese-patie/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/lp-a-above-117-nmol-l-more-than-doubles-ischaemic-stroke-risk-driven-by-the-large-artery-a/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/concurrent-high-lp-a-and-hs-crp-nearly-quadruples-cardiovascular-death-risk-after-acute-my/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/combining-lp-a-and-fibrinogen-improves-all-cause-mortality-prediction-in-43-367-coronary-a/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/elevated-lp-a-30-mg-dl-more-than-quadruples-risk-of-adverse-cardiac-events-after-pci-in-60/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/long-term-lipoprotein-apheresis-cuts-cardiovascular-events-by-72-in-25-patients-with-isola/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/lp-a-improves-20-year-cardiovascular-risk-reclassification-beyond-the-framingham-and-reyno/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/combined-elevation-of-lp-a-and-lp-pla2-raises-1-year-stroke-recurrence-risk-in-10-675-isch/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/lp-a-rises-with-carotid-atherosclerosis-severity-in-2-018-acute-ischaemic-stroke-patients-/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/lp-a-testing-rose-109-over-five-years-at-a-uae-quaternary-centre-and-abnormal-lp-a-tracked/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/mendelian-randomisation-finds-no-causal-link-between-lp-a-and-type-2-diabetes-despite-an-i/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/saudi-arabia-first-lp-a-reference-intervals-median-50-nmol-l-in-361-individuals-unaffected/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/27-8-of-511-polish-cardiology-and-endocrinology-patients-have-lp-a-above-30-mg-dl-first-re/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/serum-lp-a-300-mg-l-predicts-early-neurological-deterioration-after-thrombolysis-for-acute/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/combined-elevation-of-lp-a-and-hs-crp-not-lp-a-alone-raises-platelet-reactivity-on-clopido/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/only-31-of-university-of-pennsylvania-physicians-regularly-test-for-lp-a-citing-unfamiliar/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/non-hispanic-black-and-hispanic-patients-are-tested-for-lp-a-far-less-often-than-white-pat/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/elevated-lp-a-predicts-major-adverse-cardiovascular-events-after-pci-in-1-168-patients-wit/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/a-10-day-water-only-fast-followed-by-a-whole-food-no-added-salt-oil-sugar-diet-cut-lp-a-by/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/27-of-2-001-high-risk-polish-patients-have-elevated-lp-a-the-zabrze-lipoprotein-a-registry/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/combining-lp-a-with-neck-circumference-improves-diagnostic-accuracy-for-coronary-heart-dis/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/a-pilot-study-proposes-a-lower-lp-a-cut-off-of-21-1-mg-dl-for-atherosclerotic-risk-in-kaza/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/elevated-lp-a-30-mg-dl-is-associated-with-higher-sarcopenia-risk-in-426-patients-with-type/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/lp-a-distribution-varies-by-ethnicity-and-sex-in-521-hospitalised-singaporean-patients-wit/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/sustained-high-lp-a-does-not-significantly-increase-in-stent-restenosis-or-repeat-pci-risk/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/high-lp-a-is-associated-with-greater-cerebral-white-matter-hyperintensity-burden-in-153-st/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/low-pretreatment-lp-a-predicts-egfr-mutations-and-shorter-progression-free-survival-in-338/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/smaller-apo-a-isoforms-and-denser-fibrin-networks-link-elevated-lp-a-to-thromboembolism-a-/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/high-lp-a-raises-diabetic-vascular-complication-risk-while-low-lp-a-predicts-new-onset-typ/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/about-a-quarter-of-the-world-has-lp-a-above-50-mg-dl-and-gene-silencing-drugs-dosed-a-few-/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/the-spanish-society-of-arteriosclerosis-issues-a-consensus-statement-on-lipoprotein-a-test/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/testing-every-adult-once-for-lp-a-cascade-screening-relatives-and-pcsk9-inhibition-on-top-/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/elevated-lp-a-independently-predicts-major-adverse-cardiovascular-events-and-mortality-aft/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/alirocumab-cuts-cardiovascular-events-regardless-of-sex-with-a-larger-benefit-at-higher-ba/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/three-phase-3-lp-a-lowering-outcomes-trials-will-start-reporting-from-2025-a-national-lipi/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/olpasiran-and-pelacarsen-could-be-cost-effective-at-au-1867-and-au-984-per-year-for-second/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/lp-a-s-structural-resemblance-to-plasminogen-drives-both-plaque-instability-and-impaired-f/2026-08-18monthly0.6 https://lp-a.org/2024/01/01/nla-focused-update-2024-measure-lp-a-at-least-once-in-every-adult-with-three-risk-bands-ko/2026-08-17monthly0.6 https://lp-a.org/2023/12/30/patients-with-elevated-lp-a-125-nmol-l-face-very-high-cardiovascular-risk-with-early-event/2026-08-18monthly0.6 https://lp-a.org/2023/12/30/lp-a-falls-as-triglycerides-rise-above-300-mg-dl-but-only-without-diabetes-obesity-or-fami/2026-08-18monthly0.6 https://lp-a.org/2023/12/30/coronary-microvascular-dysfunction-is-five-times-more-common-in-asymptomatic-people-with-h/2026-08-18monthly0.6 https://lp-a.org/2023/12/29/review-reports-elevated-lp-a-affects-25-of-indians-versus-1-in-5-worldwide-and-correlated-/2026-08-18monthly0.6 https://lp-a.org/2023/12/27/uk-biobank-study-of-32-537-patients-finds-elevated-lp-a-raises-subsequent-mace-risk-most-s/2026-08-18monthly0.6 https://lp-a.org/2023/12/24/review-calls-out-ethnic-and-racial-disparities-in-lp-a-inheritance-as-an-underappreciated-/2026-08-18monthly0.6 https://lp-a.org/2023/12/12/high-lp-a-triples-peripheral-artery-disease-and-doubles-abdominal-aortic-aneurysm-risk-con/2026-08-18monthly0.6 https://lp-a.org/2023/12/12/elevated-lp-a-is-linked-to-subclinical-myocardial-fibrosis-and-left-atrial-remodelling-in-/2026-08-18monthly0.6 https://lp-a.org/2023/12/12/one-in-three-ghanaian-ischaemic-stroke-survivors-has-elevated-lipoprotein-a-linked-to-fema/2026-08-18monthly0.6 https://lp-a.org/2023/12/05/lepodisiran-phase-1-a-single-608-mg-dose-keeps-lp-a-94-percent-down-at-day-337-nissen-et-a/2026-08-17monthly0.6 https://lp-a.org/2023/12/03/elevated-lp-a-is-associated-with-both-the-prevalence-and-progression-of-coronary-artery-ca/2026-08-18monthly0.6 https://lp-a.org/2023/12/01/cascade-screening-yields-elevated-lp-a-in-47-of-first-degree-relatives-a-7-4-fold-higher-o/2026-08-18monthly0.6 https://lp-a.org/2023/12/01/systematic-review-of-40-045-patients-finds-the-lp-a-fatty-liver-relationship-remains-genui/2026-08-18monthly0.6 https://lp-a.org/2023/11/28/lipoprotein-apheresis-transiently-depletes-very-long-chain-fatty-acids-for-at-least-7-days/2026-08-18monthly0.6 https://lp-a.org/2023/11/27/lp-a-does-not-predict-carotid-intima-media-thickness-over-20-years-in-88-children-without-/2026-08-18monthly0.6 https://lp-a.org/2023/11/24/review-argues-lp-a-testing-helps-solve-the-ascvd-risk-puzzle-specifically-for-statin-poor-/2026-08-18monthly0.6 https://lp-a.org/2023/11/18/hegele-mancini-and-colleagues-update-how-to-apply-lp-a-in-ascvd-risk-assessment-under-cana/2026-08-18monthly0.6 https://lp-a.org/2023/11/17/cascade-testing-for-lp-a-yields-4x-more-elevated-cases-when-starting-from-fh-index-patient/2026-08-18monthly0.6 https://lp-a.org/2023/11/14/review-poses-the-10-biggest-unanswered-questions-about-lp-a-from-its-physiological-role-to/2026-08-18monthly0.6 https://lp-a.org/2023/11/08/mfsd5-identified-as-a-receptor-mediating-lipoprotein-a-uptake-and-calcification-in-heart-v/2026-08-18monthly0.6 https://lp-a.org/2023/11/08/uk-national-survey-finds-only-3-of-65-responding-labs-had-fully-adopted-the-2019-heart-uk-/2026-08-18monthly0.6 https://lp-a.org/2023/11/08/nature-reviews-cardiology-essay-revisits-how-lp-a-affects-platelets-and-why-the-aspree-tri/2026-08-18monthly0.6 https://lp-a.org/2023/11/04/a-national-database-of-87-379-patients-confirms-no-link-between-lp-a-and-retinal-vein-occl/2026-08-18monthly0.6 https://lp-a.org/2023/11/03/international-guidelines-now-support-a-once-in-a-lifetime-lp-a-measurement-in-every-adult-/2026-08-18monthly0.6 https://lp-a.org/2023/10/31/the-hellenicscore-ii-improves-10-year-cardiovascular-risk-classification-by-4-when-stratif/2026-08-18monthly0.6 https://lp-a.org/2023/10/26/lipoprotein-a-levels-do-not-differ-in-graves-ophthalmopathy-versus-graves-disease-without-/2026-08-18monthly0.6 https://lp-a.org/2023/10/19/extended-dual-antiplatelet-therapy-beyond-1-year-cuts-ischaemic-events-in-acs-patients-wit/2026-08-18monthly0.6 https://lp-a.org/2023/10/18/elevated-lp-a-predicts-long-term-recurrent-myocardial-infarction-but-not-mortality-in-1-22/2026-08-18monthly0.6 https://lp-a.org/2023/10/17/sixty-years-after-its-discovery-lp-a-still-lacks-a-standardised-assay-an-approved-lowering/2026-08-18monthly0.6 https://lp-a.org/2023/10/16/tibolone-lowers-lipoprotein-a-by-7-49-mg-dl-in-postmenopausal-women-a-meta-analysis-of-13-/2026-08-18monthly0.6 https://lp-a.org/2023/10/06/olpasiran-and-pelacarsen-cut-lp-a-by-85-90-with-phase-3-outcome-trials-testing-whether-thi/2026-08-18monthly0.6 https://lp-a.org/2023/10/04/ocean-a-dose-shows-dose-dependent-lp-a-lowering-with-olpasiran-every-12-weeks-part-of-a-br/2026-08-18monthly0.6 https://lp-a.org/2023/09/30/lp-a-is-not-elevated-in-familial-hypercholesterolaemia-and-is-metabolically-independent-of/2026-08-18monthly0.6 https://lp-a.org/2023/09/30/elevated-lp-a-triples-recurrent-cardiovascular-event-risk-in-coronary-patients-with-predia/2026-08-18monthly0.6 https://lp-a.org/2023/09/22/chemotherapy-may-raise-lp-a-in-breast-cancer-survivors-adding-cardiovascular-risk-on-top-o/2026-08-18monthly0.6 https://lp-a.org/2023/09/19/lp-a-testing-in-a-large-us-academic-health-system-0-3-percent-of-adults-over-ten-years-bha/2026-08-17monthly0.6 https://lp-a.org/2023/09/19/muvalaplin-the-first-oral-inhibitor-of-lp-a-formation-phase-1-nicholls-et-al-jama-2023/2026-08-17monthly0.6 https://lp-a.org/2023/09/15/a-healthy-lifestyle-lowers-coronary-artery-disease-risk-regardless-of-lp-a-level-though-ri/2026-08-18monthly0.6 https://lp-a.org/2023/09/09/interleukin-6-receptor-inhibitors-lower-lp-a-by-16-41-less-than-dedicated-lp-a-drugs-but-w/2026-08-18monthly0.6 https://lp-a.org/2023/09/06/lp-a-risk-rises-above-30-mg-dl-with-the-accepted-50-mg-dl-threshold-and-levels-can-range-b/2026-08-18monthly0.6 https://lp-a.org/2023/09/05/new-aso-and-sirna-drugs-cut-lp-a-by-up-to-98-far-beyond-what-existing-lipid-lowering-thera/2026-08-18monthly0.6 https://lp-a.org/2023/09/04/lipoprotein-a-should-be-measured-once-in-a-lifetime-as-part-of-standard-non-fasting-lipid-/2026-08-18monthly0.6 https://lp-a.org/2023/09/03/traditional-lp-a-drugs-barely-reach-50-reduction-while-new-rna-interfering-agents-may-exce/2026-08-18monthly0.6 https://lp-a.org/2023/08/29/is-lp-a-more-than-a-bystander-in-hypertension-a-review-of-the-mechanistic-evidence-linking/2026-08-18monthly0.6 https://lp-a.org/2023/08/28/lp-a-is-a-causal-risk-factor-for-calcific-aortic-valve-disease-via-oxidised-phospholipids-/2026-08-18monthly0.6 https://lp-a.org/2023/08/26/testing-and-treating-lp-a-is-clinically-actionable-today-via-cascade-screening-and-pcsk9-i/2026-08-18monthly0.6 https://lp-a.org/2023/08/26/mass-molar-and-mass-spectrometry-lp-a-assays-predict-cardiovascular-risk-and-alirocumab-be/2026-08-18monthly0.6 https://lp-a.org/2023/08/25/young-stemi-patients-have-nearly-double-the-lp-a-of-middle-aged-stemi-patients-in-a-287-pa/2026-08-18monthly0.6 https://lp-a.org/2023/08/17/plasminogen-receptors-plgrkt-annexin-a2-and-s100a10-drive-lp-a-uptake-into-liver-cells-via/2026-08-18monthly0.6 https://lp-a.org/2023/08/09/adding-lp-a-to-the-pooled-cohort-equations-meaningfully-improves-10-year-ascvd-risk-reclas/2026-08-18monthly0.6 https://lp-a.org/2023/08/08/statin-therapy-masks-the-inverse-relationship-between-kidney-function-and-lp-a-in-149-japa/2026-08-18monthly0.6 https://lp-a.org/2023/08/06/genetically-higher-lp-a-raises-atrial-fibrillation-risk-in-europeans-but-not-in-a-chinese-/2026-08-18monthly0.6 https://lp-a.org/2023/07/31/aspirin-may-benefit-primary-prevention-specifically-in-people-with-genetically-elevated-lp/2026-08-18monthly0.6 https://lp-a.org/2023/07/29/gene-silencing-drugs-cut-lp-a-by-70-90-and-ldl-c-by-over-30-positioning-pcsk9-and-lp-a-as-/2026-08-18monthly0.6 https://lp-a.org/2023/07/28/about-20-of-people-carry-elevated-lp-a-and-phase-3-outcome-trials-of-pelacarsen-and-olpasi/2026-08-18monthly0.6 https://lp-a.org/2023/07/26/20-25-of-people-worldwide-have-lp-a-50-mg-dl-or-above-and-existing-drugs-barely-touch-it-w/2026-08-18monthly0.6 https://lp-a.org/2023/07/24/in-16-150-chinese-coronary-disease-patients-the-lowest-lp-a-quintile-not-the-highest-had-t/2026-08-18monthly0.6 https://lp-a.org/2023/07/22/insulin-like-growth-factor-i-may-suppress-lp-a-synthesis-opening-a-novel-avenue-for-hyperl/2026-08-18monthly0.6 https://lp-a.org/2023/07/21/lp-a-drives-progressive-carotid-wall-thickening-in-children-with-familial-hypercholesterol/2026-08-18monthly0.6 https://lp-a.org/2023/07/19/the-italian-society-for-the-study-of-atherosclerosis-publishes-a-national-consensus-on-lip/2026-08-18monthly0.6 https://lp-a.org/2023/07/19/elevated-lp-a-shows-a-consistent-positive-association-with-heart-failure-across-73-410-pat/2026-08-18monthly0.6 https://lp-a.org/2023/07/14/elevated-lp-a-raises-coronary-artery-calcification-risk-by-58-in-asymptomatic-adults-a-met/2026-08-18monthly0.6 https://lp-a.org/2023/07/14/elevated-lp-a-is-already-present-by-age-5-and-remains-largely-unmodifiable-by-lifestyle-or/2026-08-18monthly0.6 https://lp-a.org/2023/07/12/a-meta-analysis-of-9-studies-finds-no-overall-association-between-lp-a-and-atrial-fibrilla/2026-08-18monthly0.6 https://lp-a.org/2023/07/07/decreased-lp-a-unlike-increased-apob-is-paradoxically-linked-to-metabolic-syndrome-in-a-me/2026-08-18monthly0.6 https://lp-a.org/2023/07/06/lp-a-predicts-faster-aortic-valve-stenosis-progression-and-higher-mortality-confirmed-gene/2026-08-18monthly0.6 https://lp-a.org/2023/07/05/lp-a-reaches-adult-levels-by-age-2-and-stays-stable-for-life-supporting-a-single-universal/2026-08-18monthly0.6 https://lp-a.org/2023/07/04/one-in-five-people-of-european-ancestry-has-elevated-lp-a-and-new-rna-drugs-can-lower-it-m/2026-08-18monthly0.6 https://lp-a.org/2023/07/03/lp-a-drives-atherosclerosis-through-plaque-formation-thrombogenicity-and-inflammation-but-/2026-08-18monthly0.6 https://lp-a.org/2023/07/01/median-lp-a-ranges-from-12-to-41-nmol-l-across-hispanic-latino-backgrounds-in-the-us-track/2026-08-18monthly0.6 https://lp-a.org/2023/07/01/every-rna-based-lp-a-drug-tested-lowers-it-by-more-than-90-a-systematic-assessment-of-22-t/2026-08-18monthly0.6 https://lp-a.org/2023/07/01/elevated-lp-a-200-nmol-l-raises-cardiovascular-event-risk-by-33-in-a-cohort-mirroring-the-/2026-08-18monthly0.6 https://lp-a.org/2023/06/20/pelacarsen-does-not-alter-platelet-reactivity-via-thromboxane-a2-or-p2y12-pathways-in-275-/2026-08-18monthly0.6 https://lp-a.org/2023/06/08/lp-a-evidence-in-children-lags-far-behind-adults-but-early-testing-could-still-guide-famil/2026-08-18monthly0.6 https://lp-a.org/2023/06/07/women-with-polycystic-ovary-syndrome-have-higher-lp-a-than-controls-regardless-of-weight-a/2026-08-18monthly0.6 https://lp-a.org/2023/06/05/a-single-apheresis-session-immediately-clears-over-60-of-atherogenic-apob-particles-remain/2026-08-18monthly0.6 https://lp-a.org/2023/06/03/lp-a-and-family-history-of-cardiovascular-disease-combine-to-raise-heart-failure-risk-by-4/2026-08-18monthly0.6 https://lp-a.org/2023/06/01/evolocumab-140-mg-or-alirocumab-150-mg-every-two-weeks-are-the-most-effective-pcsk9-inhibi/2026-08-18monthly0.6 https://lp-a.org/2023/06/01/thirty-frequent-questions-on-the-2022-eas-lp-a-consensus-answered-kronenberg-mora-stroes-e/2026-08-17monthly0.6 https://lp-a.org/2023/05/30/transgenic-mice-expressing-human-lp-a-develop-larger-more-vulnerable-more-calcified-athero/2026-08-18monthly0.6 https://lp-a.org/2023/05/16/beyond-statins-and-pcsk9-inhibitors-several-non-lipid-drug-classes-also-alter-lp-a-levels-/2026-08-18monthly0.6 https://lp-a.org/2023/05/15/42-5-g-of-mixed-nuts-daily-for-16-weeks-does-not-lower-ldl-c-or-lp-a-though-it-reduces-bod/2026-08-18monthly0.6 https://lp-a.org/2023/05/09/lp-a-and-its-oxidised-phospholipids-predict-multivessel-coronary-disease-and-cardiovascula/2026-08-18monthly0.6 https://lp-a.org/2023/05/09/elevated-lp-a-is-linked-to-a-roughly-fourfold-higher-risk-of-ischaemic-stroke-and-thrombos/2026-08-18monthly0.6 https://lp-a.org/2023/04/25/trial-design-challenges-for-lp-a-lowering-therapies-take-center-stage-as-pelacarsen-and-ol/2026-08-18monthly0.6 https://lp-a.org/2023/04/24/aortic-valve-calcification-is-strongly-linked-to-elevated-lp-a-a-meta-analysis-pooling-446/2026-08-18monthly0.6 https://lp-a.org/2023/04/21/lp-a-drives-ascvd-mi-and-aortic-stenosis-risk-independent-of-c-reactive-protein-copenhagen/2026-08-17monthly0.6 https://lp-a.org/2023/04/21/lp-a-in-children-with-suspected-familial-hypercholesterolaemia-de-boer-et-al-ehj-2023/2026-08-17monthly0.6 https://lp-a.org/2023/04/12/inclisiran-needs-only-two-doses-a-year-to-sustain-ldl-c-lowering-with-the-orion-victorion-/2026-08-18monthly0.6 https://lp-a.org/2023/04/08/elevated-lp-a-predicts-cardiovascular-events-and-death-in-chronic-kidney-disease-patients-/2026-08-18monthly0.6 https://lp-a.org/2023/04/07/lp-a-levels-are-significantly-higher-in-patients-with-premature-coronary-artery-disease-a-/2026-08-18monthly0.6 https://lp-a.org/2023/04/01/antisense-oligonucleotides-and-sirnas-cut-lp-a-by-98-101-in-recent-trials-though-whether-t/2026-08-18monthly0.6 https://lp-a.org/2023/03/21/elevated-lp-a-triples-myocardial-infarction-risk-in-young-patients-a-systematic-review-of-/2026-08-18monthly0.6 https://lp-a.org/2023/03/15/lp-a-above-50-mg-dl-raises-carotid-plaque-risk-by-30-in-a-chinese-population-distribution-/2026-08-18monthly0.6 https://lp-a.org/2023/03/01/lp-a-above-50-mg-dl-raises-cardiovascular-mortality-risk-by-83-independent-of-ldl-choleste/2026-08-18monthly0.6 https://lp-a.org/2023/02/23/lp-a-promotes-aortic-valve-calcification-via-a-three-hit-mechanism-lipid-deposition-inflam/2026-08-18monthly0.6 https://lp-a.org/2023/02/23/75-5-of-surveyed-european-lipid-clinicians-routinely-measure-lp-a-but-reimbursement-and-tr/2026-08-18monthly0.6 https://lp-a.org/2023/02/16/lp-a-is-linked-to-mitral-valve-calcification-but-shows-mixed-results-for-mitral-dysfunctio/2026-08-18monthly0.6 https://lp-a.org/2023/02/11/lp-a-is-higher-in-black-populations-and-in-women-but-a-lack-of-standardised-assays-and-cut/2026-08-18monthly0.6 https://lp-a.org/2023/02/08/in-chinese-populations-elevated-lp-a-is-linked-to-post-pci-thrombosis-aortic-stenosis-stro/2026-08-18monthly0.6 https://lp-a.org/2023/01/28/every-50-mg-dl-rise-in-lp-a-raises-cardiovascular-death-risk-by-up-to-31-a-dose-response-m/2026-08-18monthly0.6 https://lp-a.org/2023/01/25/the-australian-atherosclerosis-society-issues-a-position-statement-recommending-selective-/2026-08-18monthly0.6 https://lp-a.org/2023/01/24/smaller-apo-a-isoforms-raise-lp-a-mainly-by-boosting-production-and-ancestry-strengthens-t/2026-08-18monthly0.6 https://lp-a.org/2023/01/20/lp-a-testing-is-performed-in-only-0-34-of-german-patients-but-when-done-is-linked-to-bette/2026-08-18monthly0.6 https://lp-a.org/2023/01/18/lp-a-drives-inflammation-atherosclerosis-and-thrombosis-via-oxidised-phospholipid-transpor/2026-08-18monthly0.6 https://lp-a.org/2023/01/18/nissen-and-laffin-call-lp-a-an-overlooked-risk-factor-affecting-20-30-of-the-world-s-popul/2026-08-18monthly0.6 https://lp-a.org/2023/01/06/elevated-lp-a-most-robustly-predicts-coronary-events-in-postmenopausal-women-though-result/2026-08-18monthly0.6 https://lp-a.org/2023/01/01/lp-a-is-higher-in-children-with-homozygous-familial-hypercholesterolaemia-than-heterozygou/2026-08-18monthly0.6 https://lp-a.org/2023/01/01/elevated-lp-a-30-mg-dl-raises-long-term-mace-risk-by-31-after-pci-for-in-stent-restenosis-/2026-08-18monthly0.6 https://lp-a.org/2023/01/01/higher-lp-a-predicts-a-61-lower-risk-of-new-onset-type-2-diabetes-in-patients-with-familia/2026-08-18monthly0.6 https://lp-a.org/2023/01/01/high-lp-a-doubles-coronary-heart-disease-risk-only-in-people-with-elevated-factor-viii-or-/2026-08-18monthly0.6 https://lp-a.org/2023/01/01/unlike-ldl-c-lp-a-is-not-associated-with-baseline-coronary-artery-calcium-and-only-modestl/2026-08-18monthly0.6 https://lp-a.org/2023/01/01/high-dose-omega-3-fatty-acids-cut-arterial-inflammation-by-4-in-patients-with-elevated-lp-/2026-08-18monthly0.6 https://lp-a.org/2023/01/01/lp-a-testing-rose-steadily-but-remained-rare-at-the-university-of-rochester-medical-center/2026-08-18monthly0.6 https://lp-a.org/2023/01/01/only-0-25-of-2-4-million-patients-in-a-us-healthcare-network-have-ever-had-lp-a-measured-w/2026-08-18monthly0.6 https://lp-a.org/2023/01/01/lp-a-is-50-lower-in-patients-with-fatty-liver-inflammation-nash-than-simple-fatty-liver-na/2026-08-18monthly0.6 https://lp-a.org/2023/01/01/lp-a-independently-predicts-diabetic-nephropathy-with-extreme-statistical-certainty-in-6-9/2026-08-18monthly0.6 https://lp-a.org/2023/01/01/high-lp-a-brings-cardiovascular-events-about-7-years-earlier-than-high-ldl-alone-in-polyge/2026-08-18monthly0.6 https://lp-a.org/2023/01/01/bempedoic-acid-modestly-raises-lp-a-by-2-4-while-lowering-hscrp-by-26-5-and-ldl-c-by-21-1-/2026-08-18monthly0.6 https://lp-a.org/2023/01/01/lp-a-is-moving-from-a-passive-risk-marker-to-an-active-therapeutic-target-in-acute-coronar/2026-08-18monthly0.6 https://lp-a.org/2023/01/01/alirocumab-and-evolocumab-cut-lp-a-by-about-20-in-familial-hypercholesterolaemia-a-meta-an/2026-08-18monthly0.6 https://lp-a.org/2023/01/01/a-practical-clinical-guide-to-lp-a-genetics-real-world-risk-factor-interactions-and-emergi/2026-08-18monthly0.6 https://lp-a.org/2023/01/01/elevated-lp-a-raises-cognitive-impairment-odds-by-62-and-stroke-related-disability-by-46-i/2026-08-18monthly0.6 https://lp-a.org/2023/01/01/13-of-17-studies-link-elevated-lp-a-to-diabetic-retinopathy-risk-in-type-2-diabetes-a-syst/2026-08-18monthly0.6 https://lp-a.org/2022/12/22/as-lp-a-lowering-drugs-approach-outcome-trials-aortic-stenosis-joins-atherosclerosis-as-a-/2026-08-18monthly0.6 https://lp-a.org/2022/12/21/anti-oestrogen-therapy-lowers-lp-a-by-5-92-in-postmenopausal-women-a-meta-analysis-of-10-d/2026-08-18monthly0.6 https://lp-a.org/2022/12/20/statins-raise-lp-a-while-pcsk9-inhibitors-and-rna-therapies-lower-it-a-57-year-literature-/2026-08-18monthly0.6 https://lp-a.org/2022/12/16/about-20-of-europeans-have-elevated-lp-a-that-current-lipid-drugs-cannot-adequately-lower-/2026-08-18monthly0.6 https://lp-a.org/2022/12/16/about-5-of-the-population-has-highly-elevated-lp-a-a-norwegian-review-of-assessment-and-tr/2026-08-18monthly0.6 https://lp-a.org/2022/12/15/lp-a-tracks-worsening-kidney-function-and-predicts-advanced-ckd-stage-in-224-patients-with/2026-08-18monthly0.6 https://lp-a.org/2022/12/13/pcsk9-inhibitors-are-currently-the-most-effective-approved-option-for-lowering-lp-a-but-me/2026-08-18monthly0.6 https://lp-a.org/2022/12/12/hormone-therapy-with-17beta-estradiol-plus-norethisterone-lowers-lp-a-by-67-6-mg-l-in-post/2026-08-18monthly0.6 https://lp-a.org/2022/12/08/pelacarsen-lowers-lp-a-by-up-to-106-in-healthy-japanese-subjects-supporting-the-80-mg-mont/2026-08-18monthly0.6 https://lp-a.org/2022/12/05/universal-lp-a-screening-meets-nearly-every-criterion-except-outcome-trial-proof-that-lowe/2026-08-18monthly0.6 https://lp-a.org/2022/12/01/pelacarsen-olpasiran-and-sln360-headline-a-wave-of-recent-lp-a-lowering-rna-trials-with-ou/2026-08-18monthly0.6 https://lp-a.org/2022/11/29/correcting-ldl-c-for-genetically-estimated-lp-a-reclassifies-up-to-9-of-suspected-fh-patie/2026-08-18monthly0.6 https://lp-a.org/2022/11/28/high-lp-a-in-youth-ages-9-24-doubles-the-risk-of-adult-cardiovascular-disease-decades-late/2026-08-18monthly0.6 https://lp-a.org/2022/11/26/a-new-formula-corrects-ldl-cholesterol-for-lipoprotein-a-cholesterol-content-eliminating-n/2026-08-18monthly0.6 https://lp-a.org/2022/11/22/lp-a-of-180-mg-dl-carries-the-same-heart-attack-risk-as-genetically-diagnosed-familial-hyp/2026-08-18monthly0.6 https://lp-a.org/2022/11/21/every-10-mg-dl-rise-in-lp-a-raises-peripheral-artery-disease-risk-by-6-a-dose-response-met/2026-08-18monthly0.6 https://lp-a.org/2022/11/17/ocean-a-dose-olpasiran-lowers-lp-a-by-more-than-95-percent-in-patients-with-ascvd-o-donogh/2026-08-17monthly0.6 https://lp-a.org/2022/11/04/about-20-of-people-have-elevated-lp-a-above-50-mg-dl-and-a-meaningful-share-also-have-fami/2026-08-18monthly0.6 https://lp-a.org/2022/11/01/the-beijing-heart-society-issues-an-expert-scientific-statement-on-lp-a-and-cardiovascular/2026-08-18monthly0.6 https://lp-a.org/2022/10/25/elevated-lp-a-raises-cardiac-event-risk-only-when-hs-crp-is-also-high-an-interaction-found/2026-08-18monthly0.6 https://lp-a.org/2022/10/20/lp-a-cardiovascular-risk-may-run-through-inflammation-and-lowering-it-partly-reverses-the-/2026-08-18monthly0.6 https://lp-a.org/2022/10/18/pelacarsen-and-olpasiran-achieve-up-to-90-lp-a-reductions-positioning-routine-lp-a-testing/2026-08-18monthly0.6 https://lp-a.org/2022/10/14/a-pan-european-north-american-comparison-of-lp-a-guidelines-converges-on-a-risk-calculator/2026-08-18monthly0.6 https://lp-a.org/2022/10/14/lp-a-is-associated-with-the-onset-but-not-the-progression-of-aortic-valve-calcification-th/2026-08-17monthly0.6 https://lp-a.org/2022/10/14/the-2022-eas-consensus-statement-on-lp-a-in-ascvd-and-aortic-stenosis-kronenberg-mora-stro/2026-08-17monthly0.6 https://lp-a.org/2022/10/13/mechanistic-epidemiologic-and-genetic-evidence-converges-on-lp-a-as-a-causal-driver-of-bot/2026-08-18monthly0.6 https://lp-a.org/2022/10/13/no-association-found-between-lp-a-and-cardiovascular-mortality-in-1-222-patients-with-peri/2026-08-18monthly0.6 https://lp-a.org/2022/10/08/elevated-lp-a-50-mg-dl-raises-coronary-heart-disease-risk-regardless-of-ldl-c-level-in-4-5/2026-08-18monthly0.6 https://lp-a.org/2022/10/06/menopause-raises-lp-a-by-3-77-mg-dl-though-ageing-itself-cannot-be-ruled-out-as-the-driver/2026-08-18monthly0.6 https://lp-a.org/2022/10/04/aspirin-benefits-older-adults-with-lp-a-raising-genotypes-in-primary-prevention-aspree-lac/2026-08-17monthly0.6 https://lp-a.org/2022/10/01/lp-a-levels-in-a-global-ascvd-population-lp-a-heritage-nissen-et-al-open-heart-2022/2026-08-17monthly0.6 https://lp-a.org/2022/09/26/pcsk9-inhibition-lp-a-lowering-effect-explains-under-4-of-its-coronary-disease-benefit-a-m/2026-08-18monthly0.6 https://lp-a.org/2022/09/24/sln360-is-well-tolerated-in-preclinical-rat-and-primate-studies-with-reversible-liver-kidn/2026-08-18monthly0.6 https://lp-a.org/2022/09/12/should-children-with-high-lp-a-be-treated-with-asos-or-sirnas-a-dutch-review-argues-yes-bu/2026-08-18monthly0.6 https://lp-a.org/2022/09/09/growth-hormone-treatment-may-raise-lp-a-and-explain-reported-cardiovascular-morbidity-in-t/2026-08-18monthly0.6 https://lp-a.org/2022/09/06/pelacarsen-olpasiran-and-sln360-lower-lp-a-by-up-to-90-with-pelacarsen-phase-3-outcome-tri/2026-08-18monthly0.6 https://lp-a.org/2022/08/30/ancestry-lp-a-and-cardiovascular-risk-thresholds-tsimikas-and-marcovina-jacc-2022/2026-08-17monthly0.6 https://lp-a.org/2022/08/11/olpasiran-cuts-lp-a-by-up-to-99-with-similar-effect-in-japanese-and-non-japanese-subjects-/2026-08-18monthly0.6 https://lp-a.org/2022/08/02/lp-a-rises-with-thrombotic-activity-but-falls-with-inflammation-during-covid-19-hospitalis/2026-08-18monthly0.6 https://lp-a.org/2022/08/02/effects-of-randomized-treatment-with-icosapent-ethyl-and-a-mineral-oil-comparator-on-inter/2026-08-17monthly0.6 https://lp-a.org/2022/08/01/is-lp-a-a-real-risk-multiplier-in-familial-hypercholesterolaemia-or-just-along-for-the-rid/2026-08-18monthly0.6 https://lp-a.org/2022/08/01/sex-differences-in-lp-a-levels-and-associated-risk-by-age-copenhagen-simony-et-al-atherosc/2026-08-17monthly0.6 https://lp-a.org/2022/07/16/lp-a-stays-remarkably-stable-over-25-years-but-people-from-eastern-finland-run-20-higher-l/2026-08-18monthly0.6 https://lp-a.org/2022/07/01/lp-a-and-its-significance-in-cardiovascular-disease-a-review-duarte-lau-and-giugliano-jama/2026-08-17monthly0.6 https://lp-a.org/2022/06/25/from-kare-berg-1963-discovery-to-today-targeted-drugs-a-practising-clinician-guide-to-lp-a/2026-08-18monthly0.6 https://lp-a.org/2022/06/18/elevated-lp-a-50-mg-dl-doubles-coronary-event-risk-even-in-older-men-a-prospective-study-o/2026-08-18monthly0.6 https://lp-a.org/2022/06/08/a-new-isoform-independent-lp-a-elisa-matches-the-gold-standard-assay-and-mass-spectrometry/2026-08-18monthly0.6 https://lp-a.org/2022/06/08/nano-curcumin-80-mg-day-cuts-lp-a-and-hs-crp-over-90-days-in-64-type-2-diabetic-patients-w/2026-08-18monthly0.6 https://lp-a.org/2022/06/01/lp-a-levels-are-driven-mainly-by-how-much-the-liver-makes-not-how-fast-it-clears-redirecti/2026-08-18monthly0.6 https://lp-a.org/2022/05/26/adding-orlistat-to-ethinyl-estradiol-drospirenone-lowers-lp-a-in-overweight-pcos-patients-/2026-08-18monthly0.6 https://lp-a.org/2022/05/16/the-ocean-a-dose-trial-enrolls-281-patients-to-find-olpasiran-optimal-dose-ahead-of-a-card/2026-08-18monthly0.6 https://lp-a.org/2022/05/05/how-much-must-lp-a-fall-to-matter-clinically-a-critical-overview-of-treatment-targets-stra/2026-08-18monthly0.6 https://lp-a.org/2022/05/05/statin-therapy-does-not-meaningfully-change-lp-a-a-dutch-meta-analysis-of-39-trials-and-24/2026-08-18monthly0.6 https://lp-a.org/2022/05/05/finding-very-high-lp-a-the-case-for-routine-assessment-nurmohamed-et-al-eur-j-prev-cardiol/2026-08-17monthly0.6 https://lp-a.org/2022/05/03/apollo-single-ascending-doses-of-sln360-zerlasiran-lower-lp-a-by-up-to-98-percent-nissen-e/2026-08-17monthly0.6 https://lp-a.org/2022/05/01/the-lpa-gene-il-6-response-elements-make-lp-a-an-inflammatory-driver-not-just-a-lipid-part/2026-08-18monthly0.6 https://lp-a.org/2022/05/01/pcsk9-inhibitors-and-apheresis-are-the-only-current-lp-a-lowering-options-proven-to-also-c/2026-08-18monthly0.6 https://lp-a.org/2022/05/01/black-individuals-have-the-highest-lp-a-levels-of-any-ethnicity-studied-followed-by-south-/2026-08-18monthly0.6 https://lp-a.org/2022/05/01/oral-hormone-therapy-lowers-lp-a-more-than-transdermal-and-kidney-disease-raises-it-while-/2026-08-18monthly0.6 https://lp-a.org/2022/05/01/lower-lp-a-predicts-new-onset-diabetes-but-whether-the-link-is-truly-causal-remains-muddle/2026-08-18monthly0.6 https://lp-a.org/2022/05/01/up-to-1-billion-people-worldwide-may-have-high-risk-lp-a-levels-a-genetic-epidemiology-rev/2026-08-18monthly0.6 https://lp-a.org/2022/05/01/despite-decades-of-study-how-the-liver-assembles-and-clears-lp-a-remains-only-partly-under/2026-08-18monthly0.6 https://lp-a.org/2022/05/01/oxidised-phospholipids-bound-to-apo-a-kringle-iv-10-domain-may-explain-why-lp-a-is-such-a-/2026-08-18monthly0.6 https://lp-a.org/2022/05/01/lp-a-genetics-beyond-the-kringle-iv-repeat-coassin-and-kronenberg-atherosclerosis-2022/2026-08-17monthly0.6 https://lp-a.org/2022/05/01/lp-a-measurement-issues-a-mountain-out-of-a-molehill-kronenberg-atherosclerosis-2022/2026-08-17monthly0.6 https://lp-a.org/2022/04/26/lp-a-causally-raises-atrial-fibrillation-risk-largely-independent-of-atherosclerosis-a-men/2026-08-18monthly0.6 https://lp-a.org/2022/04/26/a-common-lpa-gene-variant-only-raises-lp-a-and-coronary-disease-risk-in-the-96-of-people-w/2026-08-18monthly0.6 https://lp-a.org/2022/04/25/children-with-fh-and-lp-a-above-30-mg-dl-are-nearly-twice-as-likely-to-have-family-history/2026-08-18monthly0.6 https://lp-a.org/2022/04/25/elevated-lp-a-raises-limb-amputation-risk-more-than-20-fold-in-peripheral-artery-disease-a/2026-08-18monthly0.6 https://lp-a.org/2022/04/22/the-receptor-sortilin-boosts-apo-a-secretion-from-liver-cells-and-promotes-lp-a-uptake-but/2026-08-18monthly0.6 https://lp-a.org/2022/04/10/elevated-lp-a-tracks-with-lipid-rich-vulnerable-coronary-plaque-specifically-in-diabetic-p/2026-08-18monthly0.6 https://lp-a.org/2022/04/08/elevated-lp-a-predicts-worse-cardiac-outcomes-after-acute-coronary-syndrome-most-strongly-/2026-08-18monthly0.6 https://lp-a.org/2022/04/07/familial-hypercholesterolaemia-doubles-cardiovascular-risk-when-lp-a-is-also-elevated-maki/2026-08-18monthly0.6 https://lp-a.org/2022/04/01/sln360-sustains-up-to-95-lp-a-reduction-for-at-least-9-weeks-in-cynomolgus-monkeys-preclin/2026-08-18monthly0.6 https://lp-a.org/2022/03/30/apoe2-carriers-have-lower-lp-a-with-apoe-the-second-most-important-gene-after-lpa-in-deter/2026-08-18monthly0.6 https://lp-a.org/2022/03/25/1-4-billion-people-worldwide-have-elevated-lp-a-and-sirna-drugs-dosed-just-3-4-times-a-yea/2026-08-18monthly0.6 https://lp-a.org/2022/03/22/pelacarsen-lowers-lp-a-cholesterol-and-reveals-how-much-of-ldl-c-is-really-lp-a-yeang-et-a/2026-08-17monthly0.6 https://lp-a.org/2022/03/21/lp-a-rises-22-43-from-childhood-to-adulthood-depending-on-lipid-lowering-treatment-with-70/2026-08-18monthly0.6 https://lp-a.org/2022/03/01/elevated-lp-a-plus-a-coronary-calcium-score-of-100-carries-a-4-7-fold-higher-cardiovascula/2026-08-18monthly0.6 https://lp-a.org/2022/02/28/lp-a-above-the-90th-percentile-nearly-doubles-aortic-valve-stenosis-incidence-over-14-year/2026-08-18monthly0.6 https://lp-a.org/2022/02/22/a-single-lp-a-measurement-suffices-for-cad-risk-prediction-since-repeat-levels-stay-96-cor/2026-08-18monthly0.6 https://lp-a.org/2022/02/15/extreme-lp-a-and-extreme-body-weight-together-carry-a-3-5-fold-risk-of-calcific-aortic-val/2026-08-18monthly0.6 https://lp-a.org/2022/02/09/lp-a-above-175-nmol-l-explains-3-of-population-cardiovascular-disease-burden-and-lowering-/2026-08-18monthly0.6 https://lp-a.org/2022/02/09/lp-a-above-the-90th-decile-raises-coronary-artery-disease-risk-by-62-in-routinely-tested-p/2026-08-18monthly0.6 https://lp-a.org/2022/02/02/up-to-a-quarter-of-familial-hypercholesterolaemia-diagnoses-are-actually-driven-by-high-lp/2026-08-18monthly0.6 https://lp-a.org/2022/01/25/severe-aortic-stenosis-patients-have-35-higher-lp-a-and-more-lysis-prone-fibrin-clots-link/2026-08-18monthly0.6 https://lp-a.org/2022/01/25/high-lp-a-accelerates-low-attenuation-necrotic-core-plaque-progression-on-serial-ct-angiog/2026-08-17monthly0.6 https://lp-a.org/2022/01/01/lp-a-makes-up-15-of-all-atherogenic-particles-at-the-highest-lp-a-levels-a-particle-based-/2026-08-18monthly0.6 https://lp-a.org/2022/01/01/very-high-lp-a-100-mg-dl-predicts-multivessel-coronary-disease-and-a-stepwise-rise-in-in-h/2026-08-18monthly0.6 https://lp-a.org/2022/01/01/about-1-in-5-people-has-lp-a-above-50-mg-dl-and-it-raises-cardiovascular-risk-even-with-ld/2026-08-18monthly0.6 https://lp-a.org/2022/01/01/seven-international-stakeholder-organisations-convene-a-global-think-tank-to-answer-clinic/2026-08-18monthly0.6 https://lp-a.org/2022/01/01/lp-a-drives-calcific-aortic-valve-disease-through-four-distinct-mechanistic-routes-but-no-/2026-08-18monthly0.6 https://lp-a.org/2022/01/01/lp-a-above-50-mg-dl-but-not-30-mg-dl-is-significantly-linked-to-calcific-aortic-valve-dise/2026-08-18monthly0.6 https://lp-a.org/2022/01/01/cascade-testing-for-fh-finds-a-new-case-of-elevated-lp-a-for-every-2-1-2-4-relatives-teste/2026-08-18monthly0.6 https://lp-a.org/2022/01/01/c-peptide-outperforms-lp-a-as-a-cardiometabolic-risk-predictor-in-type-2-diabetes-a-nested/2026-08-18monthly0.6 https://lp-a.org/2022/01/01/a-bibliometric-map-of-lp-a-research-finds-inflammation-aortic-valve-stenosis-and-postmenop/2026-08-18monthly0.6 https://lp-a.org/2022/01/01/bariatric-surgery-lowers-circulating-lp-a-a-meta-analysis-of-1-551-patients-across-13-stud/2026-08-18monthly0.6 https://lp-a.org/2022/01/01/patients-with-abdominal-aortic-aneurysm-have-significantly-higher-lp-a-than-controls-a-met/2026-08-18monthly0.6 https://lp-a.org/2022/01/01/olpasiran-a-galnac-conjugated-sirna-against-lpa-preclinical-development-and-phase-1-koren-/2026-08-17monthly0.6 https://lp-a.org/2022/01/01/aha-scientific-statement-lp-a-is-a-genetically-determined-causal-and-prevalent-risk-factor/2026-08-17monthly0.6 https://lp-a.org/2021/12/24/lpa-shares-up-to-70-of-its-sequence-with-plasminogen-explaining-lp-a-triple-threat-of-athe/2026-08-18monthly0.6 https://lp-a.org/2021/12/21/lp-a-surges-during-covid-19-hospitalisation-and-those-with-the-biggest-rise-face-a-3-fold-/2026-08-18monthly0.6 https://lp-a.org/2021/12/09/about-30-of-hypertensive-patients-in-one-clinic-had-elevated-lp-a-though-the-mechanistic-l/2026-08-18monthly0.6 https://lp-a.org/2021/12/03/lp-a-causally-drives-both-mitral-and-aortic-valve-calcification-mediating-31-of-its-effect/2026-08-18monthly0.6 https://lp-a.org/2021/11/27/how-much-do-oxidised-phospholipids-explain-lp-a-danger-and-can-drugs-lower-them-an-update-/2026-08-18monthly0.6 https://lp-a.org/2021/11/26/lp-a-predicts-coronary-disease-and-its-severity-across-ethnicities-highest-in-asian-indian/2026-08-18monthly0.6 https://lp-a.org/2021/11/25/the-french-society-of-atherosclerosis-issues-a-consensus-statement-recommending-lp-a-testi/2026-08-18monthly0.6 https://lp-a.org/2021/11/24/high-lp-a-predicts-major-limb-events-after-leg-artery-surgery-for-peripheral-artery-diseas/2026-08-18monthly0.6 https://lp-a.org/2021/11/12/cascade-testing-for-both-fh-and-elevated-lp-a-uncovers-a-new-case-of-either-every-1-5-2-1-/2026-08-18monthly0.6 https://lp-a.org/2021/10/27/genetic-studies-now-confirm-lp-a-causally-drives-aortic-valve-stenosis-but-no-approved-the/2026-08-18monthly0.6 https://lp-a.org/2021/09/28/lp-a-in-the-top-quartile-raises-subclinical-coronary-plaque-odds-by-up-to-67-in-7-201-asym/2026-08-18monthly0.6 https://lp-a.org/2021/09/20/pcsk9-inhibitors-modestly-lower-lp-a-with-cardiovascular-benefit-independent-of-ldl-c-whil/2026-08-18monthly0.6 https://lp-a.org/2021/09/14/lp-a-related-cardiovascular-risk-only-appears-when-hs-crp-is-also-elevated-a-mesa-analysis/2026-08-18monthly0.6 https://lp-a.org/2021/09/07/no-fda-approved-drug-specifically-lowers-lp-a-yet-but-pelacarsen-could-change-that-a-clini/2026-08-18monthly0.6 https://lp-a.org/2021/09/01/lp-a-carried-oxidised-phospholipids-drive-valve-calcification-through-pro-osteogenic-signa/2026-08-18monthly0.6 https://lp-a.org/2021/08/24/whether-lp-a-raising-gene-variants-add-predictive-value-beyond-lp-a-concentration-itself-r/2026-08-18monthly0.6 https://lp-a.org/2021/08/23/lp-a-is-highest-in-apob-dependent-familial-hypercholesterolaemia-36-5-mg-dl-versus-21-9-mg/2026-08-18monthly0.6 https://lp-a.org/2021/08/03/a-newly-discovered-lpa-splicing-variant-lowers-lp-a-by-13-6-mg-dl-and-cuts-coronary-diseas/2026-08-18monthly0.6 https://lp-a.org/2021/08/03/lipoprotein-a-and-benefit-of-pcsk9-inhibition-in-patients-with-nominally-controlled-ldl-ch/2026-08-17monthly0.6 https://lp-a.org/2021/08/02/elevated-lp-a-raises-ischaemic-stroke-risk-and-specifically-large-artery-atherosclerosis-s/2026-08-18monthly0.6 https://lp-a.org/2021/08/01/2021-canadian-cardiovascular-society-dyslipidaemia-guidelines-lp-a-once-in-a-lifetime-pear/2026-08-17monthly0.6 https://lp-a.org/2021/07/19/apheresis-remains-the-most-effective-lp-a-treatment-while-antisense-oligonucleotides-show-/2026-08-18monthly0.6 https://lp-a.org/2021/07/19/lp-a-lowering-could-become-the-third-pillar-of-lipid-therapy-alongside-ldl-c-and-triglycer/2026-08-18monthly0.6 https://lp-a.org/2021/07/08/over-20-of-the-population-has-lp-a-above-50-mg-dl-and-antisense-oligonucleotides-can-cut-i/2026-08-18monthly0.6 https://lp-a.org/2021/07/01/as-lp-a-lowering-drugs-enter-outcome-trials-should-everyone-be-screened-a-review-by-a-lead/2026-08-18monthly0.6 https://lp-a.org/2021/07/01/apo-a-lrx-leads-the-field-of-antisense-oligonucleotides-targeting-lp-a-driven-residual-car/2026-08-18monthly0.6 https://lp-a.org/2021/07/01/elevated-lp-a-more-than-doubles-retinal-vein-occlusion-risk-a-meta-analysis-of-17-688-peop/2026-08-18monthly0.6 https://lp-a.org/2021/06/20/genetics-explains-80-90-of-lp-a-variation-up-to-1000-fold-between-people-and-antisense-dru/2026-08-18monthly0.6 https://lp-a.org/2021/06/19/pelacarsen-cuts-lp-a-by-up-to-80-one-of-five-rna-targeted-drugs-reshaping-dyslipidaemia-tr/2026-08-18monthly0.6 https://lp-a.org/2021/06/19/lp-a-elevation-above-50-mg-dl-may-be-the-most-common-monogenic-lipid-disorder-affecting-ov/2026-08-18monthly0.6 https://lp-a.org/2021/06/11/lp-a-is-linked-to-more-vulnerable-carotid-plaque-features-with-sex-specific-patterns-in-th/2026-08-18monthly0.6 https://lp-a.org/2021/06/07/familial-hypercholesterolaemia-patients-face-nearly-4-fold-higher-risk-of-needing-aortic-v/2026-08-18monthly0.6 https://lp-a.org/2021/06/07/elevated-lp-a-triples-stroke-recurrence-risk-in-patients-under-60-the-biosignal-study-of-1/2026-08-18monthly0.6 https://lp-a.org/2021/06/01/black-populations-of-sub-saharan-descent-have-higher-lp-a-than-whites-yet-remain-underrepr/2026-08-18monthly0.6 https://lp-a.org/2021/05/23/il-6-receptor-blockade-with-tocilizumab-reverses-high-lp-a-in-rheumatoid-arthritis-hinting/2026-08-18monthly0.6 https://lp-a.org/2021/05/01/flaxseed-supplementation-modestly-lowers-lp-a-a-meta-analysis-of-6-randomised-trials-alter/2026-08-18monthly0.6 https://lp-a.org/2021/05/01/statins-fibrates-and-bile-acid-sequestrants-fail-to-lower-lp-a-leaving-newer-asos-cetp-and/2026-08-18monthly0.6 https://lp-a.org/2021/05/01/genotyping-for-lp-a-raising-variants-adds-little-beyond-simply-measuring-lp-a-itself-a-rev/2026-08-18monthly0.6 https://lp-a.org/2021/04/01/low-lp-a-predicts-new-onset-diabetes-yet-high-lp-a-still-raises-cardiovascular-risk-in-peo/2026-08-18monthly0.6 https://lp-a.org/2021/04/01/low-cost-lifestyle-coaching-not-just-costly-drugs-could-help-manage-cardiovascular-risk-in/2026-08-18monthly0.6 https://lp-a.org/2021/04/01/about-20-of-people-have-elevated-lp-a-yet-guidelines-diverge-sharply-on-how-to-manage-it-a/2026-08-18monthly0.6 https://lp-a.org/2021/03/30/pelacarsen-cut-lp-a-by-80-in-phase-2-letting-98-of-patients-reach-target-levels-as-the-7-6/2026-08-18monthly0.6 https://lp-a.org/2021/03/30/pelacarsen-lowers-lp-a-equally-regardless-of-lpa-genotype-or-apo-a-isoform-size-a-pooled-a/2026-08-18monthly0.6 https://lp-a.org/2021/03/21/low-lp-a-shows-no-safety-signal-for-cancer-or-infection-risk-reassuring-news-as-lowering-d/2026-08-18monthly0.6 https://lp-a.org/2021/03/01/measured-lp-a-and-a-43-variant-genetic-risk-score-predict-cardiovascular-disease-equally-w/2026-08-18monthly0.6 https://lp-a.org/2021/03/01/elevated-lp-a-drives-residual-cardiovascular-risk-even-at-optimal-ldl-c-but-proof-that-low/2026-08-18monthly0.6 https://lp-a.org/2021/03/01/pcsk9-inhibitors-lower-lp-a-by-27-with-a-bigger-effect-in-the-first-12-weeks-than-beyond-a/2026-08-18monthly0.6 https://lp-a.org/2021/03/01/an-lc-ms-ms-candidate-reference-method-for-standardising-lp-a-measurement-marcovina-et-al-/2026-08-17monthly0.6 https://lp-a.org/2021/01/08/high-lp-a-affects-10-20-of-the-population-and-up-to-1-billion-people-worldwide-tripling-ri/2026-08-18monthly0.6 https://lp-a.org/2021/01/08/lp-a-still-predicts-cardiovascular-risk-even-when-ldl-c-is-under-70-mg-dl-one-of-three-res/2026-08-18monthly0.6 https://lp-a.org/2021/01/01/a-new-assay-measuring-lp-a-carried-cholesterol-shows-standard-ldl-c-tests-overestimate-tru/2026-08-18monthly0.6 https://lp-a.org/2021/01/01/elevated-lp-a-raises-hard-coronary-event-risk-by-71-in-acs-patients-aged-80-and-older-a-st/2026-08-18monthly0.6 https://lp-a.org/2021/01/01/a-global-think-tank-of-major-cardiovascular-societies-reaches-unanimous-consensus-on-stand/2026-08-18monthly0.6 https://lp-a.org/2021/01/01/pcsk9-inhibitors-and-second-generation-antisense-oligonucleotides-can-now-effectively-lowe/2026-08-18monthly0.6 https://lp-a.org/2021/01/01/conjugated-linoleic-acid-supplements-raise-lp-a-by-up-to-26-mg-l-especially-at-higher-dose/2026-08-18monthly0.6 https://lp-a.org/2021/01/01/higher-lp-a-raises-diabetic-nephropathy-odds-by-63-in-type-2-diabetes-a-meta-analysis-of-9/2026-08-18monthly0.6 https://lp-a.org/2021/01/01/pcsk9-inhibitors-are-the-only-current-lipid-drugs-that-both-lower-lp-a-and-reduce-cardiova/2026-08-18monthly0.6 https://lp-a.org/2021/01/01/lp-a-and-incident-ascvd-in-460-506-uk-biobank-participants-patel-et-al-atvb-2021/2026-08-17monthly0.6 https://lp-a.org/2020/12/16/evolocumab-lowers-ldl-c-similarly-across-racial-and-ethnic-groups-with-asian-patients-with/2026-08-18monthly0.6 https://lp-a.org/2020/12/11/bariatric-surgery-paradoxically-raises-lp-a-by-66-while-cutting-oxidised-phospholipid-mark/2026-08-18monthly0.6 https://lp-a.org/2020/12/01/lp-a-derived-cholesterol-inflates-ldl-c-readings-in-30-50-of-familial-hypercholesterolaemi/2026-08-18monthly0.6 https://lp-a.org/2020/11/23/lp-a-above-60-mg-dl-is-linked-to-greater-coronary-plaque-volume-on-ivus-a-pooled-analysis-/2026-08-18monthly0.6 https://lp-a.org/2020/11/23/standard-ldl-c-tests-only-predict-cardiovascular-risk-because-they-secretly-include-lp-a-c/2026-08-18monthly0.6 https://lp-a.org/2020/11/21/lp-a-lowering-by-alirocumab-reduces-total-cardiovascular-events-independent-of-ldl-c-odyss/2026-08-17monthly0.6 https://lp-a.org/2020/11/07/no-statin-type-or-dose-meaningfully-lowers-lp-a-a-network-meta-analysis-of-23-605-patients/2026-08-18monthly0.6 https://lp-a.org/2020/11/02/ldl-c-measurements-can-misclassify-familial-hypercholesterolaemia-when-lp-a-cholesterol-in/2026-08-18monthly0.6 https://lp-a.org/2020/10/29/apoh-encoding-beta2-glycoprotein-i-emerges-as-a-new-genetic-locus-for-lp-a-levels-a-gwas-o/2026-08-18monthly0.6 https://lp-a.org/2020/10/01/effect-of-c-reactive-protein-on-lipoprotein-a-associated-cardiovascular-risk-in-optimally-/2026-08-17monthly0.6 https://lp-a.org/2020/09/18/lp-a-predicts-aortic-valve-calcium-in-whites-and-blacks-but-not-south-asians-despite-south/2026-08-18monthly0.6 https://lp-a.org/2020/09/08/lp-a-above-30-mg-dl-raises-cardiovascular-death-risk-by-50-in-ami-patients-aged-80-and-old/2026-08-18monthly0.6 https://lp-a.org/2020/08/18/elevated-lp-a-and-family-history-combine-for-a-43-higher-cardiovascular-risk-than-either-a/2026-08-18monthly0.6 https://lp-a.org/2020/07/30/low-lp-a-combined-with-high-insulin-resistance-nearly-doubles-fatty-liver-disease-risk-in-/2026-08-18monthly0.6 https://lp-a.org/2020/07/25/could-lp-a-explain-covid-19-clotting-complications-a-dutch-led-team-proposes-il-6-driven-l/2026-08-18monthly0.6 https://lp-a.org/2020/07/23/elevated-lp-a-doubles-risk-of-declining-kidney-function-especially-in-diabetic-and-hyperte/2026-08-18monthly0.6 https://lp-a.org/2020/07/03/apo-a-lrx-pelacarsen-can-cut-lp-a-by-up-to-80-far-surpassing-pcsk9-inhibitors-in-patients-/2026-08-18monthly0.6 https://lp-a.org/2020/07/01/monozygotic-twins-with-homozygous-fh-and-lp-a-above-270-nmol-l-develop-nearly-identical-co/2026-08-18monthly0.6 https://lp-a.org/2020/06/21/potent-lp-a-lowering-with-apo-a-antisense-reduces-pro-inflammatory-activation-of-monocytes/2026-08-17monthly0.6 https://lp-a.org/2020/06/21/statin-therapy-increases-lp-a-levels-subject-level-meta-analysis-of-six-trials-tsimikas-et/2026-08-17monthly0.6 https://lp-a.org/2020/06/08/pcsk9-inhibitors-remain-the-only-drugs-proven-to-reduce-cardiovascular-events-partly-via-l/2026-08-18monthly0.6 https://lp-a.org/2020/06/07/aortic-stenosis-affects-2-of-people-over-65-and-lp-a-drives-its-progression-through-oxidis/2026-08-18monthly0.6 https://lp-a.org/2020/06/02/familial-hypercholesterolaemia-does-not-cause-elevated-lp-a-instead-high-lp-a-makes-fh-mor/2026-08-18monthly0.6 https://lp-a.org/2020/06/01/lp-a-matches-ldl-as-a-cause-of-heart-attacks-but-outweighs-it-for-mortality-risk-a-head-to/2026-08-18monthly0.6 https://lp-a.org/2020/06/01/an-exploratory-analysis-of-proprotein-convertase-subtilisin-kexin-type-9-inhibition-and-ao/2026-08-17monthly0.6 https://lp-a.org/2020/05/25/people-of-african-descent-have-the-highest-lp-a-levels-of-any-ethnicity-yet-standardisatio/2026-08-18monthly0.6 https://lp-a.org/2020/05/19/the-effect-of-pcsk9-proprotein-convertase-subtilisin-kexin-type-9-inhibition-on-the-risk-o/2026-08-17monthly0.6 https://lp-a.org/2020/05/19/peripheral-artery-disease-and-venous-thromboembolic-events-after-acute-coronary-syndrome-r/2026-08-17monthly0.6 https://lp-a.org/2020/05/05/soy-isoflavones-cut-lp-a-by-10-and-raise-hdl-c-by-11-5-in-peritoneal-dialysis-patients-an-/2026-08-18monthly0.6 https://lp-a.org/2020/04/24/mendelian-randomisation-confirms-lp-a-drives-coronary-disease-aortic-stenosis-stroke-and-h/2026-08-18monthly0.6 https://lp-a.org/2020/04/24/antisense-apo-a-inhibitors-could-pair-with-statins-for-patients-with-both-high-lp-a-and-hi/2026-08-18monthly0.6 https://lp-a.org/2020/04/10/alirocumab-ldl-c-and-lp-a-lowering-effects-are-discordant-in-21-5-of-patients-suggesting-s/2026-08-18monthly0.6 https://lp-a.org/2020/04/07/lp-a-risk-is-independent-of-every-other-lipid-marker-but-treatment-options-remain-scarce-a/2026-08-18monthly0.6 https://lp-a.org/2020/04/01/replacing-saturated-fat-with-walnuts-or-vegetable-oils-improves-cholesterol-without-raisin/2026-08-18monthly0.6 https://lp-a.org/2020/03/19/south-asians-face-premature-cardiovascular-disease-compounded-by-elevated-lp-a-a-systemati/2026-08-18monthly0.6 https://lp-a.org/2020/03/07/advanced-liver-fibrosis-from-nash-lowers-lp-a-levels-undermining-its-value-as-a-cardiovasc/2026-08-18monthly0.6 https://lp-a.org/2020/02/19/flaxseed-supplementation-lowers-lp-a-by-2-06-mg-dl-especially-with-longer-treatment-durati/2026-08-18monthly0.6 https://lp-a.org/2020/02/07/high-lp-a-20-mg-dl-blocks-coronary-plaque-regression-despite-statin-therapy-after-acs-the-/2026-08-18monthly0.6 https://lp-a.org/2020/02/06/vldl-apoe-production-may-drive-lp-a-synthesis-a-kinetic-study-of-pcsk9-mutation-carriers-a/2026-08-18monthly0.6 https://lp-a.org/2020/02/05/genetically-elevated-lp-a-shortens-parental-lifespan-and-health-span-arsenault-et-al-jama-/2026-08-17monthly0.6 https://lp-a.org/2020/02/01/antisense-apo-a-and-apob-inhibitors-could-cut-lp-a-by-up-to-80-a-review-of-lp-a-lowering-s/2026-08-18monthly0.6 https://lp-a.org/2020/01/21/alirocumab-induced-lp-a-lowering-independently-predicts-fewer-mace-after-acs-odyssey-outco/2026-08-17monthly0.6 https://lp-a.org/2020/01/16/pelacarsen-akcea-apo-a-lrx-lowers-lp-a-by-up-to-80-percent-in-patients-with-cardiovascular/2026-08-17monthly0.6 https://lp-a.org/2020/01/01/two-women-with-normal-cholesterol-and-low-coronary-calcium-scores-still-had-significant-co/2026-08-18monthly0.6 https://lp-a.org/2020/01/01/high-lp-a-independently-raises-cardiovascular-mortality-risk-in-1492-peritoneal-dialysis-p/2026-08-18monthly0.6 https://lp-a.org/2020/01/01/lipoprotein-apheresis-lowers-macrophage-cholesterol-loading-capacity-alongside-lp-a-an-ita/2026-08-18monthly0.6 https://lp-a.org/2020/01/01/1-in-7-americans-has-lp-a-above-the-risk-threshold-and-lp-a-predicts-heart-attack-but-not-/2026-08-18monthly0.6 https://lp-a.org/2020/01/01/testing-and-emerging-rna-targeted-therapies-for-lp-a-a-review-of-the-case-for-population-r/2026-08-18monthly0.6 https://lp-a.org/2020/01/01/elevated-lp-a-affects-30-50-of-familial-hypercholesterolaemia-patients-compounding-their-i/2026-08-18monthly0.6 https://lp-a.org/2020/01/01/lp-a-levels-above-300-mg-l-significantly-raise-cardiovascular-risk-a-review-of-lp-a-struct/2026-08-18monthly0.6 https://lp-a.org/2020/01/01/lp-a-above-50-mg-dl-raises-cardiovascular-risk-above-180-mg-dl-matches-familial-hyperchole/2026-08-18monthly0.6 https://lp-a.org/2020/01/01/lp-a-causally-drives-calcific-aortic-valve-stenosis-and-predicts-faster-disease-progressio/2026-08-18monthly0.6 https://lp-a.org/2020/01/01/apo-a-targeted-drugs-can-lower-lp-a-by-up-to-90-a-review-of-lp-a-mechanisms-in-atheroscler/2026-08-18monthly0.6 https://lp-a.org/2020/01/01/2019-esc-eas-guidelines-for-the-management-of-dyslipidaemias-mach-et-al-ehj-2020/2026-08-17monthly0.6 https://lp-a.org/2020/01/01/lp-a-lowering-of-about-50-mg-dl-may-be-needed-for-a-20-percent-mace-reduction-in-secondary/2026-08-17monthly0.6 https://lp-a.org/2019/12/17/lp-a-molar-concentration-not-apo-a-size-drives-cardiovascular-risk-loss-of-lp-a-raises-dia/2026-08-17monthly0.6 https://lp-a.org/2019/12/01/pcsk9-inhibitors-lower-lp-a-by-15-30-and-fourier-shows-most-benefit-in-patients-with-high-/2026-08-18monthly0.6 https://lp-a.org/2019/12/01/antisense-drug-ionis-apo-a-lrx-cuts-lp-a-by-90-in-a-phase-2-trial-a-review-of-lp-a-and-ath/2026-08-18monthly0.6 https://lp-a.org/2019/12/01/heart-uk-consensus-statement-on-lp-a-a-call-to-action-cegla-et-al-atherosclerosis-2019/2026-08-17monthly0.6 https://lp-a.org/2019/11/27/lp-a-is-a-proven-causal-cardiovascular-risk-factor-but-still-lacks-a-specific-therapy-or-s/2026-08-18monthly0.6 https://lp-a.org/2019/11/21/lp-a-triggers-a-cascade-from-valve-damage-to-calcification-via-autotaxin-and-nf-kb-a-revie/2026-08-18monthly0.6 https://lp-a.org/2019/10/13/higher-lp-a-predicts-cardiovascular-events-in-393-chinese-patients-with-familial-hyperchol/2026-08-18monthly0.6 https://lp-a.org/2019/09/24/antisense-oligonucleotide-cuts-lp-a-by-69-but-does-not-affect-fibrinolysis-a-placebo-contr/2026-08-18monthly0.6 https://lp-a.org/2019/09/01/emerging-apo-a-targeted-therapies-could-transform-lp-a-management-a-review-of-lp-a-s-role-/2026-08-18monthly0.6 https://lp-a.org/2019/09/01/conjugated-linoleic-acid-supplements-raise-both-crp-and-lp-a-levels-a-meta-analysis-of-21-/2026-08-18monthly0.6 https://lp-a.org/2019/09/01/arterial-wall-inflammation-persists-in-high-lp-a-patients-despite-60-percent-ldl-c-lowerin/2026-08-17monthly0.6 https://lp-a.org/2019/09/01/high-lp-a-and-high-risk-of-cardiovascular-and-all-cause-mortality-langsted-et-al-ehj-2019/2026-08-17monthly0.6 https://lp-a.org/2019/08/27/six-commercial-lp-a-immunoassays-diverge-from-a-reference-standard-by-8-to-22-a-comparison/2026-08-18monthly0.6 https://lp-a.org/2019/07/30/phytosterol-supplements-modestly-lower-lp-a-a-meta-analysis-of-7-randomised-trials-nutr-me/2026-08-18monthly0.6 https://lp-a.org/2019/07/26/lp-a-in-the-highest-tertile-raises-stroke-risk-by-34-in-a-prospective-cohort-of-8500-chine/2026-08-18monthly0.6 https://lp-a.org/2019/07/13/l-carnitine-and-coenzyme-q10-emerge-as-the-most-promising-lp-a-lowering-supplements-a-revi/2026-08-18monthly0.6 https://lp-a.org/2019/07/09/elevated-lp-a-and-risk-of-ischaemic-stroke-observational-and-genetic-langsted-et-al-jacc-2/2026-08-17monthly0.6 https://lp-a.org/2019/07/08/elevated-lp-a-raises-cardiac-event-risk-by-78-in-cad-patients-a-meta-analysis-of-17-studie/2026-08-18monthly0.6 https://lp-a.org/2019/07/03/starting-statins-raises-lp-a-only-in-patients-with-the-low-molecular-weight-apo-a-phenotyp/2026-08-18monthly0.6 https://lp-a.org/2019/07/01/a-systematic-review-of-19-studies-finds-a-moderate-but-inconsistent-lp-a-cardiovascular-di/2026-08-18monthly0.6 https://lp-a.org/2019/06/18/2018-aha-acc-guideline-on-the-management-of-blood-cholesterol-lp-a-as-a-risk-enhancing-fac/2026-08-17monthly0.6 https://lp-a.org/2019/06/11/four-lp-a-associated-gene-variants-predict-more-severe-coronary-disease-in-1403-han-chines/2026-08-18monthly0.6 https://lp-a.org/2019/06/08/lp-a-reduction-from-pcsk9-inhibition-does-not-independently-lower-cardiovascular-events-a-/2026-08-18monthly0.6 https://lp-a.org/2019/06/01/how-much-lp-a-lowering-for-a-clinically-relevant-chd-reduction-the-lp-a-gwas-consortium-es/2026-08-17monthly0.6 https://lp-a.org/2019/05/20/antisense-drug-akcea-apo-a-lrx-cuts-lp-a-by-up-to-80-as-a-phase-3-outcomes-trial-is-planne/2026-08-18monthly0.6 https://lp-a.org/2019/05/09/lp-a-does-not-predict-future-venous-thromboembolism-risk-a-finnish-cohort-of-2180-men-pool/2026-08-18monthly0.6 https://lp-a.org/2019/05/07/lp-a-and-oxidised-phospholipids-drive-valve-calcification-activity-and-progression-in-aort/2026-08-17monthly0.6 https://lp-a.org/2019/05/01/oxidised-phospholipids-as-a-unifying-theory-for-lp-a-in-ascvd-and-aortic-valve-disease-bof/2026-08-17monthly0.6 https://lp-a.org/2019/04/30/lp-a-is-shifting-from-a-mere-biomarker-to-a-potential-therapeutic-target-a-review-of-the-e/2026-08-18monthly0.6 https://lp-a.org/2019/04/24/lp-a-is-not-linked-to-bone-density-or-hip-fracture-risk-in-9698-postmenopausal-women-a-wom/2026-08-18monthly0.6 https://lp-a.org/2019/04/12/lp-a-is-genetically-fixed-and-diet-resistant-a-review-of-its-biology-and-response-to-stati/2026-08-18monthly0.6 https://lp-a.org/2019/04/01/lp-a-predicts-ischemic-stroke-risk-nearly-twice-as-strongly-in-black-versus-white-american/2026-08-18monthly0.6 https://lp-a.org/2019/04/01/lp-a-apheresis-may-reduce-limb-events-in-peripheral-arterial-disease-as-effectively-as-it-/2026-08-18monthly0.6 https://lp-a.org/2019/04/01/testing-for-elevated-lp-a-still-lacks-routine-clinical-adoption-despite-causal-evidence-a-/2026-08-18monthly0.6 https://lp-a.org/2019/03/19/lp-a-and-myocardial-infarction-across-seven-ethnic-groups-interheart-pare-et-al-circulatio/2026-08-17monthly0.6 https://lp-a.org/2019/03/19/lp-a-pcsk9-inhibition-and-cardiovascular-risk-in-fourier-o-donoghue-et-al-circulation-2019/2026-08-17monthly0.6 https://lp-a.org/2019/03/12/testing-for-lp-a-during-fh-cascade-screening-finds-new-high-lp-a-relatives-and-quadruples-/2026-08-18monthly0.6 https://lp-a.org/2019/03/07/whether-lowering-lp-a-on-top-of-statins-reduces-cardiovascular-risk-remains-unproven-a-rev/2026-08-18monthly0.6 https://lp-a.org/2019/03/01/lp-a-link-to-carotid-plaque-is-strongest-in-white-participants-and-weaker-in-black-partici/2026-08-18monthly0.6 https://lp-a.org/2019/02/19/pcsk9-inhibition-lowers-ldl-cholesterol-and-lp-a-discordantly-in-20-of-patients-a-pooled-a/2026-08-18monthly0.6 https://lp-a.org/2019/02/01/pcsk9-monoclonal-antibodies-cut-lp-a-by-21-9-on-average-across-27-trials-and-11-864-patien/2026-08-18monthly0.6 https://lp-a.org/2019/02/01/about-one-third-of-aortic-stenosis-cases-are-linked-to-high-lp-a-and-oxidized-phospholipid/2026-08-18monthly0.6 https://lp-a.org/2019/01/13/natural-compounds-like-l-carnitine-coenzyme-q10-and-xuezhikang-emerge-as-lp-a-lowering-opt/2026-08-18monthly0.6 https://lp-a.org/2019/01/02/a-single-apheresis-session-cuts-ldl-and-lp-a-by-about-65-a-review-of-apheresis-for-severe-/2026-08-18monthly0.6 https://lp-a.org/2019/01/01/adding-pcsk9-inhibitors-to-niacin-further-lowers-lp-a-by-about-15-a-retrospective-analysis/2026-08-18monthly0.6 https://lp-a.org/2019/01/01/lipoprotein-apheresis-cuts-major-cardiovascular-events-by-94-in-us-patients-with-high-lp-a/2026-08-18monthly0.6 https://lp-a.org/2019/01/01/the-2018-cholesterol-guideline-recognizes-elevated-lp-a-as-a-risk-enhancer-for-statin-ther/2026-08-18monthly0.6 https://lp-a.org/2019/01/01/lipoprotein-apheresis-improves-clot-formation-and-fibrinolysis-markers-in-refractory-angin/2026-08-18monthly0.6 https://lp-a.org/2019/01/01/elevated-lp-a-affects-25-of-south-asians-and-doubles-to-triples-their-coronary-disease-ris/2026-08-18monthly0.6 https://lp-a.org/2019/01/01/lp-a-above-200-mg-l-raises-cardiovascular-risk-through-both-atherogenic-and-thrombotic-pat/2026-08-18monthly0.6 https://lp-a.org/2019/01/01/nla-scientific-statement-use-of-lp-a-in-clinical-practice-a-biomarker-whose-time-has-come-/2026-08-17monthly0.6 https://lp-a.org/2018/12/30/lp-a-predicts-additional-cardiovascular-risk-in-people-with-diabetes-or-prediabetes-the-ar/2026-08-18monthly0.6 https://lp-a.org/2018/12/27/lp-a-is-cleared-by-five-distinct-receptor-families-but-none-are-yet-clear-drug-targets-a-r/2026-08-18monthly0.6 https://lp-a.org/2018/12/14/ezetimibe-does-not-lower-lp-a-a-meta-analysis-of-10-randomised-trials-and-5188-patients-sc/2026-08-18monthly0.6 https://lp-a.org/2018/12/07/an-estimated-5-million-people-with-familial-hypercholesterolaemia-worldwide-have-lp-a-high/2026-08-18monthly0.6 https://lp-a.org/2018/12/01/higher-lp-a-linearly-predicts-faster-aortic-valve-stenosis-progression-especially-in-young/2026-08-18monthly0.6 https://lp-a.org/2018/10/13/baseline-and-on-statin-lp-a-predict-events-in-statin-trials-patient-level-meta-analysis-wi/2026-08-17monthly0.6 https://lp-a.org/2018/10/07/mipomersen-lowers-lp-a-mainly-by-speeding-its-clearance-not-by-reducing-production-a-kinet/2026-08-18monthly0.6 https://lp-a.org/2018/10/01/lp-a-correlates-with-pcsk9-levels-only-in-patients-with-the-low-molecular-weight-apo-a-phe/2026-08-18monthly0.6 https://lp-a.org/2018/10/01/lp-a-raises-heart-failure-risk-in-white-participants-only-not-in-black-hispanic-or-chinese/2026-08-18monthly0.6 https://lp-a.org/2018/07/14/elevated-lp-a-risk-fades-when-ldl-cholesterol-is-below-2-5-mmol-l-an-epic-norfolk-and-cope/2026-08-18monthly0.6 https://lp-a.org/2018/07/14/evolocumab-lowers-lp-a-by-cutting-production-alone-but-by-speeding-clearance-when-combined/2026-08-18monthly0.6 https://lp-a.org/2018/07/09/lp-a-predicts-cardiovascular-risk-in-women-only-when-total-cholesterol-is-high-an-analysis/2026-08-18monthly0.6 https://lp-a.org/2018/07/04/lp-a-above-50-mg-dl-confers-over-10-fold-higher-risk-of-heart-attack-stroke-or-amputation-/2026-08-18monthly0.6 https://lp-a.org/2018/07/04/whole-genome-sequencing-of-lp-a-in-european-and-african-ancestries-zekavat-et-al-nat-commu/2026-08-17monthly0.6 https://lp-a.org/2018/07/01/how-much-lp-a-lowering-equals-1-mmol-l-of-ldl-c-the-mendelian-randomisation-answer-burgess/2026-08-17monthly0.6 https://lp-a.org/2018/06/27/blocking-il-6-with-tocilizumab-does-not-lower-lp-a-in-heart-attack-patients-a-randomised-t/2026-08-18monthly0.6 https://lp-a.org/2018/06/18/lp-a-concentration-not-apo-a-isoform-size-predicts-angiographic-coronary-disease-severity-/2026-08-18monthly0.6 https://lp-a.org/2018/06/01/lp-a-clinical-utility-remains-undefined-despite-mounting-evidence-for-its-causal-role-in-a/2026-08-18monthly0.6 https://lp-a.org/2018/05/31/lpa-may-be-an-unprocessed-pseudogene-duplicated-from-the-plasminogen-gene-a-hypothesis-for/2026-08-18monthly0.6 https://lp-a.org/2018/05/01/lp-a-varies-up-to-1000-fold-between-individuals-and-1-in-4-has-levels-that-raise-cardiovas/2026-08-18monthly0.6 https://lp-a.org/2018/03/22/finns-have-about-50-lower-lp-a-than-central-europeans-with-known-genetic-variants-explaini/2026-08-18monthly0.6 https://lp-a.org/2018/03/15/lp-a-drives-calcium-deposition-and-oxidative-stress-in-human-aortic-valve-cells-more-than-/2026-08-18monthly0.6 https://lp-a.org/2018/03/01/ezetimibe-modestly-lowers-lp-a-by-7-06-with-no-clear-clinical-relevance-a-meta-analysis-of/2026-08-18monthly0.6 https://lp-a.org/2018/02/01/niacin-laropiprant-lowers-lp-a-by-just-18-in-patients-with-the-highest-baseline-lp-a-and-s/2026-08-18monthly0.6 https://lp-a.org/2018/02/01/association-of-lipoprotein-a-with-risk-of-recurrent-ischemic-events-following-acute-corona/2026-08-17monthly0.6 https://lp-a.org/2018/01/29/kidney-disease-raises-lp-a-mainly-in-patients-with-large-apo-a-isoforms-or-heavy-protein-l/2026-08-18monthly0.6 https://lp-a.org/2018/01/16/nhlbi-working-group-recommendations-to-reduce-lp-a-mediated-risk-of-cvd-and-aortic-stenosi/2026-08-17monthly0.6 https://lp-a.org/2018/01/04/lp-a-predicts-continued-carotid-plaque-progression-despite-intensive-ldl-lowering-therapy-/2026-08-18monthly0.6 https://lp-a.org/2018/01/01/elevated-lp-a-predicts-higher-coronary-calcium-scores-in-healthy-relatives-of-patients-wit/2026-08-18monthly0.6 https://lp-a.org/2018/01/01/elevated-lp-a-and-ldl-together-predict-the-most-severe-coronary-lesions-in-young-patients-/2026-08-18monthly0.6 https://lp-a.org/2018/01/01/lp-a-molar-to-mass-conversion-ratios-vary-two-to-three-fold-by-assay-and-isoform-a-study-o/2026-08-18monthly0.6 https://lp-a.org/2018/01/01/lp-a-predicts-early-onset-cardiovascular-disease-in-families-better-than-ldl-cholesterol-a/2026-08-18monthly0.6 https://lp-a.org/2018/01/01/new-antisense-and-rna-interference-drugs-may-lower-lp-a-by-up-to-90-a-jcl-roundtable-exper/2026-08-18monthly0.6 https://lp-a.org/2018/01/01/the-lp-a-hypothesis-awaits-its-first-clinical-trial-test-unlike-the-ldl-hypothesis-a-revie/2026-08-18monthly0.6 https://lp-a.org/2018/01/01/antisense-drug-ionis-apo-a-rx-reveals-standard-ldl-c-tests-overestimate-true-ldl-c-by-up-t/2026-08-18monthly0.6 https://lp-a.org/2018/01/01/lp-a-value-for-predicting-recurrent-events-in-secondary-prevention-remains-inconsistent-a-/2026-08-18monthly0.6 https://lp-a.org/2018/01/01/lp-a-lowering-therapies-cut-levels-by-25-30-in-familial-hypercholesterolaemia-though-clini/2026-08-18monthly0.6 https://lp-a.org/2017/12/21/combining-pcsk9-inhibitors-with-apo-a-antisense-therapy-may-best-address-residual-risk-in-/2026-08-18monthly0.6 https://lp-a.org/2017/12/20/antisense-therapy-could-push-lp-a-below-the-30-50-mg-dl-risk-threshold-a-review-of-lp-a-me/2026-08-18monthly0.6 https://lp-a.org/2017/12/19/inflammatory-il-1-genotype-doubles-the-cardiovascular-risk-from-high-lp-a-the-ioannina-stu/2026-08-18monthly0.6 https://lp-a.org/2017/12/15/high-lp-a-predicts-aortic-valve-surgery-only-in-patients-who-also-have-coronary-artery-dis/2026-08-18monthly0.6 https://lp-a.org/2017/12/07/elevated-lp-a-triples-acute-coronary-syndrome-risk-in-adults-under-45-but-the-link-fades-a/2026-08-18monthly0.6 https://lp-a.org/2017/11/26/lp-a-in-the-top-25-raises-abdominal-aortic-aneurysm-risk-by-57-the-aric-study-of-13-683-ad/2026-08-18monthly0.6 https://lp-a.org/2017/11/02/lp-a-varies-by-more-than-25-at-some-point-in-40-of-placebo-patients-in-antisense-trials-a-/2026-08-18monthly0.6 https://lp-a.org/2017/10/17/soy-isoflavones-do-not-affect-lp-a-levels-a-meta-analysis-of-10-trials-and-973-subjects-j-/2026-08-18monthly0.6 https://lp-a.org/2017/10/12/diabetes-lowers-lp-a-but-raises-pcsk9-and-cetp-inhibition-with-torcetrapib-cuts-lp-a-by-11/2026-08-18monthly0.6 https://lp-a.org/2017/09/13/different-lp-a-assay-methods-perform-similarly-for-predicting-valve-and-coronary-disease-b/2026-08-18monthly0.6 https://lp-a.org/2017/09/06/lp-a-re-emerges-as-a-major-cardiology-focus-more-than-50-years-after-its-discovery-a-revie/2026-08-18monthly0.6 https://lp-a.org/2017/08/24/lpa-gene-variants-triple-lp-a-levels-and-the-highest-lp-a-quartile-raises-heart-attack-ris/2026-08-18monthly0.6 https://lp-a.org/2017/08/24/coffee-lowers-lp-a-by-up-to-11-mg-dl-short-term-but-boiled-coffee-raises-it-long-term-a-sy/2026-08-18monthly0.6 https://lp-a.org/2017/08/21/lp-a-risk-is-highest-in-southern-europe-and-in-people-with-diabetes-the-biomarcare-consort/2026-08-18monthly0.6 https://lp-a.org/2017/07/20/cetp-inhibitor-anacetrapib-lowers-lp-a-by-cutting-its-production-41-a-kinetic-trial-of-39-/2026-08-18monthly0.6 https://lp-a.org/2017/07/18/lp-a-assembly-and-clearance-mechanisms-remain-unresolved-since-its-1963-discovery-a-review/2026-08-18monthly0.6 https://lp-a.org/2017/07/11/lp-a-remains-an-underused-target-in-athero-thrombosis-management-due-to-assay-standardizat/2026-08-18monthly0.6 https://lp-a.org/2017/07/01/lp-a-lowering-therapies-remain-limited-despite-proven-links-to-residual-cardiovascular-ris/2026-08-18monthly0.6 https://lp-a.org/2017/07/01/tamoxifen-significantly-lowers-lp-a-a-meta-analysis-of-5-studies-and-215-participants-drug/2026-08-18monthly0.6 https://lp-a.org/2017/06/15/lp-a-does-not-predict-coronary-plaque-progression-during-intensive-statin-therapy-a-saturn/2026-08-18monthly0.6 https://lp-a.org/2017/05/31/apheresis-lowers-lp-a-by-over-60-while-a-phase-1-antisense-drug-reaches-88-8-a-review-of-l/2026-08-18monthly0.6 https://lp-a.org/2017/05/26/lp-a-and-its-gene-variants-predict-coronary-disease-severity-but-not-mortality-once-heart-/2026-08-18monthly0.6 https://lp-a.org/2017/05/21/antisense-therapy-can-cut-lp-a-by-up-to-90-in-phase-1-2-trials-as-three-treatment-approach/2026-08-18monthly0.6 https://lp-a.org/2017/05/21/lipoprotein-apheresis-improves-myocardial-perfusion-and-plaque-burden-in-refractory-angina/2026-08-18monthly0.6 https://lp-a.org/2017/05/16/48-gene-variants-and-a-rare-snp-with-an-odds-ratio-of-1-73-for-cad-found-in-the-largest-lp/2026-08-18monthly0.6 https://lp-a.org/2017/05/12/lp-a-predicts-heart-failure-hospitalization-but-the-link-disappears-once-prior-heart-attac/2026-08-18monthly0.6 https://lp-a.org/2017/04/10/both-smaller-apo-a-isoform-size-and-higher-lp-a-concentration-independently-cause-coronary/2026-08-18monthly0.6 https://lp-a.org/2017/04/01/elevated-lp-a-above-50-mg-dl-affects-1-in-5-people-worldwide-a-review-of-modern-genomic-in/2026-08-18monthly0.6 https://lp-a.org/2017/04/01/raloxifene-lowers-lp-a-with-the-effect-fading-over-longer-treatment-duration-a-meta-analys/2026-08-18monthly0.6 https://lp-a.org/2017/03/27/lp-a-is-linked-to-a-56-higher-risk-of-venous-thromboembolism-though-the-effect-is-small-a-/2026-08-18monthly0.6 https://lp-a.org/2017/03/23/lp-a-predicts-carotid-artery-thickening-only-in-hiv-infected-young-women-the-women-s-inter/2026-08-18monthly0.6 https://lp-a.org/2017/03/21/low-lp-a-below-7-mg-dl-not-high-lp-a-raises-type-2-diabetes-risk-the-bruneck-study-combine/2026-08-18monthly0.6 https://lp-a.org/2017/03/18/lp-a-and-familial-hypercholesterolaemia-together-predict-early-severe-coronary-disease-a-c/2026-08-18monthly0.6 https://lp-a.org/2017/03/01/nephrological-guidelines-ignore-lp-a-despite-its-cardiovascular-risk-in-chronic-kidney-dis/2026-08-18monthly0.6 https://lp-a.org/2017/02/16/oral-hormone-replacement-therapy-lowers-lp-a-by-about-20-but-tibolone-does-not-a-meta-anal/2026-08-18monthly0.6 https://lp-a.org/2017/02/14/a-test-in-context-lp-a-diagnosis-prognosis-controversies-and-emerging-therapies-tsimikas-j/2026-08-17monthly0.6 https://lp-a.org/2017/02/07/lp-a-and-inflammation-together-erode-endothelial-integrity-a-review-of-their-dangerous-int/2026-08-18monthly0.6 https://lp-a.org/2017/02/03/fibrates-lower-lp-a-more-than-statins-and-adding-fibrates-boosts-statins-effect-a-meta-ana/2026-08-18monthly0.6 https://lp-a.org/2017/02/01/how-pcsk9-antibodies-lower-lp-a-remains-unexplained-unlike-statins-which-raise-ldl-recepto/2026-08-18monthly0.6 https://lp-a.org/2017/01/17/lpa-variants-apo-a-isoforms-and-events-differ-by-ethnicity-the-dallas-heart-study-lee-et-a/2026-08-17monthly0.6 https://lp-a.org/2017/01/05/apoe-genotype-e4-e4-carriers-have-65-higher-lp-a-than-e2-e2-carriers-an-analysis-of-431-23/2026-08-18monthly0.6 https://lp-a.org/2017/01/01/tocilizumab-lowers-lp-a-in-rheumatoid-arthritis-patients-unlike-other-biologic-therapies-t/2026-08-18monthly0.6 https://lp-a.org/2017/01/01/homozygous-autosomal-dominant-hypercholesterolaemia-doubles-lp-a-levels-compared-to-hetero/2026-08-18monthly0.6 https://lp-a.org/2017/01/01/pcsk9-inhibitors-show-discordant-ldl-and-lp-a-responses-in-40-of-real-world-patients-a-stu/2026-08-18monthly0.6 https://lp-a.org/2017/01/01/elevated-lp-a-is-common-in-patients-needing-coronary-intervention-despite-controlled-risk-/2026-08-18monthly0.6 https://lp-a.org/2017/01/01/guidelines-recommend-lp-a-testing-for-risk-reclassification-in-intermediate-risk-patients-/2026-08-18monthly0.6 https://lp-a.org/2017/01/01/apheresis-remains-the-only-option-for-very-high-lp-a-since-no-drug-lowers-it-without-affec/2026-08-18monthly0.6 https://lp-a.org/2017/01/01/lp-a-ranges-from-under-0-1-to-over-100-mg-ml-between-individuals-and-is-higher-in-women-a-/2026-08-18monthly0.6 https://lp-a.org/2017/01/01/lifestyle-and-hormones-can-modestly-influence-lp-a-levels-a-review-of-non-pharmacological-/2026-08-18monthly0.6 https://lp-a.org/2017/01/01/antisense-drug-ionis-apo-a-rx-cuts-lp-a-by-about-80-a-review-of-apolipoprotein-a-antisense/2026-08-18monthly0.6 https://lp-a.org/2017/01/01/lp-a-microrna-regulation-could-hold-clues-to-its-role-in-stroke-a-review-calling-for-furth/2026-08-18monthly0.6 https://lp-a.org/2016/12/27/the-phenotypic-consequences-of-genetically-lowered-lp-a-emdin-et-al-jacc-2016/2026-08-17monthly0.6 https://lp-a.org/2016/12/02/adding-l-carnitine-to-simvastatin-modestly-lowers-lp-a-by-19-a-randomised-trial-of-two-29-/2026-08-18monthly0.6 https://lp-a.org/2016/12/01/lp-a-lowering-therapies-range-from-20-modest-to-80-dramatic-reductions-a-review-of-emergin/2026-08-18monthly0.6 https://lp-a.org/2016/12/01/hormone-therapy-cuts-lp-a-by-up-to-44-in-postmenopausal-women-more-than-niacin-or-pcsk9-in/2026-08-18monthly0.6 https://lp-a.org/2016/11/11/ideal-cardiovascular-health-cuts-the-excess-risk-from-high-lp-a-by-two-thirds-the-epic-nor/2026-08-18monthly0.6 https://lp-a.org/2016/11/07/lp-a-was-discovered-in-1963-and-its-size-heterogeneity-explained-decades-later-by-gerd-ute/2026-08-18monthly0.6 https://lp-a.org/2016/11/05/ionis-apo-a-rx-and-the-galnac-conjugated-apo-a-lrx-two-dose-ranging-trials-viney-et-al-lan/2026-08-17monthly0.6 https://lp-a.org/2016/11/01/lp-a-as-a-cause-of-cardiovascular-disease-epidemiology-genetics-and-biology-nordestgaard-a/2026-08-17monthly0.6 https://lp-a.org/2016/09/29/alirocumab-sustainably-lowers-lp-a-by-up-to-29-over-1-5-years-a-pooled-analysis-of-10-phas/2026-08-18monthly0.6 https://lp-a.org/2016/09/29/lp-a-is-significantly-higher-in-patients-with-abdominal-aortic-aneurysm-a-meta-analysis-of/2026-08-18monthly0.6 https://lp-a.org/2016/09/09/omega-3-plus-vitamin-e-supplementation-lowers-lp-a-gene-expression-in-women-with-polycysti/2026-08-18monthly0.6 https://lp-a.org/2016/09/01/five-years-of-lipoprotein-apheresis-for-lp-a-associated-disease-the-german-prospective-fol/2026-08-17monthly0.6 https://lp-a.org/2016/08/31/extended-release-niacin-lowers-lp-a-by-about-23-regardless-of-dose-a-meta-analysis-of-14-t/2026-08-18monthly0.6 https://lp-a.org/2016/08/27/pcsk9-and-lp-a-levels-independently-predict-coronary-calcium-buildup-in-statin-treated-fh-/2026-08-18monthly0.6 https://lp-a.org/2016/08/23/oxidised-phospholipids-on-lp-a-drive-arterial-wall-inflammation-and-a-primed-monocyte-resp/2026-08-17monthly0.6 https://lp-a.org/2016/08/20/lp-a-not-apo-a-size-independently-predicts-unexplained-stroke-in-young-white-adults-a-case/2026-08-18monthly0.6 https://lp-a.org/2016/08/01/the-only-controlled-trial-of-lp-a-specific-apheresis-showed-plaque-regression-after-18-mon/2026-08-18monthly0.6 https://lp-a.org/2016/07/01/statins-may-worsen-aortic-stenosis-by-raising-lp-a-and-oxidized-phospholipids-a-review-of-/2026-08-18monthly0.6 https://lp-a.org/2016/07/01/high-lp-a-as-a-possible-cause-of-clinical-familial-hypercholesterolaemia-langsted-et-al-la/2026-08-17monthly0.6 https://lp-a.org/2016/07/01/lp-a-the-impact-of-ethnicity-and-of-environmental-and-medical-conditions-enkhmaa-et-al-j-l/2026-08-17monthly0.6 https://lp-a.org/2016/06/26/lp-a-has-modest-predictive-value-for-cardiovascular-and-cerebrovascular-outcomes-a-review-/2026-08-18monthly0.6 https://lp-a.org/2016/05/24/a-pcsk9-loss-of-function-mutation-lowers-lp-a-and-reduces-aortic-valve-stenosis-risk-a-dan/2026-08-18monthly0.6 https://lp-a.org/2016/04/13/lp-a-lpa-gene-copy-number-variation-remains-only-partly-understood-despite-its-strong-coro/2026-08-18monthly0.6 https://lp-a.org/2016/04/12/a-rare-case-links-elevated-lp-a-to-aortic-thrombosis-in-a-non-aneurysmal-aorta-for-the-fir/2026-08-18monthly0.6 https://lp-a.org/2016/04/01/elevated-lp-a-above-30-mg-dl-affects-20-30-of-the-global-population-a-review-of-emerging-l/2026-08-18monthly0.6 https://lp-a.org/2016/04/01/lp-a-measurements-for-clinical-application-why-the-assays-disagree-marcovina-and-albers-j-/2026-08-17monthly0.6 https://lp-a.org/2016/03/03/the-standard-30-mg-dl-lp-a-cutoff-predicts-aortic-valve-calcification-in-white-and-black-a/2026-08-18monthly0.6 https://lp-a.org/2016/02/17/a-single-apheresis-session-cuts-lp-a-by-60-75-a-review-of-lipoprotein-apheresis-for-elevat/2026-08-18monthly0.6 https://lp-a.org/2016/02/02/coenzyme-q10-modestly-lowers-lp-a-but-not-other-lipids-a-meta-analysis-of-7-trials-and-409/2026-08-18monthly0.6 https://lp-a.org/2016/02/01/mouse-and-rabbit-lp-a-models-fall-short-since-animals-naturally-express-under-20-mg-dl-and/2026-08-18monthly0.6 https://lp-a.org/2016/02/01/diet-and-lifestyle-barely-affect-genetically-determined-lp-a-but-new-drugs-finally-can-a-r/2026-08-18monthly0.6 https://lp-a.org/2016/02/01/mendelian-randomisation-applied-to-lp-a-two-decades-ago-proved-causality-for-cardiovascula/2026-08-18monthly0.6 https://lp-a.org/2016/01/31/coronary-disease-risk-rises-at-lp-a-levels-below-the-standard-50-mg-dl-threshold-an-epic-n/2026-08-18monthly0.6 https://lp-a.org/2016/01/14/high-lp-a-marks-vulnerable-lipid-rich-coronary-plaques-in-acute-coronary-syndrome-an-imagi/2026-08-18monthly0.6 https://lp-a.org/2016/01/12/oral-l-carnitine-lowers-lp-a-by-9-mg-dl-but-intravenous-administration-does-not-a-meta-ana/2026-08-18monthly0.6 https://lp-a.org/2016/01/10/high-lp-a-predicts-death-from-infection-in-younger-dialysis-patients-with-diabetes-the-4d-/2026-08-18monthly0.6 https://lp-a.org/2016/01/01/lp-a-predicts-diabetic-retinopathy-with-a-five-fold-higher-risk-when-combined-with-poor-gl/2026-08-18monthly0.6 https://lp-a.org/2016/01/01/a-patient-with-lp-a-3-5-times-the-fh-average-developed-clotting-during-apheresis-a-case-re/2026-08-18monthly0.6 https://lp-a.org/2016/01/01/guidelines-recommend-lp-a-screening-but-treatment-options-remain-scarce-a-review-of-lp-a-a/2026-08-18monthly0.6 https://lp-a.org/2016/01/01/niacin-lowers-oxidized-phospholipids-and-lp-a-but-statins-raise-both-by-over-20-a-study-of/2026-08-18monthly0.6 https://lp-a.org/2016/01/01/one-lp-a-test-can-reclassify-up-to-40-of-intermediate-risk-patients-a-review-of-lp-a-re-em/2026-08-18monthly0.6 https://lp-a.org/2016/01/01/a-34-year-old-man-with-lp-a-of-212-mg-dl-and-stroke-saw-his-level-drop-15-with-aspirin-but/2026-08-18monthly0.6 https://lp-a.org/2016/01/01/apheresis-cuts-cardiovascular-events-by-more-than-80-in-patients-with-elevated-lp-a-a-revi/2026-08-18monthly0.6 https://lp-a.org/2016/01/01/a-common-lab-method-for-estimating-lp-a-cholesterol-correlates-poorly-with-actual-lp-a-mas/2026-08-18monthly0.6 https://lp-a.org/2016/01/01/elevated-lp-a-and-lpa-risk-genotypes-raise-the-risk-of-heart-failure-kamstrup-and-nordestg/2026-08-17monthly0.6 https://lp-a.org/2015/12/29/a-liver-transplant-recipient-developed-elevated-lp-a-and-accelerated-atherosclerosis-after/2026-08-18monthly0.6 https://lp-a.org/2015/12/22/ten-studies-confirm-lipoprotein-apheresis-lowers-lp-a-and-cardiovascular-events-a-critical/2026-08-18monthly0.6 https://lp-a.org/2015/12/18/evacetrapib-cuts-lp-a-by-up-to-40-alone-and-small-ldl-particles-by-up-to-95-a-randomised-t/2026-08-18monthly0.6 https://lp-a.org/2015/12/18/the-charge-consortium-s-discovery-that-lpa-variants-cause-aortic-valve-calcification-affec/2026-08-18monthly0.6 https://lp-a.org/2015/12/08/whether-lp-a-directly-causes-thrombosis-or-acts-only-through-atherosclerosis-remains-unres/2026-08-18monthly0.6 https://lp-a.org/2015/12/04/proving-lp-a-lowering-improves-cardiovascular-outcomes-remains-the-field-s-next-urgent-cha/2026-08-18monthly0.6 https://lp-a.org/2015/11/04/isis-apo-a-rx-cuts-lp-a-by-up-to-89-in-a-phase-1-trial-the-first-drug-specifically-designe/2026-08-18monthly0.6 https://lp-a.org/2015/10/10/first-antisense-drug-against-apo-a-in-humans-isis-apo-a-rx-phase-1-tsimikas-et-al-lancet-2/2026-08-17monthly0.6 https://lp-a.org/2015/09/15/elevated-lp-a-and-oxidized-phospholipids-predict-faster-aortic-stenosis-progression-and-ne/2026-08-18monthly0.6 https://lp-a.org/2015/08/29/lp-a-may-drive-livedoid-vasculopathy-through-thrombosis-fibrinolysis-inhibition-and-autoim/2026-08-18monthly0.6 https://lp-a.org/2015/08/25/only-4-studies-have-examined-lp-a-and-arterial-stiffness-but-most-find-a-positive-link-a-r/2026-08-18monthly0.6 https://lp-a.org/2015/08/15/lp-a-raises-ischemic-stroke-risk-by-about-a-third-especially-in-younger-patients-a-meta-an/2026-08-18monthly0.6 https://lp-a.org/2015/07/29/autotaxin-carried-by-lp-a-drives-aortic-valve-mineralization-raising-valve-autotaxin-activ/2026-08-18monthly0.6 https://lp-a.org/2015/07/17/garlic-raises-lp-a-by-55-with-long-term-use-over-12-weeks-though-short-term-use-has-no-eff/2026-08-18monthly0.6 https://lp-a.org/2015/07/15/a-key-european-lp-a-risk-variant-found-in-up-to-11-6-of-asians-has-no-effect-on-lp-a-or-is/2026-08-18monthly0.6 https://lp-a.org/2015/07/14/lp-a-does-not-predict-carotid-plaque-in-statin-treated-familial-hypercholesterolaemia-a-du/2026-08-18monthly0.6 https://lp-a.org/2015/07/06/elevated-lp-a-and-prothrombotic-changes-may-drive-cardiovascular-risk-even-in-early-kidney/2026-08-18monthly0.6 https://lp-a.org/2015/07/02/tibolone-lowers-lp-a-by-up-to-29-depending-on-dose-a-meta-analysis-of-12-trials-and-1009-p/2026-08-18monthly0.6 https://lp-a.org/2015/05/01/numerous-drugs-developed-for-other-lipid-targets-also-lower-lp-a-but-their-clinical-role-r/2026-08-18monthly0.6 https://lp-a.org/2015/05/01/a-randomised-sham-controlled-crossover-trial-will-test-whether-apheresis-helps-refractory-/2026-08-18monthly0.6 https://lp-a.org/2015/05/01/apheresis-remains-the-only-proven-lp-a-lowering-therapy-in-europe-cutting-levels-by-60-70-/2026-08-18monthly0.6 https://lp-a.org/2015/04/06/lp-a-oxidized-phospholipids-boost-hdl-production-machinery-by-up-to-3-fold-in-liver-cells-/2026-08-18monthly0.6 https://lp-a.org/2015/03/04/india-lacks-its-own-lp-a-threshold-using-a-20-mg-dl-cutoff-versus-30-mg-dl-for-caucasians-/2026-08-18monthly0.6 https://lp-a.org/2015/02/21/tocilizumab-blocks-il-6-to-lower-lp-a-via-a-specific-lpa-gene-promoter-site-but-tnf-alpha-/2026-08-18monthly0.6 https://lp-a.org/2015/02/19/the-standard-30-mg-dl-lp-a-cutoff-misses-risk-in-white-and-hispanic-adults-who-need-the-50/2026-08-18monthly0.6 https://lp-a.org/2015/02/04/high-familial-lp-a-impairs-blood-vessel-function-in-children-an-effect-blunted-by-early-di/2026-08-18monthly0.6 https://lp-a.org/2015/02/03/higher-lp-a-is-linked-to-lower-diabetes-risk-in-a-chinese-cohort-of-10-122-adults-j-lipid-/2026-08-18monthly0.6 https://lp-a.org/2015/01/22/mipomersen-cuts-lp-a-by-26-across-diverse-hypercholesterolaemia-populations-a-pooled-analy/2026-08-18monthly0.6 https://lp-a.org/2015/01/01/elevated-lp-a-shifts-monocytes-toward-a-more-inflammatory-subset-a-study-of-90-patients-wi/2026-08-18monthly0.6 https://lp-a.org/2015/01/01/only-1-of-4-studies-found-higher-lp-a-in-migraine-patients-a-systematic-review-questioning/2026-08-18monthly0.6 https://lp-a.org/2015/01/01/lp-a-fully-expresses-by-age-2-but-guidelines-only-recommend-testing-children-after-stroke-/2026-08-18monthly0.6 https://lp-a.org/2014/11/01/ribose-cysteine-supplementation-raises-antioxidant-glutathione-and-lowers-lp-a-in-transgen/2026-08-18monthly0.6 https://lp-a.org/2014/09/02/lp-a-improves-15-year-cardiovascular-risk-prediction-especially-for-people-at-intermediate/2026-08-18monthly0.6 https://lp-a.org/2014/06/12/a-common-lpa-null-allele-carried-by-3-of-people-lowers-lp-a-and-cuts-coronary-disease-risk/2026-08-18monthly0.6 https://lp-a.org/2014/06/04/lp-a-above-30-mg-dl-triples-the-risk-of-death-or-heart-attack-after-bypass-surgery-a-russi/2026-08-18monthly0.6 https://lp-a.org/2014/05/20/lp-a-predicts-cardiovascular-disease-in-familial-hypercholesterolaemia-independent-of-the-/2026-08-17monthly0.6 https://lp-a.org/2014/05/16/the-thyroid-hormone-drug-eprotirome-cuts-ldl-cholesterol-by-up-to-31-and-lowers-lp-a-a-ran/2026-08-18monthly0.6 https://lp-a.org/2014/05/10/lp-a-and-apob-are-more-closely-linked-in-african-americans-than-caucasians-a-study-of-336-/2026-08-18monthly0.6 https://lp-a.org/2014/03/11/lp-a-correlates-with-coronary-disease-severity-only-in-men-not-women-a-study-of-351-patien/2026-08-18monthly0.6 https://lp-a.org/2014/02/12/lp-a-barely-changes-after-eating-or-with-inflammation-and-still-predicts-heart-disease-reg/2026-08-18monthly0.6 https://lp-a.org/2014/02/12/pro-inflammatory-il-1-genotype-raises-coronary-disease-risk-from-oxidized-phospholipids-se/2026-08-18monthly0.6 https://lp-a.org/2014/02/11/elevated-lp-a-and-risk-of-aortic-valve-stenosis-in-the-general-population-kamstrup-et-al-j/2026-08-17monthly0.6 https://lp-a.org/2014/02/05/evolocumab-cuts-lp-a-by-up-to-29-5-a-pooled-analysis-of-4-phase-2-trials-and-1359-patients/2026-08-18monthly0.6 https://lp-a.org/2014/01/01/lp-a-mass-measurements-conflate-particle-size-with-true-risk-a-review-calling-for-a-mass-i/2026-08-18monthly0.6 https://lp-a.org/2013/12/17/lipoprotein-apheresis-cuts-event-rates-in-lp-a-hyperlipoproteinaemia-with-progressive-dise/2026-08-17monthly0.6 https://lp-a.org/2013/11/17/statins-do-not-lower-lp-a-yet-lp-a-still-predicts-residual-cardiovascular-risk-after-stati/2026-08-18monthly0.6 https://lp-a.org/2013/11/01/low-lp-a-and-large-apo-a-isoforms-are-causally-linked-to-type-2-diabetes-kamstrup-and-nord/2026-08-17monthly0.6 https://lp-a.org/2013/10/23/lp-a-predicts-heart-disease-risk-in-secondary-prevention-only-when-ldl-cholesterol-is-elev/2026-08-18monthly0.6 https://lp-a.org/2013/10/03/lp-a-above-73-mg-dl-predicts-future-heart-attacks-in-patients-with-stable-coronary-disease/2026-08-18monthly0.6 https://lp-a.org/2013/08/21/niacin-lowers-lp-a-by-21-but-does-not-reduce-cardiovascular-events-the-aim-high-trial-anal/2026-08-18monthly0.6 https://lp-a.org/2013/07/24/amg145-evolocumab-cuts-lp-a-by-up-to-32-in-statin-treated-patients-the-laplace-timi-57-pha/2026-08-18monthly0.6 https://lp-a.org/2013/07/04/oxidized-phospholipids-bind-apo-a-via-a-specific-kringle-site-unique-to-humans-explaining-/2026-08-18monthly0.6 https://lp-a.org/2013/06/29/scavenger-receptor-sr-bi-is-identified-as-a-novel-lp-a-clearance-receptor-a-mechanistic-st/2026-08-18monthly0.6 https://lp-a.org/2013/06/04/new-drugs-like-apob-antisense-mtp-and-cetp-inhibitors-could-finally-test-whether-lowering-/2026-08-18monthly0.6 https://lp-a.org/2013/05/10/lp-a-carries-the-inflammatory-chemokine-mcp-1-in-human-plasma-via-oxidized-phospholipids-a/2026-08-18monthly0.6 https://lp-a.org/2013/02/07/lpa-is-the-genome-wide-signal-for-aortic-valve-calcification-and-stenosis-thanassoulis-et-/2026-08-17monthly0.6 https://lp-a.org/2013/01/30/extreme-lp-a-or-its-gene-variants-correctly-reclassify-up-to-23-of-heart-attack-risk-predi/2026-08-18monthly0.6 https://lp-a.org/2013/01/21/elevated-lp-a-predicts-stent-restenosis-especially-in-asian-patients-a-meta-analysis-of-9-/2026-08-18monthly0.6 https://lp-a.org/2013/01/01/lipoprotein-a-resurrected-by-genetics-kronenberg-and-utermann-j-intern-med-2013/2026-08-17monthly0.6 https://lp-a.org/2012/11/29/hiv-disease-control-raises-apo-a-levels-tied-to-atherogenic-small-isoforms-a-study-of-139-/2026-08-18monthly0.6 https://lp-a.org/2012/10/11/lp-a-predicts-peripheral-artery-disease-and-coronary-disease-but-not-stroke-the-epic-norfo/2026-08-18monthly0.6 https://lp-a.org/2012/10/05/lp-a-assembles-inside-the-cell-from-newly-made-ldl-and-apo-a-a-stable-isotope-kinetic-stud/2026-08-18monthly0.6 https://lp-a.org/2012/08/21/lp-a-above-25-mg-dl-affects-30-of-caucasians-and-up-to-70-of-black-people-a-rationale-for-/2026-08-18monthly0.6 https://lp-a.org/2012/04/19/lp-a-genetically-drives-atherosclerotic-narrowing-but-not-venous-blood-clots-a-mendelian-r/2026-08-18monthly0.6 https://lp-a.org/2012/02/17/lp-a-rises-stepwise-with-coronary-vessel-disease-and-abdominal-but-not-thoracic-aortic-pla/2026-08-18monthly0.6 https://lp-a.org/2012/01/17/lp-a-predicts-cardiovascular-events-in-black-and-white-adults-alike-aric-virani-et-al-circ/2026-08-17monthly0.6 https://lp-a.org/2012/01/01/two-common-lp-a-assays-disagree-on-classification-for-23-of-patients-a-study-of-144-patien/2026-08-18monthly0.6 https://lp-a.org/2012/01/01/thyroid-hormone-replacement-kept-lowering-a-hypothyroid-patient-s-lp-a-for-over-a-year-a-c/2026-08-18monthly0.6 https://lp-a.org/2011/12/03/ldl-apheresis-halted-coronary-disease-progression-in-a-50-year-old-with-refractory-angina-/2026-08-18monthly0.6 https://lp-a.org/2011/09/13/lp-a-particle-behavior-shifts-dramatically-with-high-triglycerides-correlating-mainly-with/2026-08-18monthly0.6 https://lp-a.org/2011/09/13/lp-a-does-not-predict-early-carotid-thickening-suggesting-a-thrombotic-rather-than-atherog/2026-08-18monthly0.6 https://lp-a.org/2011/09/06/in-people-with-type-2-diabetes-genetically-high-lp-a-does-not-raise-cardiovascular-risk-un/2026-08-18monthly0.6 https://lp-a.org/2011/06/21/84-of-high-lp-a-patients-in-a-lipid-clinic-were-not-on-niacin-despite-meeting-treatment-cr/2026-08-18monthly0.6 https://lp-a.org/2011/06/12/high-lp-a-independently-predicts-polyvascular-disease-in-patients-undergoing-bypass-surger/2026-08-18monthly0.6 https://lp-a.org/2011/04/12/the-first-antisense-drug-targeting-apo-a-cuts-lp-a-by-up-to-25-and-oxidized-phospholipids-/2026-08-18monthly0.6 https://lp-a.org/2011/04/07/lp-a-doubles-coronary-disease-risk-in-men-but-not-women-with-apo-a-isoform-size-adding-no-/2026-08-18monthly0.6 https://lp-a.org/2011/03/03/lp-a-is-higher-in-familial-hypercholesterolaemia-patients-who-develop-early-heart-disease-/2026-08-18monthly0.6 https://lp-a.org/2011/01/21/oxidized-lp-a-appears-early-in-endothelial-cells-while-native-lp-a-marks-later-fibrin-depo/2026-08-18monthly0.6 https://lp-a.org/2010/12/01/lp-a-as-a-cardiovascular-risk-factor-the-first-eas-consensus-panel-nordestgaard-et-al-ehj-/2026-08-17monthly0.6 https://lp-a.org/2010/09/14/oxidized-phospholipids-potentiate-lp-a-coronary-risk-two-fold-when-combined-with-high-phos/2026-08-18monthly0.6 https://lp-a.org/2010/08/16/a-low-fat-high-carbohydrate-diet-raises-lp-a-alongside-oxidized-phospholipids-and-smaller-/2026-08-18monthly0.6 https://lp-a.org/2010/07/16/the-highest-lp-a-quartile-raises-the-risk-of-combined-intracranial-and-extracranial-artery/2026-08-18monthly0.6 https://lp-a.org/2010/07/02/lp-a-predicts-coronary-revascularization-need-only-when-ldl-cholesterol-is-above-70-mg-dl-/2026-08-18monthly0.6 https://lp-a.org/2010/06/28/lp-a-triples-atherosclerotic-plaque-area-in-uremic-mice-a-transgenic-mouse-study-of-kidney/2026-08-18monthly0.6 https://lp-a.org/2010/01/11/genetic-studies-support-lp-a-as-a-cause-of-ischemic-heart-disease-though-no-outcome-trial-/2026-08-18monthly0.6 https://lp-a.org/2009/12/24/lpa-variants-raise-lp-a-and-coronary-risk-the-procardis-gene-chip-study-clarke-et-al-nejm-/2026-08-17monthly0.6 https://lp-a.org/2009/11/10/lp-a-above-300-mg-l-more-than-doubles-the-risk-of-retinal-vein-occlusion-an-italian-case-c/2026-08-18monthly0.6 https://lp-a.org/2009/10/30/a-new-chromatography-method-for-measuring-lp-a-cholesterol-correlates-strongly-with-standa/2026-08-18monthly0.6 https://lp-a.org/2009/07/22/lp-a-and-the-risk-of-chd-stroke-and-non-vascular-mortality-the-emerging-risk-factors-colla/2026-08-17monthly0.6 https://lp-a.org/2009/06/10/genetically-elevated-lp-a-causes-myocardial-infarction-the-copenhagen-mendelian-randomisat/2026-08-17monthly0.6 https://lp-a.org/2009/01/05/a-genome-wide-study-finds-at-least-6-genes-beyond-lpa-that-independently-affect-lp-a-level/2026-08-18monthly0.6 https://lp-a.org/2008/12/19/adding-a-specific-phospholipid-to-ldl-blocks-lp-a-assembly-and-transiently-lowers-lp-a-by-/2026-08-18monthly0.6 https://lp-a.org/2008/12/05/a-rapid-qpcr-method-replaces-laborious-electrophoresis-for-counting-lp-a-gene-repeats-a-me/2026-08-18monthly0.6 https://lp-a.org/2008/07/28/mipomersen-cuts-lp-a-by-about-75-in-transgenic-mice-an-early-study-establishing-the-antise/2026-08-18monthly0.6 https://lp-a.org/2008/07/26/an-apo-a-gene-variant-doubles-cardiovascular-risk-in-women-but-aspirin-cuts-that-risk-more/2026-08-18monthly0.6 https://lp-a.org/2008/07/08/hormone-replacement-therapy-erases-lp-a-ability-to-predict-cardiovascular-risk-in-women-a-/2026-08-18monthly0.6 https://lp-a.org/2008/07/03/lp-a-predicts-carotid-stenosis-and-occlusion-but-not-total-plaque-area-suggesting-a-thromb/2026-08-18monthly0.6 https://lp-a.org/2008/07/01/lp-a-carries-over-85-of-oxidized-phospholipids-in-human-plasma-a-foundational-mechanistic-/2026-08-18monthly0.6 https://lp-a.org/2007/12/17/extreme-lp-a-predicts-a-3-to-4-fold-higher-heart-attack-risk-with-absolute-10-year-risk-up/2026-08-18monthly0.6 https://lp-a.org/2007/07/12/lp-a-carries-an-enzyme-that-degrades-oxidized-phospholipids-a-review-of-lipoprotein-associ/2026-08-18monthly0.6 https://lp-a.org/2007/07/02/eating-fish-and-a-specific-lpa-gene-variant-together-lower-lp-a-levels-an-italian-study-of/2026-08-18monthly0.6 https://lp-a.org/2007/05/31/oxidized-phospholipids-on-lp-a-predict-10-year-cardiovascular-events-amplified-by-a-relate/2026-08-18monthly0.6 https://lp-a.org/2006/09/20/only-extremely-high-lp-a-above-the-90th-percentile-raises-cardiovascular-risk-in-women-the/2026-08-18monthly0.6 https://lp-a.org/2006/07/14/lp-a-correlates-with-the-framingham-risk-score-in-a-brazilian-cohort-of-400-people-the-our/2026-08-18monthly0.6 https://lp-a.org/2006/07/12/lp-a-not-fibrinogen-independently-predicts-coronary-plaque-progression-on-serial-imaging-a/2026-08-18monthly0.6 https://lp-a.org/2006/02/21/elevated-lp-a-does-not-thicken-carotid-arteries-in-healthy-young-adults-a-study-of-151-vol/2026-08-18monthly0.6 https://lp-a.org/2005/12/27/adding-l-carnitine-to-simvastatin-lowers-lp-a-in-type-2-diabetes-while-simvastatin-alone-r/2026-08-18monthly0.6 https://lp-a.org/2005/09/28/lp-a-more-than-triples-ischemic-stroke-risk-in-the-elderly-a-greek-case-control-study-of-1/2026-08-18monthly0.6 https://lp-a.org/2005/09/08/the-liver-clears-lp-a-mainly-via-apo-a-itself-not-the-ldl-receptor-taking-up-34-6-of-the-d/2026-08-18monthly0.6 https://lp-a.org/2005/04/11/lp-a-above-30-mg-dl-doubles-coronary-disease-risk-in-women-tripling-when-combined-with-hig/2026-08-18monthly0.6 https://lp-a.org/2005/03/21/despite-2-3-times-higher-lp-a-black-adults-show-no-link-between-lp-a-and-coronary-calcium-/2026-08-18monthly0.6 https://lp-a.org/2005/01/26/lp-a-predicts-cardiovascular-events-but-not-cognitive-decline-in-the-elderly-the-prosper-s/2026-08-18monthly0.6 https://lp-a.org/2005/01/16/a-new-mouse-model-reaches-lp-a-levels-of-700-mg-dl-over-20-times-the-human-risk-threshold-/2026-08-18monthly0.6 https://lp-a.org/2004/12/08/high-lp-a-blunts-insulin-enhanced-coronary-blood-flow-in-young-healthy-men-a-pet-imaging-s/2026-08-18monthly0.6 https://lp-a.org/2004/09/16/a-synthetic-peptide-s-arginine-swap-cuts-the-dose-needed-to-block-lp-a-assembly-eight-fold/2026-08-18monthly0.6 https://lp-a.org/2004/09/02/apo-a-protein-size-ranges-from-300-to-800-kda-driving-lp-a-extreme-variability-a-review-of/2026-08-18monthly0.6 https://lp-a.org/2004/06/07/angioplasty-acutely-raises-lp-a-by-64-and-oxidized-phospholipids-by-36-a-mechanistic-study/2026-08-18monthly0.6 https://lp-a.org/2004/05/19/lp-a-impairs-blood-vessel-function-most-strongly-in-african-americans-who-have-nearly-4-ti/2026-08-18monthly0.6 https://lp-a.org/2004/01/22/a-low-fat-diet-raises-lp-a-by-up-to-9-and-oxidized-ldl-by-up-to-27-a-dietary-trial-of-37-w/2026-08-18monthly0.6 https://lp-a.org/2004/01/01/diet-and-exercise-raise-lp-a-by-20-in-obese-african-americans-while-statins-push-it-up-30-/2026-08-18monthly0.6 https://lp-a.org/2003/09/16/swapping-four-lysines-for-serines-in-apob-impairs-lp-a-assembly-in-transgenic-mice-a-struc/2026-08-18monthly0.6 https://lp-a.org/2003/05/01/no-single-gene-explains-why-african-americans-have-higher-lp-a-a-genetic-linkage-study-acr/2026-08-18monthly0.6 https://lp-a.org/2003/02/11/a-specific-lpa-gene-haplotype-raises-heart-attack-risk-in-women-independent-of-lp-a-level-/2026-08-18monthly0.6 https://lp-a.org/2003/01/09/a-synthetic-apob-peptide-blocks-lp-a-assembly-far-more-effectively-than-a-standard-lysine-/2026-08-18monthly0.6 https://lp-a.org/2003/01/01/high-lp-a-combined-with-chronic-chlamydia-infection-may-worsen-aortic-valve-stenosis-a-swe/2026-08-18monthly0.6 https://lp-a.org/2002/10/16/high-crp-or-lp-a-but-not-homocysteine-predict-adverse-events-after-coronary-stenting-a-stu/2026-08-18monthly0.6 https://lp-a.org/2002/10/01/atorvastatin-lowers-lp-a-more-than-simvastatin-but-neither-affects-apo-a-fragments-a-doubl/2026-08-18monthly0.6 https://lp-a.org/2002/09/10/full-dose-almonds-lower-lp-a-by-7-8-alongside-oxidized-ldl-a-crossover-trial-of-27-people-/2026-08-18monthly0.6 https://lp-a.org/2002/08/01/adjusting-the-friedewald-ldl-formula-for-lp-a-does-not-improve-heart-disease-risk-predicti/2026-08-18monthly0.6 https://lp-a.org/2002/08/01/lp-a-raises-heart-disease-risk-especially-in-men-with-high-ldl-cholesterol-the-prime-study/2026-08-18monthly0.6 https://lp-a.org/2002/03/26/high-lp-a-impairs-new-blood-vessel-growth-after-limb-ischemia-but-a-growth-factor-gene-the/2026-08-18monthly0.6 https://lp-a.org/2002/02/01/soy-protein-doubles-lp-a-but-alcohol-extracting-it-eliminates-the-effect-a-crossover-trial/2026-08-18monthly0.6 https://lp-a.org/2001/12/01/anabolic-steroids-lower-lp-a-while-testosterone-suppression-raises-it-a-study-of-26-men-at/2026-08-18monthly0.6 https://lp-a.org/2001/10/01/elevated-lp-a-does-not-predict-restenosis-or-cardiac-events-after-coronary-angioplasty-a-f/2026-08-18monthly0.6 https://lp-a.org/1963/01/01/berg-describes-the-lp-system-the-first-report-of-lipoprotein-a-1963/2026-08-17monthly0.6 https://lp-a.org/trials/move-lpa/2026-08-17monthly0.7 https://lp-a.org/trials/acclaim-lpa/2026-08-17monthly0.7 https://lp-a.org/trials/oceana-outcomes/2026-08-17monthly0.7 https://lp-a.org/trials/alpacar/2026-08-17monthly0.7 https://lp-a.org/trials/kraken/2026-08-17monthly0.7 https://lp-a.org/trials/alpaca/2026-08-17monthly0.7 https://lp-a.org/trials/lpa-frontiers-apheresis/2026-08-17monthly0.7 https://lp-a.org/trials/oceana-dose/2026-08-17monthly0.7 https://lp-a.org/trials/lpa-horizon/2026-08-17monthly0.7 https://lp-a.org/trials/pelacarsen-phase-2/2026-08-17monthly0.7 https://lp-a.org/agents/obicetrapib/2026-08-17monthly0.7 https://lp-a.org/agents/muvalaplin/2026-08-17monthly0.7 https://lp-a.org/agents/lepodisiran/2026-08-17monthly0.7 https://lp-a.org/agents/olpasiran/2026-08-17monthly0.7 https://lp-a.org/agents/zerlasiran/2026-08-17monthly0.7 https://lp-a.org/agents/pelacarsen/2026-08-17monthly0.7 https://lp-a.org/agents/pcsk9-inhibitors/2026-08-17monthly0.7 https://lp-a.org/agents/lipoprotein-apheresis/2026-08-17monthly0.7 https://lp-a.org/guidelines/acc-aha-2026-dyslipidemia/2026-08-17monthly0.7 https://lp-a.org/guidelines/esc-eas-2025-focused-update/2026-08-17monthly0.7 https://lp-a.org/guidelines/brussels-declaration-2025/2026-08-17monthly0.7 https://lp-a.org/guidelines/nla-2024-focused-update/2026-08-17monthly0.7 https://lp-a.org/guidelines/eas-2022-lpa-consensus/2026-08-17monthly0.7 https://lp-a.org/guidelines/aha-2022-scientific-statement/2026-08-17monthly0.7 https://lp-a.org/guidelines/ccs-2021-dyslipidemia/2026-08-17monthly0.7 https://lp-a.org/guidelines/heart-uk-2019-consensus/2026-08-17monthly0.7 https://lp-a.org/guidelines/esc-eas-2019-dyslipidaemia/2026-08-17monthly0.7 https://lp-a.org/guidelines/eas-2010-consensus/2026-08-17monthly0.7 https://lp-a.org/video/2026-acc-aha-dyslipidemia-guideline-top-10-cho/2026-08-17monthly0.7 https://lp-a.org/video/2025-esc-eas-focused-update-key-changes-delgado/2026-08-17monthly0.7 https://lp-a.org/video/new-horizons-dyslipidaemia-2026-lpa-session/2026-08-17monthly0.7 https://lp-a.org/video/aha-2025-odonoghue-lpa-ascvd-causal-evidence/2026-08-17monthly0.7 https://lp-a.org/video/esc-2025-dyslipidaemia-focused-update-discussion/2026-08-17monthly0.7 https://lp-a.org/video/esc-2025-lipoascreen-cascade-screening/2026-08-17monthly0.7 https://lp-a.org/video/acc-2025-alpaca-lepodisiran-540-days/2026-08-17monthly0.7 https://lp-a.org/video/aha-2024-kraken-muvalaplin-oral/2026-08-17monthly0.7 https://lp-a.org/video/aha-2024-alpacar-zerlasiran/2026-08-17monthly0.7 https://lp-a.org/video/aha-2023-lepodisiran-phase-1-cardionerds/2026-08-17monthly0.7 https://lp-a.org/video/aha-2022-oceana-dose-olpasiran/2026-08-17monthly0.7 https://lp-a.org/video/acc-2022-apollo-sln360-zerlasiran/2026-08-17monthly0.7 https://lp-a.org/podcasts/parallax-ep-78-your-guide-to-lpa-virani/2026-08-17monthly0.7 https://lp-a.org/faq/2026-08-17monthly0.7 https://lp-a.org/methods/2026-08-17monthly0.7 https://lp-a.org/about/2026-08-17monthly0.7 https://lp-a.org/topics/acc-2022/2026-08-17weekly0.5 https://lp-a.org/topics/acc-2025/2026-08-17weekly0.5 https://lp-a.org/topics/acc-aha-2026/2026-08-17weekly0.5 https://lp-a.org/topics/aha-2022/2026-08-17weekly0.5 https://lp-a.org/topics/aha-2023/2026-08-17weekly0.5 https://lp-a.org/topics/aha-2024/2026-08-17weekly0.5 https://lp-a.org/topics/aha-2025/2026-08-17weekly0.5 https://lp-a.org/topics/aha-2026/2026-08-17weekly0.5 https://lp-a.org/topics/alpaca/2026-08-17weekly0.5 https://lp-a.org/topics/alpacar/2026-08-17weekly0.5 https://lp-a.org/topics/ancestry/2026-08-18weekly0.5 https://lp-a.org/topics/antisense/2026-08-17weekly0.5 https://lp-a.org/topics/aortic-stenosis/2026-08-18weekly0.5 https://lp-a.org/topics/apheresis/2026-08-18weekly0.5 https://lp-a.org/topics/apollo/2026-08-17weekly0.5 https://lp-a.org/topics/canada/2026-08-17weekly0.5 https://lp-a.org/topics/cascade-screening/2026-08-18weekly0.5 https://lp-a.org/topics/cetp/2026-08-18weekly0.5 https://lp-a.org/topics/children/2026-08-18weekly0.5 https://lp-a.org/topics/congress/2026-08-17weekly0.5 https://lp-a.org/topics/consensus/2026-08-18weekly0.5 https://lp-a.org/topics/dementia/2026-08-17weekly0.5 https://lp-a.org/topics/diabetes/2026-08-18weekly0.5 https://lp-a.org/topics/dutch/2026-08-18weekly0.5 https://lp-a.org/topics/education/2026-08-18weekly0.5 https://lp-a.org/topics/epidemiology/2026-08-18weekly0.5 https://lp-a.org/topics/esc-2025/2026-08-17weekly0.5 https://lp-a.org/topics/esc-2026/2026-08-17weekly0.5 https://lp-a.org/topics/esc-eas-2025/2026-08-17weekly0.5 https://lp-a.org/topics/europe/2026-08-17weekly0.5 https://lp-a.org/topics/familial-hypercholesterolaemia/2026-08-18weekly0.5 https://lp-a.org/topics/genetics/2026-08-18weekly0.5 https://lp-a.org/topics/guidelines/2026-08-18weekly0.5 https://lp-a.org/topics/heart-failure/2026-08-18weekly0.5 https://lp-a.org/topics/history/2026-08-18weekly0.5 https://lp-a.org/topics/inflammation/2026-08-18weekly0.5 https://lp-a.org/topics/kraken/2026-08-17weekly0.5 https://lp-a.org/topics/lepodisiran/2026-08-17weekly0.5 https://lp-a.org/topics/mechanisms/2026-08-18weekly0.5 https://lp-a.org/topics/muvalaplin/2026-08-18weekly0.5 https://lp-a.org/topics/new-horizons-2026/2026-08-17weekly0.5 https://lp-a.org/topics/oceana-dose/2026-08-17weekly0.5 https://lp-a.org/topics/olpasiran/2026-08-18weekly0.5 https://lp-a.org/topics/oral/2026-08-17weekly0.5 https://lp-a.org/topics/outcomes/2026-08-17weekly0.5 https://lp-a.org/topics/parallax/2026-08-17weekly0.5 https://lp-a.org/topics/pcsk9/2026-08-18weekly0.5 https://lp-a.org/topics/pelacarsen/2026-08-18weekly0.5 https://lp-a.org/topics/phase-1/2026-08-18weekly0.5 https://lp-a.org/topics/phase-2/2026-08-18weekly0.5 https://lp-a.org/topics/phase-3/2026-08-18weekly0.5 https://lp-a.org/topics/plaque-imaging/2026-08-18weekly0.5 https://lp-a.org/topics/policy/2026-08-17weekly0.5 https://lp-a.org/topics/primary-prevention/2026-08-17weekly0.5 https://lp-a.org/topics/readout/2026-08-17weekly0.5 https://lp-a.org/topics/regulatory/2026-08-17weekly0.5 https://lp-a.org/topics/risk/2026-08-17weekly0.5 https://lp-a.org/topics/risk-prediction/2026-08-18weekly0.5 https://lp-a.org/topics/rna-therapeutics/2026-08-18weekly0.5 https://lp-a.org/topics/screening/2026-08-17weekly0.5 https://lp-a.org/topics/secondary-prevention/2026-08-17weekly0.5 https://lp-a.org/topics/sirna/2026-08-17weekly0.5 https://lp-a.org/topics/small-molecule/2026-08-17weekly0.5 https://lp-a.org/topics/statins/2026-08-18weekly0.5 https://lp-a.org/topics/stroke/2026-08-18weekly0.5 https://lp-a.org/topics/testing/2026-08-18weekly0.5 https://lp-a.org/topics/therapy/2026-08-18weekly0.5 https://lp-a.org/topics/thrombosis/2026-08-18weekly0.5 https://lp-a.org/topics/trials/2026-08-18weekly0.5 https://lp-a.org/topics/united-kingdom/2026-08-17weekly0.5 https://lp-a.org/topics/united-states/2026-08-17weekly0.5 https://lp-a.org/topics/women/2026-08-18weekly0.5 https://lp-a.org/topics/zerlasiran/2026-08-17weekly0.5